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Dietary! carbohydrates! are! hydrolyzed! in! the! small! intestine! ultimately,! by!
the! brushIborder! membrane! disaccharidases! (sucrase,! maltase! and! lactase)! into!
monosaccharides:! DIglucose,! DIgalactose! and! DIfructose.! DIglucose! and! DI
galactose! are! transported! across! the! brush! border! membrane! (BBM)! from! the!
intestinal! lumen! into! enterocytes! by! the! Na+I! dependent! glucose! transporter! 1,!
SGLT1,!while!DIfructose!is!transported!by!GLUT5.!These!monosaccharides,!exit!the!
cell! across! the!basoIlateral!membrane! (BLM)! into! the! systemic! circulation! via! the!
facilitated! monosaccharide! transporter,! GLUT2.! SGLT1! regulation! is! vital! for! the!
provision! of! glucose! to! the! body! and! for! maintaining! glucose! homoeostasis.! The!
expression!and!activity!of!SGLT1!are!adaptively!regulated!by!dietary!sugars!in!most!
species! studied.! The! intestinal! capacity! to! absorb! glucose! is!maintained! via! basal!









evoking! secretion!of! vasoactive! intestinal!peptide! (VIP)!and/or!Pituitary!adenylate!
cyclaseIactivating! polypeptide! (PACAP)! by! subImucosal! plexus.! ! Binding! of!
VIP/PACAP! to! their! receptor! VPAC1! (VIP! and! PACAP! receptor! type! 1)! on! the!
basolateral!membrane!of!absorptive!enterocytes! leads! to! increased!concentration!
of!intracellular! cAMP! which! in! turn! enhances! the! halfIlife! of! SGLT1! mRNA,!
increasing!the!number!of!SGLT1!proteins!per!enterocytes.!!!!
!




The!work! in! this! thesis!was!aimed!at! identify!molecular!basis!of!enhanced!
SGLT1! expression! in! the! diabetic! intestine! using! intestinal! tissues! from! rats! with!







and!SGLT1!mRNA!expression!was! increased!by!3Ifold!compared!to! that! in!healthy!
individuals.!SGLT1!protein!was!expressed!on!the!BBM!of!enterocytes!on!the!entire!
villus! in! the! duodenum! of! both! diabetics! and! healthy! subjects,! with! relatively!
stronger!staining!on!the!BBM!lining!the!villi!of!the!diabetic! intestine.!However,!no!
expression! was! observed! in! the! crypts.! The! experimental! data! support! that! the!
enhanced! SGLT1! expression! and! glucose! absorption! in! the! intestine! of! diabetic!
humans!with! nonIinsulin! dependent! diabetes! mellitus! (NIDDM)! is! attributable! to!
more! enterocytes! expressing! SGLT1,! but!mostly! due! to! a! specific! increase! in! the!
number!of!SGLT1!protein!per!each!enterocyte.!
!
The! changes! in! body! and! small! intestinal! parameters! brought! about! by!
diabetes!were!assessed! in!streptozotocinIinduced!diabetic! rats.!They!had!a! loss! in!
body!weight,!while! showed! an! increase! in! the! small! intestinal!weight! and! length!
compared! to! that! in! control! rats.! Intestinal! villi! were! longer! in! the! diabetic! rats!
compared!to!that!in!controls.!This!was!accompanied!by!higher!activities!of!intestinal!
BBM!enzymes!(maltase,!sucrase!and!alkaline!phosphatase)!compared!to!that!in!the!




transport! studies,! western! blot! analysis,! quantitative! RTIPCR! and!








The! basolateral! membrane! monosaccharide! transporter,! GLUT2! was!
exclusively!expressed!on!the!BLM!of!enterocytes!in!the!intestine!of!both!control!and!
diabetic! rats.! GLUT2! protein! was! absent! in! BBMV! isolated! from! the! intestine! of!
control!and!diabetic!rats!rejecting!the!controversial!proposition!that!GLUT2!protein!
is!trafficked!to!the!BBM!in!the!diabetic!intestine.!The!data!however,!demonstrated!
the! exclusive! role! of! GLUT2! in! glucose! transport! across! the! BLM.! GLUT2! mRNA!
expression!was!significantly!elevated! in! the! intestine!of!diabetic! rats!compared! to!




The! magnitude! of! changes! in! the! villus! length! and! the! activity! of! BBM!








were! investigated,! whenever! possible! in! human! and! rat! intestinal! tissues.! In! the!
diabetic! intestine,! the! intestinal! glucose! sensor,! T1R2IT1R3!was! expressed! in! the!
enteroendocrine!cells,!with!no!change!in!the!expression!pattern!at!either!mRNA!or!
protein! levels.! The! proIglucagon! gene,! encoding! for! gut! hormones! GLPI1! and! I2,!
was! also! unchanged,! as! well! as! the! expression! of! the! receptor! for! GLPI2! on! the!
enteric!neurons.!However,!GLPI2!secretion!was!significantly!higher!in!the!intestine!
of!diabetic! rats,! and!was! independent!of! the! concentration!of! luminal! glucose.! In!
the!diabetic! intestine!of!both!humans!and! rats! there!were! significant! increases! in!
























For! healthy! living! of! all! organisms,! oxygen! and! nutrition! are! the! basic!
requisites! for! growth! and! function.! What! we! consume! from! the! natural! dietary!




like! fatty! acids,! amino! acids,! purine! and! pyrimidine! bases! have! structural! roles,!
while!minerals!and!vitamins!are!needed! in!minute!amounts.! For! the!utilization!of!
these! ingested! dietary! components,! the! digestive! system! transfers! the! food! into!






! The! digestive! system! is! composed! of! two! groups! of! organs:! the!
gastrointestinal!tract!(GIT)!and!the!accessory!organs.!The!GIT,!or!alimentary!canal,!is!
a! tube! consists!of! connected!hollow!organs!extending! from! the!oral! cavity! to! the!
anus.!The!GIT!includes:!mouth,!pharynx,!oesophagus,!stomach,!small!intestine!and!
large! intestine! ending! at! the! anal! canal.! These! structures! have! overlapping!
functions,!but!each!region!has!distinctive!histological!characteristics!for!specialized!






the! tongue! manipulates! food! for! mastication! before! swallowing! and! its! upper!
surface! is! covered! by! the! sensory! taste! buds.! The! salivary! glands! produce! saliva,!
which!lubricates!the!mouth!and!secrete!salivary!amylase,!which!mixed!with!food!to!
start! the! digestion! of! carbohydrates.! Food!bolus! passes! through! the! pharynx! and!
esophagus! to! reach! the! stomach,!which! further!mixes!and!grinds! food!along!with!
some! food! digestion! by! pepsin! and! hydrochloric! acid.! The! stomach! releases! the!








9! metres! in! adult! human! cadaver,! but! it! is! shorter! in! living! human! due! to! the!
smooth!muscular!tone.!It!extends!from!the!pylorus!of!the!stomach!to!the!ileocaecal!
valve! and! subdivided! into! three! structural! segments:! duodenum,! jejunum! and!




luminal! contents! are!mixed!with! the! pancreatic! juice,! bile! and!mucosal! digestive!
enzymes.!The!mechanical!peristalsis!moves!the!content!through!the!small!intestinal!
length!toward!the!large!intestine.!)
D The! duodenum! constitutes! the! proximal! 25D30! cm! that! is! the! widest! and!
shortest! region! of! the! SI! occupied! between! the! pylorus! to! the! ligament! of!
Treitz.!Mucus! secreting!glands! (Brunner’s! glands)! are!exclusively! found! in! the!
duodenum!to!facilitate!the!mechanical!breakdown!of!nutrients.!!Anatomically,!






membrane! folding! (Plicae' circularis,! or! valves! of! Kerckring),! which! becomes!
smaller!and! less!numerous!distally! in! the!small! intestine!and! totally!absent! in!
the!distal!ileum!(Ross!et'al.,!2003).!
D The! ileum! is! twoDtoDthree!meters! long! of! freely!mobile! coils! attached! to! the!






canal! is!basically!composed!of! fourDlayered!tissues,!as!shown! in! figure!1.!They!are!
arranged! from! inner! to! outer! (deep! to! superficial)! surface:! mucosa,! submucosa,!














epithelium! layer! including! the! absorptive! enterocytes,! the! enteroendocrine!
cells!and!the!goblet!cells.!The!lamina!propria!is!loose!connective!tissue!contains!
blood!and!lymphatic!vessels!plus!the!mucus!and!a!thin!layer!of!smooth!muscles.!
It! also! contains! secretory! cells! of! the! Brunner’s! glands! in! the! duodenum! for!
moisturising!(Martini!et'al.,!2001),!and!the!mucosaDassociated!lymphatic!tissue!
(MALT)! cells,! which! has! a! role! in! protection! and! immunity! (Tortora! and!
Derrickson,! 2006).! The! muscularis! mucosa! is! a! thin! layer! of! smooth! muscle!
fibres! arranged! in! two! sheets:! innerDcircular! layer! (encircles! the! lumen)! and!
outerDlongitudinal! layer! (oriented! parallel! to! the! long! axis! of! the! GIT).! The!
contractions! of! those! muscles! alter! the! shape! of! the! lumen! and! move! the!
epithelial!folds.!!!
2. The! submucosa! is! a! dense! connective! tissue! layer! containing! blood! and!
lymphatic! vessels! plus! the! submucosal! neuronal! network! of! sensory! and!
autonomic!nerve!fibers!known!as!the!submucosal!Meissner’s!plexus!.!
3. The!muscularis!externa!are!two!sheets!of!smooth!muscle!layers:! innerDcircular!
and! outerDlongitudinal! muscles! fibres.! They! are! innervated! by! the! myenteric!
plexus! (Auerbach’s)! of! autonomic! nerves! to! perform! involuntary! contractions!
for! the!movement! of! the! luminal! contents! along! the! tract! toward! the! distal!
ileum.!!
4. The!serosa!is!the!outermost!thin!layer!of!serous!membrane!covering!the!whole!


















nutrient! absorption.! Each! villus! is! covered! by! epithelial! cells! and! has! a! core! of!
lamina! propria,! smooth! muscle! cells,! and! lacteal! lymphatic! and! blood! capillary!
networks.! These! villi! vary! in! their! length! and! shape! in! different! regions;! they! are!
leafDlike! in! the! duodenum,! while! they! are! larger! and! more! numerous! in! the!
jejunum.!Therefore,!the!absorptive!surface!area! is!much!greater! in!the!duodenum!
and! jejunum! than! the! ileum.! The! ileum! is! also! characterized! by! Peyer’s! patches,!
which! are! consisting!of! aggregated! lymphatic! nodules.! These!nodules! originate! in!
the! lymph!tissues!of! the! lamina!propria!and!reach!the!mucosal!surface!where!the!




The! intestinal! epithelium! is! capable! of! fast! repair! and! regeneration! to!
replace! the! damaged! cells! due! to! the! harsh! luminal! environment. Progenitor!
undifferentiated!stem!cells!in!the!intestinal!crypts!proliferate!and!differentiate!into!
subtypes! of! epithelial! cells! covering! the! villi.! The! four!main! cell! lineages! include:!




migrate!downward! to! the!crypt!base,!whereas,!other! cells!migrate!upward! to! the!
villus! tip!where! they!undergo!apoptosis!and!shed! into! the! lumen!of! the! intestine.!
This! leads!to!complete!cell!renewal!every!2D3!days! in!mice!(Ferraris!and!Diamond,!















! The! absorptive! cells! (enterocytes)! are! the! predominant! cell! type! of! the!
intestinal! mucosal! lining,! comprising! 90! %! of! the! total! epithelial! population.! The!
enterocytes! are! simple! columnar! cells! responsible! for! the! absorption! of! digested!
nutrients!and! ions! from!the!gut! lumen! into! the!bloodstream!(Cheng!and!Leblond,!
1974b).! Adjacent! enterocytes! are! firmly! oriented! and! closely! apposed! with! tight!
junctions,! where! the!membranes! actually! fuse! and! no! gaps! between! cells! at! the!
apical!part.!However,!membranes!appear!adjacent!or!separated!at!the!basal!side!of!
the! cells.! Figure! 3! shows! the! structure! of! the! enterocytes,! the! nucleus! and!Golgi!
apparatus!occupy!the!basal!part!of!the!cell,!while!the!rough!endoplasmic!reticulum!
and! the! lysosomes! are! in! the! apical! part.! The! cytoplasmic! membrane! of! the!
enterocyte! has! two! domains,! which! are! separated! by! tight! junctions:! the!
luminal/apical!and!the!basal!domains.!
The!brushDborder!membrane! (BBM)! is!on! the!apical! side!of! the!cell!having!
microvilli! on! its! surface! and! facing! the! intestinal! lumen.! While! the! basolateral!
membrane!(BLM)! is!on!the!serosal!and!lateral!sides!of!the!cell! facing!the!systemic!
circulation! (Madara! et' al.,! 1981).! The! BBM! exhibits! distinctive! packed! array! of!
microvilli,! each! about! 1! µm! in! high! and! 0.1D0.2! µm! in!width,!which! serve! a! huge!
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expanded! surface! area! for! intestinal! absorption.! The! microvilli! are! covered! by!
glycocalyx! and! stiffened! by! fibrils! bundle.! Enterocytes! contain! blood! vessels! and!
lacteal! lymphatic! capillary! inside,! and! enzymes! and! nutrient! transporters! are!
implemented! on! the! luminal! side! of! the! membrane.! The! low! fluidity! of! this!




These! membranes! have! different! thickness,! about! 1! or! 1.5! µm! thick,!
different!surface!charges!and!properties!that!facilitate!the!pure!isolation!of!brushD
border! and! basolateral! membrane! vesicles! (ShiraziDBeechey! et' al.,! 1990),! as!
discussed!in!a!later!section.!!!
!
About!300! cells! to!each!villus!per!day!are!newly!generated! from! the! stem!
cells!in!the!intestinal!crypt!(Wright,!2006).!These!cells!migrate!along!the!crypt/villus!
axis! to! reach! the! villus! tip! during! their! lifespan! for! continuous! turnover! of! the!
enterocyte!(Thomson!et'al.,!1994,!Cheng!and!Leblond,!1974b).!During!the!migration!
of! the! enterocyte,! it! undergoes! maturation! and! differentiation,! which! result! in!
































These! gobletDshaped! cells! are! glandular! simple! columnar! cells! having!
microvilli!on!their!apical!membrane!and!found!scattered!along!the!villi!between!the!
enterocytes.! They! secrete! glycoproteins,! known! as! mucins,! to! moisturize! the!
mucosal! epithelial! surface! and! to! protect! the! microvilli! from! abrasion.! They! are!




These! are! specialised! epithelial! cells! sparsely! distributed! along! the! villus!
between! the! enterocytes.! In! total,! they! form! the! largest! endocrine! organ! in! the!
body!although!they!only!represent!<!1%!of!the!intestinal!epithelium!(Sternini!et'al.,!
2008).! The! EECs! are! flask! shaped!with! a! prolonged! narrow! apical! domain! that! is!
directly! in! contact! with! the! luminal! contents.!More! than! twenty! subtypes! of! the!
EECs! have! been! identified! according! to! their! endocrine! secretions! ‘peptide!
hormones’! which! are! produced! in! response! to! the! changes! in! the! luminal!
components.! These! secretions! either! influence! neighbouring! enterocytes! or! exert!
effects! on! distant! tissues! or! activate! the! vagal! and! enteric! afferents! neurons! to!
control! the! gastrointestinal! physiological! functions! and! gutDbrain! sensing! for! the!
coordination!of!food!intake.!Some!of!these!hormones!act!distally!and!are!known!as!
incretins!that!promote!pancreatic!insulin!secretion!and!regulate!food!intake!(Cheng!




There! are! various! types! of! endocrine! cells,! for! examples:! KDcells,! IDcells,! LD
cells,!SDcells,!GDcells!and!others.!KDcells!are!predominantly!found!in!the!duodenum!
and! secrete! glucagonDdependent! insulinotrophic! peptide! (GIP).! LDcells! are! found!
scattered! throughout! the! small! and! large! intestine,! highly! numerous! in! the! distal!
ileum!and!colon!than!the!jejunum!and!duodenum!(Mortensen!et'al.,!2003,!Eissele!et'
al.,! 1992),! they! secrete! glucagonDlike! peptides! (GLPD1! and! GLPD2)! and! hormone!











These! are! pyramidalDshaped! cells! with! large! coarse! granules! pushing! the!
nucleus! toward! the! cell! base.! Paneth! cells! are! found! in! the! base! of! the! crypts!
throughout!the!intestine.!They!secrete!antimicrobial!substances!like!peptidases, αD









which! lies! within! the! submucosa,! and! the! myenteric! plexus,! which! is! located!
between!the! two!muscle!sheets!of! the!muscularis! layer! (Sasselli!et'al.,!2012).!The!
ENS!is!the!main!division!of!the!autonomic!nervous!system!that!governs!the!function!




water! and! electrolyte! transport,! and! regulates! the! immune! and! inflammatory!
processes!(Hansen,!2003).!
!
More! than!30! functional! types!of!enteric!neurons!are!present! that! secrete!
an!intimidating!array!of!about!25!different!neurotransmitters.!Most!neurons!utilize!
several! transmitters! and! neuromodulators! like! acetylcholine! and! norepinephrine,!
which!have!stimulatory!and!inhibitory!effects,!respectively,!on!the!gut!functions!and!
activity.! Others! include:! serotonin,! dopamine,! cholecystokinin,! substance! P,!







The' enteric' nervous' sysytem' includes' two'main' plexi.' An' inner' submucosal' plexus'
resides'within'the'submucosal'layer;'and'an'outer'myenteric'plexus'lies'between'the'






tissue! growth! and! repair! processes.! Carbohydrates! are! needed! for! body! energy!
storage! like! starch! and! glycogen;! provide! structural! support! like! cellulose! in! the!
plants! and! chitin! in! the! extraDskeleton! of! arthropods,! spiders,! fungi! and! yeast!
(Hamid!et'al.,!2013)!and!serve!as!a!blood!major!carbohydrate!energy! storage! like!
trehalose!in!the!insects!(Becker!et'al.,!1996).!To!obtain!the!benefit!of!nutrition,!the!




Dietary! carbohydrates! (CHO)! are! organic! compounds! also! known! as!
saccharides.! They! are! divided,! depending! on! the! backbone! number! of! sugar!
molecules,! into! monosaccharides,! disaccharides,! oligosaccharides! and!
polysaccharides.! Monosaccharides! naturally! exist! as! sugars:! glucose! in! honey,!
galactose! in! dairy! products! and! fructose! in! many! fruits.! ! Disaccharides! include:!
maltose,! sucrose! and! lactose.! Maltose! is! found! in! germinating! grain;! sucrose! is!
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present! in! sugar! beet,! table! sugar! and! sugar! cane,! while! lactose! is! the! main!
carbohydrate! in! human! and! other! mammalian! milk.! Polysaccharide! like! starch! is!
found! in! bread,! corn! and! potatoes,! while! the! cellulose! is! a! complex! indigestible!
plant!fibre.!!
Among! monosaccharides,! glucose! is! a! principle! metabolite! in! nutrition;! it!
forms!the!unit!component!of!all!the!other!short!and!long!chain!polysaccharides.!It’s!
chemical! formula! is! C6H12O6! that! is! mainly! abundant! as! natural! sugars! in! grape,!
honey,! starch! and! some! fruits.! Glucose! is! the! main! essential! carbohydrate!
metabolite,! especially! for! the! glucoseDdependent! tissues! like! the! brain! and! red!
blood!cells.!Hence,! it! is!required!for!normal!physiological!functions! in!all!the! living!




Digestion! is! the! mixing! of! food! with! enzymes! and! the! mechanical! and!
chemical! breakdown! of! the! nutrients! into! their! smallest! molecular! structures!
capable!of!being!absorbed.!In!the!mouth,!starch!digestion!begins!where!it!is!broken!
down! into! maltose! by! the! salivary! αDamylase! secreted! from! the! salivary! glands,!
although!its!action!is!inhibited!by!the!low!pH!in!the!stomach.!In!the!duodenum,!the!
presence! of! fats! and! proteins! evokes! the! release! of! cholecystokinin! (CCK)! that!
stimulates! the! release! of! pancreatic! αDamylase! to! breakdown! carbohydrates! by!
hydrolysing! αD1,4! linkages.! This! completes! the! digestion! process! of! starch! and!
oligosaccharides! into! disaccharides.! In! the! small! intestinal! lumen,!where! the! final!
stages!of!carbohydrate!digestion!occur,!disaccharides!are!further!hydrolysed!by!the!







intestinal! wall.! Intestinal! disaccharidases! are! synthesized! then! anchored! and!
expressed! on! the! brush! border! membrane! (BBM)! of! the! enterocytes,! therefore,!
they! are! considered! BBM! markers.! Disaccharidases! are! glycoside! hydrolases! ‘αD
glucosidases’! that! catalyse! disaccharides! into! the! simplest! sugar! form,!
monosaccharide,!to!be!absorbed!via!monosaccharide!transporters.!However,!higher!
disaccharidase! activities! have! been! reported! during! pregnancy! and! lactation! to!





glucoamylase! and! alphaD1,4Dglucosidase,! and! is! encoded! by! the! MGAM! gene!
located!on!chromosome!7!(Nichols!et'al.,!2003).!Maltase!is!synthesized!as!a!single!
polypeptide! chain! and! cleaved! postDtranslationally! by! pancreatic! proteases.! It! is!
predominantly! present! as! a! homodimeric! complex! that! is! anchored! by! the! NH2D
terminal!segment!to!the!brush!border!membrane!(Noren!et'al.,!1986).'!




a! slower! rate! (Sorensen! et' al.,! 1982).! Intestinal! maltase! also! hydrolyses!
polysaccharides.! The! activity! of! mucosal! maltaseDglucoamylase! and! mucosal!
sucraseDisomaltase! constitute! the! final! steps! of! small! intestinal! digestion! of! the!
linear! starch!oligosaccharides! to! glucose.! Thus,! these!enzymes!play! crucial! role! in!
starch! digestion! and! prandial! glucose! homeostasis! (QuezadaDCalvillo! et' al.,! 2007,!
Nichols!et'al.,!2009,!Nichols!et'al.,!2003).!
)
Sucrase) enzyme! (EC!3.2.1.48),! also! known!as! sucrose! alphaDglucosidase,! is!
encoded!by!the!SI'gene,!which!resides!on!chromosome!3q26!(Nichols!et'al.,!2003).!
SucraseDisomaltase! (SI)! is! synthesized! intracellularly! as! a! singleDchain! precursor!
protein! (proDsucraseDisomaltase)! that! undergoes! rapid! trimming! in! the! rough!
endoplasmic! reticulum,! then,! slowly! transported! to! the! Golgi! where! complex!
glycosylation!occurs.!Finally,!when!destined! for! the! luminal! side!of! the!microvillus!




ionic! interactions! (Naim!et'al.,! 1988).!Those! two!domains!of! the!enzyme!complex!





Lactase) enzyme! (EC! 3.2.1.23D62),! also! known! as!βDglycosidase! complex! or!
lactaseDphlorizin! hydrolase! (LPH),! is! a! member! of! the!βDgalactosidase! family! of!
enzymes.! It! is! present! predominantly! along! the! brush! border! membrane! of! the!
enterocytes!lining!the!small! intestinal!mucosa.! It!can!be!divided!into!five!domains:!
(i)! a! 19! amino! acid! cleaved! signal! sequence;! (ii)! a! large! proDdomain! that! is! not!
present! in! mature! lactase;! (iii)! the! mature! lactase! fragment;! (iv)! a! hydrophobic!
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(Mantei! et' al.,! 1988).!In! humans,! lactase! is! encoded! by! the! LCT! gene,! which! is!
localized!to!the!second!chromosome!2q21!(Harvey!et'al.,!1993).!!LPH!is!synthesized!
as! a! singleDchain! polypeptide! precursor,! preproDLPH,! that! is! cleaved! in! two!
sequential! steps:! firstly,!amino!acid!signal! sequence! is!cleaved! in! the!endoplasmic!
reticulum! resulting! in!proDLPH! (215DkDa),!which! is! sent! to! the!Golgi! apparatus! for!
terminal! glycosylation.! Secondly,! two! amino! acids! are! cleaved! by! the! luminal!
pancreatic!protease,! trypsin,! to! form!mature!LPH!(160DkDa).! It! is!anchored!via!the!
NH2Dterminal! segment! to! the! brush! border! membrane! and! oriented! with! an!




for! lactose! hydrolysis,! connected! to! GluD1749,! and! one! for! phlorizin! hydrolysis,!





Newborn! humans! have! high! levels! of! lactase! expression! that! is! downD
regulated!after!weaning!resulting!in!lower!lactase!expression!in!the!small!intestine.!
However,! lactase! deficiency! causes! the! common! symptoms! of! hypolactasia,! or!
lactose!intolerance.!Some!adults!exhibit!lactase!persistence!that!is!characterized!by!





Alkaline! phosphatase! (ALP)! (EC! 3.1.3.1)! is! a! hydrolase! enzyme! responsible!
for!the!dephosphorylation!(removing!phosphate!groups)!of!its!substrate!molecules!




The! intestinal! alkaline! phosphatase! (IAP)! is! anchored! to! the! brushDborder!
membrane! of! the! enterocytes! through! a! phosphatidylinositolglycan! attached!
covalently! to! the! CDterminal! amino! acid! (Engle! et' al.,! 1995).! IAP! has! a! crucial!
defense! function! in! the! gut! by! limiting! bacterial! transDepithelial! invasion! and!
detoxifying! luminal! bacterial! lipopolysaccharide! (LPS).! ALP! prevents! the! bacterial!
endotoxinDinduced! inflammation! by! dephosphorylating! and! detoxifying! the!




Vaishnava! and! Hooper,! 2007).! ALP! enzyme! has! also! a! role! in! regulating! the!
secretion! of! bicarbonate! and! adjusting! the! duodenal! pH.! It! maintains! intestinal!
homeostasis!and!monitors!the!absorption!of!lipids!across!the!luminal!membrane!of!
enterocytes.!Some!dietary!molecules! like! fat,!protein,!and!carbohydrate!modulate!








(BLM)! in! its! structure! and! composition! of! lipids! and! proteins.! ! The! BBM! has!








and! mixed! population! of! rightDsideDout! and! inside! out! vesicles! (BLM).! The! pure!


































































































to! isolate! separately!pure! cell!membranes,!which!overcame! the! limitations!of! the!
previously! used! methods.! The! technique! of! isolating! brush! border! membrane!
vesicles!(BBMV)!offers!experimental!benefits!over!the!use!of! isolated! intact!whole!
cells!or! tissues!as! the! latter! lose! their! functional!polarity!upon! isolation.!Hence,! it!
becomes!possible!to!validate!the!role!of!each!membrane!in!various!intraD!and!extraD
cellular! conditions! (Stevens! et' al.,! 1984,! Murer! and! Kinne,! 1980,! Hopfer! et' al.,!
1973).!The!most!important!advantages!of!membrane!vesicle!preparation!include:!!
!
1) Vesicles! are! almost! free! of! cellular! contamination! by! other! organelles,!
facilitating! the! studies! to! identify! the! structure! and! function! of! pure!
membranes.!!






4) Membrane! vesicles! can! be! stored! for! long! time! in! liquid! nitrogen! without!
detectable!loss!of!transport!activity,!also!short!incubation!time!can!be!enough!
for!the!measurement!of!substrate!uptake!(Berteloot!and!Semenza,!1990).!




paracellular! shunt,! which! interfere! with! the! results! of! transport! studies!
(Stevens!et'al.,!1984).!!
7) When!using!difficult!to!obtain!and!limited!human!biopsies!or!animal!samples,!
membrane! vesicles! reduce! the! number! of! experimental! animals! or! human!






In! this! study,! brush! borderDmembrane! vesicles! (BBMV)! and! postDnuclear!
membrane! fractions! (PNMF)! were! used.! The! method! of! selective! purification! of!
BBM! from! cellular! homogenates! of! intestinal! tissue! was! done! by! the! cation!










of! the! BLM! fragments.! By! differential! centrifugation,! the! intracellular! and!
basolateral! membranes! are! precipitated! and! separated! from! the! brush! border!
membranes.!!
!
Under! optimized! conditions! of! this! rapid,! simple! and! reliable! procedure,!
BBM!forms! tightly! sealed,!oriented! rightDsideDout!vesicles!with!a!diameter!of!100D
150! nm! (Hearn! et' al.,! 1981).! These! vesicles! separate! the! intravesicular! aqueous!
space! from! the! suspending! extravesicular!medium! and! are! impermeable! to! highD
molecular! weight! compounds.! Essentially! the! BBMV! are! stable,! pure! and! free! of!
contamination!by!basolateral,!cytosolic!and!mitochondrial!membranes.!In!studies!of!
Na+D!dependent!glucose!uptake! into!BBMV,!the! lipidDpermeable!anion!thiocyanate!




Previous! studies!have! confirmed! the! characterisation!and! the! integrity!of!
the! prepared! vesicles! by! several! independent! methods! like! DDglucose! uptake,!
electronDmicroscopic! technique! and! immunological! methods.! The! uptake! studies!
with!different!conditions!demonstrated!that!the!vesicles!retain!the!glucose!carrier!
system! in! a! sodiumDdependent! manner,! which! occurs! in! purified! brushDborder!








Food!passes! from!the!stomach!to! the!duodenum!and! is! then!moved!along!
the! small! intestine! by! peristalsis.! Absorption! is! the! transport! processes! of! the!
digested! nutrients! from! the! gut! lumen! into! the! bloodstream!across! the! intestinal!









The! transport! of! monosaccharide! (glucose,! galactose! and! fructose)! across!
the!lipid!bilayer!of!the!plasma!membrane!is!mediated!by!two!distinctive!groups:!the!
SGLT!family!(sodiumDdependent!glucose!transporters)!and!the!GLUT!family!(sodiumD
independent! glucose! transporters)! (Wood! and! Trayhurn,! 2003,! Scheepers! et' al.,!
2004).!!
!
! SGLT! family:! More! than! 450! members! of! this! gene! family! ! (sodiumD
dependent! glucose! transporters;! encoded! by! gene! SLC5A),! also! known! as! the!
sodium/substrate! symporter! family! (SSSF),! are! now! recognized! in! many! species.!
This!family!of!transporters!are!responsible!for!the!classical!model!of!active!nutrient!
transport,! energyDdependent,! against! their! concentration! gradient! and! with! coD
transportation!of!Na+!ions.!SGLT!family!members!are!expressed!in!different!tissues!
to!transport!specific!substrates!with!varying!affinities!(Turk!and!Wright,!1997).!They!




choline! transporter! (protein! SLC5A7)! (Michel! et' al.,! 2006,! Scheepers! et' al.,! 2004,!
Wood!and!Trayhurn,!2003).!!
 




• SGLT1!(encoded!by!gene!SLC5A1)! is!highly!expressed!in!the!small! intestine!for!





convoluted! tubules! of! the! kidney;! it! is! responsible! for! renal! glucose!
reabsorption! (Wright,! 2001,! Yang! et' al.,! 2010).! SGLT2! (encoded! by! gene!
SLC5A2)! is! located!on! chromosome!16,! close! to! the! centromere! (Wells!et'al.,!








laevis! oocytes,! acting! as! a! glucoseDgated! ion! channel! (DiezDSampedro! et' al.,!
2003).! It!coDlocalizes!with!the!acetylcholine!receptor! in!the!plasma!membrane!
of! cholinergic! neurons! at! the! neuromuscular! junction! and! is! abundant! in! the!
enteric!nervous!system.!It!is!expressed!in!the!skeletal!muscles,!small!intestine,!
kidney,! uterus! and! testes! (Kong! et' al.,! 1993,! DiezDSampedro! et' al.,! 2003). 
hSGLT3! (encoded! by! gene! SLC5A4)! composed! of! 659! amino! acids! with! 70%!
identity! to! the! human! SGLT1.! However,! a! single! amino! acid! mutation,!
substitution! of! glutamate! by! glutamine! at! position! 457,! shifts! this! SGLT3!
glucose!sensor!into!a!glucose!transporter!resembles!SGLT1,!as!in!pigs!where!it!is!
a! sodium/glucose! cotransporter! (Wright,! 2001,! Bianchi! and! DiezDSampedro,!
2010).!!
• SGLT4! (encoded! by! gene! SLC5A9)! is! the! low! affinity! glucose! and! mannose!
transporter.! It! is!expressed!mainly! in! the! small! intestine!and!kidney!playing!a!
role! in! the! absorption!and! reabsorption!of!mannose,! 1,5DAnhydroglucitol! and!
fructose!in!addition!to!the!glucose!and!galactose!(Tazawa!et'al.,!2005,!Koga!et'
al.,!2010).!!
• SGLT5! (encoded! by! gene! SLC5A10)! is! a! kidney! mannose! and! fructose!
transporter!that!is!exclusively!expressed!in!the!renal!brush!border!membrane,!
but!its!function!is!unknown!(Fukuzawa!et'al.,!2013).!SGLT5!is!an!orphan!sodiumD
dependent! transporter! with! poorly! recognized! function.! It! consists! of! 597!
amino!acids!with!protein!molecular!weight!of! approximately! 65! kDa! (Zhao!et'
al.,!2005).!!







D The! sodium/myoinositol! coDtransporter! (SMIT)! (encoded! by! gene! SLC5A3),! it! is!




D The! apical! iodide! transporter! (AIT)! (encoded! by! gene! SLC5A11),! another!
Na+/iodide! cotransporter,! also! found! in! the! thyroid! gland! (Wright! and! Turk,!
2004).!
D The!sodium/multivitamin!cotransporter!(SMVT)!(encoded!by!gene!SLC5A6),!also!
transports! other! essential! cofactors! such! as! biotin,! pantothenic! acid! and! lipoic!
acid.! It! is! expressed! in! kidney,! brain,! heart,! lung! and! placenta! but! with! some!
uncertainty!as!to!its!function!(Vadlapudi!et'al.,!2012,!Wright!and!Turk,!2004).!
D The!high!affinity!choline!transporter!CHT!(encoded!by!gene!SLC5A7),!found!in!the!





energyDindependent! glucose! transporters;! gene! SLC2A)! mediates! passive! sugar!
transport! down! their! concentration! gradient! across! the! cell! membrane! (ShiraziD
Beechey,! 1995,! WilsonDO'Brien! et' al.,! 2010).! This! family! belongs! to! the! Major!
Facilitator! Superfamily! (MFS)! of! membrane! transporters! (Thorens! and! Mueckler,!
2010).! They! are! predicted! to! share! a! structural! 12! membraneDspanning! αDhelical!
segments!with!intracellularly!located!ND!and!CDtermini.!However,!they!differ!in!their!
functional! properties,! mainly! the! binding! affinity! to! the! inhibitory! ligand!















• GLUT2! is! the! facilitative! glucose,! galactose! and! fructose! transporter! that! is!
inhibited! by! both! Cytochalasin! B! and! phloretin! (Joost! et' al.,! 2002).! It! is!
expressed!in!liver!and!pancreas!plus!in!the!small!intestine!and!kidney!epithelial!
cells!(Kramer!et'al.,!2009).!It!will!be!discussed!in!more!details!separately.!!
• GLUT3! isoform! has! similar! properties! and! glucose! uptake! activity! to! GLUT1!
(Asano! et' al.,! 1992,! Olson! and! Pessin,! 1996).! GLUT3! is! a! brainDtype! glucose!
transporter!and!is!expressed!in!tissues!with!high!glucose!demand!like!neurones!
and!brain!more!than!skeletal!muscles!and!kidney!(Gould!and!Holman,!1993).!It!




with! a! high! glucose! affinity.! Therefore,! it! is! highly! abundant! in! insulinD





II. Class! II! group! (GLUTs! 5,! 7,! 9,! 11! and! 13! or! HMIT),! which! are! known! as!
fructose!transporters.!They!are,!in!contrast!to!Class!I,!insensitivite!to!Cytochalasin!B!
and!Phloretin.!This!class!involves:!
• GLUT5! is! the! fructose! specific! transporter! across! the! BBM! of! the! intestinal!
enterocytes,!and!other!tissues,!with!no!ability!to!transport!glucose!or!galactose!
(Douard!and!Ferraris,!2008).!It!will!be!discussed!shortly!in!a!separate!section.!
• GLUT7! gene! has! been! cloned! from! human! intestine! hGLUT7! encoding! 524!
residues!sharing!68!%!similarity!and!53!%!identity!with!its!closer!GLUT5!isoform.!
GLUT7! is! primarily! expressed! in! the! apical! domain! of! the! small! intestine! and!
colon,! although! mRNA! has! been! detected! in! the! prostate! and! testis.! When!
GLUT7!is!expressed!in!Xenopus!oocytes,!it!exhibits!highDaffinity!for!glucose!and!
fructose!but!not!galactose!transport!(Li!et'al.,!2004).!However,!its!physiological!
substrate! probably! has! not! been! identified! yet! (Cheeseman,! 2008).! GLUT7! is!
also!a!known!hepatic!microsomal!GlucoseDtransporter!protein! (Waddell!et'al.,!
1992,!Bell!et'al.,!1993).!
• Human! GLUT9! (encoded! by! gene! SLC2A9)! isoform! was! initially! identified! as!








40D42! %! identity! to! GLUT5.! It! has! been! suggested! that! fructose! may! be! the!
most! specific! substrate! for! GLUT11,! (Joost! and! Thorens,! 2001,! Wu! et' al.,!
2002b).!The!human!SLC2A11!gene!generates!three!GLUT11!isoforms,!which!are!
found! in! a! tissue! specific! manner! like! heart,! pancreas,! kidney,! placenta! and!
skeletal!muscles,!but!their!function!is!not!yet!certain!(Scheepers!et'al.,!2005).!
• GLUT13,! also! called! HMIT! (H+Dcoupled!myoinositol! !transporter),! is! a! recently!
cloned! protonDmyoinositol! symporter! included! in! the! GLUT! family.! It! is!
expressed! in! brain! tissues! regulating! the! myoDinositol! metabolism,! and! in!
neurons! sustaining! the! inositol! signalling! at! synapses! (Uldry! et' al.,! 2001,! Di!
Daniel!et'al.,!2009). 
!
III. Class! III! group! comprises! (GLUTs! 6,! 8,! 10,! 12,! and! 14),! which! comprises!
poorly! identified!and!structurally!atypical! isoforms!of!GLUT! family.!Comparatively,!
little!is!known!about!these!GLUT!transporters!whose!members!are!characterized!by!






intracellular! retention! motifs,! though! they! are! found! at! both! the! ND! and! CD
termini.! 
• GLUT8! (gene!SLC2A8)! is! a! recently! identified! highDaffinity! glucose! transporter!
regulated!in!a!hormonalDdependent!manner!in!various!tissues.!It!shows!insulinD
induced!expression!and! translocation,! trafficked! to! the!plasma!membranes! in!
response!to!insulin,!which!are!critical!for!embryonic!blastocyst!survival!(Pinto!et'
al.,!2002,!Carayannopoulos!et'al.,!2000).! It! is!also!expressed! in! the!acrosomal!
region! of! human! spermatozoa! in! a! gonadotropinDdependent! manner,! while!
expressed!in!the!lactating!mammary!gland!in!response!to!lactogenic!hormones!
(Schurmann!et'al.,!2002,!Zhao!et'al.,!2004).! 
• Human!GLUT10! is! encoded!by! gene!SLC2A10! that! is!mapped! to! chromosome!
20q12Dq13.1,! a! region! linked! to! non! insulinDdependent! diabetes! mellitus!
(NIDDM),!and!hence!it!is!a!candidate!gene!for!type!2!diabetes!(McVieDWylie!et'










insulinDresponsive! tissues! suggesting! its! complementary! role! in! glucose!
homeostasis!before!the!appearance!of!GLUT4!in!those!tissues.!)
• GLUT14! is! expressed! in! the! testis,! but! its! precise! roles! are!unknown! (Thorens! and!
Mueckler,! 2010).! GLUT14! maps! to! chromosome! 12p13.3! (17.1M),! which! shares!
remarkable! identity! to! GLUT3! with! a! similar! genomic! organization.! GLUT14! likely!






!GLUT2! is! a! bidirectional,! high! capacity! but! low! affinity,! transporter! that!
passively! diffuses! monosaccharides! (glucose,! galactose! and,! with! lower! affinity,!
fructose)!with! their! concentration! gradient! across! the! cell!membranes! (Zhao! and!
Keating,!2007b).!GLUT2!is!the!key!facilitative!glucose!transporter!isoform!expressed!
mainly! in! the! hepatocytes! and! insulinDsecreting! pancreatic! βDcells,! plus! the!
basolateral! membrane! of! absorptive! cells! in! the! small! intestine! and! the! kidney!
(Gould!and!Holman,!1993).!!
!
In! the! small! intestine,! GLUT2! facilitates! the! exit! of! glucose,! galactose! and!
fructose,!with!highest!affinity!to!glucose,!out!of!enterocytes!across!the!basolateral!
membrane!to!the!blood!stream!(Kellett!and!Helliwell,!2000,!ShiraziDBeechey,!1995,!
Thorens! et' al.,! 1990a).! Furthermore,! it! is! responsible! for! glucose! reabsorption!
through! the! basolateral! membrane! of! the! proximal! convoluted! tubules! in! the!
kidney!(Goestemeyer!et'al.,!2007,!Takata,!1996,!Thorens!et'al.,!1990b).!In!the!liver,!
GLUT2! mediates! glucose! uptake! through! the! sinusoidal! membrane! of! the!
hepatocytes.! Hepatic! GLUT2! mRNA! and! protein! expression! is! upDregulated! by!
thyroid! hormone! which! increases! the! hepatic! output! of! glucose! synthesized! by!
gluconeogenesis! into! the!blood! (Weinstein!et'al.,! 1994,! Thorens!et'al.,! 1990b).! In!
addition,!GLUT2!has!other!physiological!roles!including!the!regulation!of!a!glucoseD
induced!insulin!secretion!from!pancreatic!βDcells!(Tiedge!and!Lenzen,!1991).!It!also!









In!humans,! the!GLUT2!protein! is! composed!of!524!amino!acids!and!shares!
~55%! identity!with!GLUT1! isoform! (Gould!and!Bell,! 1990,! Fukumoto!et'al.,! 1988).!
The!amino!acid!sequence!of!GLUT2!displays!81%!identity!between!human,!rat!and!
mouse! (Zhao! and! Keating,! 2007b).! Its! secondary! structure! is! similar! to! the! other!
isoforms!of!GLUT!family,!comprising!12!transmembrane!domains!with!intracellular!
CD!and!ND!termini!(Takeda!et'al.,!1993).!It!is!encoded!by!the!SLC2A2'gene,!which!was!










horse! shows! that! it! has! 87.5%! and! 71.4%! identity! with! pig! and! horse! GLUT2,!
respectively! (Figure! 5A).! The! other! antibody! was! raised! to! a! synthetic! peptide!
corresponding! to! the! CDterminus! region! of! the! equine! GLUT2.! Alignment! of! this!
region!of! horse! and!pig!GLUT2! shows!92.9%! identity! (Figure! 5B).! Both! antibodies!
have! been! used,! in! previous! work,! in! immunohistochemistry! to! identify! the!













It( has( been( claimed,( by( Kellett( and( his( colleagues,( that( under( certain(
conditions,(when(luminal(glucose(or(fructose(concentrations(are(increased,(GLUT2(is(
activated( and( rapidly( inserted( into( the( BBM( of( the( enterocytes,( and( glucose(
absorption(by(GLUT2(across( the(BBM( is(3Efold(greater( than( that(by(SGLT1( (Kellett(
and( Helliwell,( 2000,( Kellett( et$ al.,( 2008,( Kellett( and( BrotELaroche,( 2005,( Kellett,(
2001,( Helliwell( et$ al.,( 2000).( It( has( been( proposed( that,( in( high( luminal( sugars,(
glucose( uptake( by( SGLT1( increases( the( volume( of( enterocyte,( (due( to( high(
osmolarity(and( the( coEtransport(of(water(molecules(by(SGLT1),(which( trigger(Ca2+(
entry( to( activate( PKCβII.( Subsequently,( via( PKCβII( and( MAP( kinaseEdependent(
pathways,( this( promotes( the( rapid( trafficking( of( cytosolic( GLUT2( into( the( apical(
membrane((Affleck(et$al.,(2003,(Mace(et$al.,(2007).(
(
The( immunohistochemical( expression( of( GLUT2( on( the( enterocyte( apical(
membrane( was( detected( using( an( antibody( to( a( sequence( within( the( large(
extracellular( loop( of( GLUT2( that( permits( the( localization( of( GLUT2( at( the( BBM(
(Affleck(et$al.,(2003).(However,(using(one(of(the(two(antibodies(is(puzzling(because(
that( was( only( observed( in( rats,( in$ vivo,( but( it( could( not( be( proven( in( any( other(
species.( The( two( antiEGLUT2( antibodies( were( used,( with( various( approaches,( by(
other( investigators(who(showed( that(GLUT2( is(exclusively( localized( to( the(BLM(of(
enterocytes( with( no( protein( expression( on( the( BBM( in( fructoseE( and( glucoseE
perfused( intestines( of( neonatal( rats( (Cui( et$ al.,( 2005),( horses( (Dyer( et$ al.,( 2009),(
dogs(and(cats((Batchelor(et$al.,(2011)(and(piglets((Moran(et$al.,(2010b).((
(
Other(authors(also( strongly(argued( that(GLUT2(does(not(participate( in( the(
transport( of(monosaccharides( across( the( BBM.( Although,( it( has( been( shown( that(
fructose( transport( is( reduced( by( half( in( the( BBM( of( GLUT2Eknockout( mice,(
suggesting( that( 50%( of( luminal( fructose( transport( is( mediated( by( apical( GLUT2(
(Gouyon( et$ al.,( 2003),( but,( in( GLUT2Enull( mice( and( humans( with( inactivating(
mutations(in(GLUT2((FanconiEBickel(syndrome),(there(was(no(evidence(of(impaired(
intestinal( glucose( transport( (Santer( et$ al.,( 2003,( Stumpel( et$ al.,( 2001).( Other(
findings(declined( the(presence(of(GLUT2(on( the( luminal( intestinal( domain( that,( if(
exist,(should(allow(fructose(absorption(when(GLUT5(is(absence(in(GLUT5Eknockout(
mice,( which( are( unable( to( absorb( fructose( at( all( (Barone( et$ al.,( 2009),( or( when(
GLUT5(activity( is( limiting,(as( in(healthy(human(volunteers(who(show(symptoms(of(
malabsorption(and(a(positive(breath(hydrogen(test(following(ingestion(of(excessive(
(50g)( fructose( (Montes( et$ al.,( 1992),( indicating( limited( capacity( of( fructose(
absorption( via( GLUT5( in( humans.( Furthermore,( the( lethal( phenotype( of( glucoseE
galactose(malabsorption(argues( against( the(presence(of( apical(GLUT2( that( should(
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not( existing( on( the( apical(membrane( of( enterocytes,( indicating( that( SGLT1( is( the(





GLUT5( is( a( highEaffinity( facilitative( transporter( that( is( the( sole( isoform( of(
GLUT( family( specific( for( fructose,( but( not( glucose( or( galactose.( It( is( an( integral(
membrane( transporter( across( epithelial( membranes( found( in( different( fructose(
consuming( tissues.( The( greatest( amount( of( GLUT5( is( expressed( in( the( small(
intestine,( where( it( passively( facilitates( the( absorption( of( luminal( fructose( into(
enterocytes(across(the(apical(membrane((BBM)(in(human((Blakemore(et$al.,(1995),(
horse((Merediz(et$al.,(2004),(rabbit((Miyamoto(et$al.,(1994),(rat(and(mouse((Corpe(
et$ al.,( 2002).( GLUT5( is( also( found( abundantly( in( the( testis,( where( it( was( first(
discovered,(in(human(mature(spermatozoa(to(mediate(uptake(of(fructose(for(use(as(
an(energy(source((Burant(et$al.,(1992)(as(well(as(in(the(brushEborder(membrane(of(




GLUT5( protein( with( 501( amino( acids( sharing( ~40%( identity( with( the( other( GLUT(
family(members( (Kayano(et$al.,(1990).(The(expression(and( localization(patterns(of(
human( GLUT5( are( regionally( modified( showing( the( highest( mRNA( level( in( small(
intestinal( BBM,( mainly( the( mature( enterocytes( of( the( jejunum.( However,( it( has(
been(claimed(that(GLUT5(can(be(expressed(on(the(BLM(with(lower(levels((Davidson(
et$al.,(1992,(Blakemore(et$al.,(1995).(This(expression(and(activity(seems(to(be(also(
regulated(by(developmental( stage,( increased( after( 1( year( in( humans( (Nobigrot(et$
al.,( 1997)( and( after(weaning( in( rats( (Toloza( and(Diamond,( 1992).( Studies( on( rats(




affected( by( intracellular( cAMP( and( by( thyroid( hormone.( In( some( tissues,( GLUT5(







diabetes( (Burant( et$ al.,( 1994,( Dyer( et$ al.,( 2002a),( and( significantly( affected( by(





(The(sodium/glucose(coEtransporter( (SGLT1)( is( the(most( studied( isoform(of(
SLC5( family.( It( was( first( recognised( in( 1987( by( Hediger( et$ al.,( who( identified( the(
primary( structure( of( rabbit( SGLT1( by( cloning( and( cDNA( sequencing( from( rabbit(
intestine((Hediger(et$al.,(1987).(Then,(human(SGLT1(was(cloned(and(sequenced( in(
1989( (Hediger( et$ al.,( 1989b),( with( significant( homology( in( SGLT1( sequence( in( a(
number(of(species(including(mouse,(rat,(cow,(sheep,(dog,(cat,(pig(and(horse((Dyer(et$
al.,( 2002a,(Hediger( and(Rhoads,( 1994,( ShiraziEBeechey,( 1995,( Tarpey(et$ al.,( 1995,(
Batchelor(et$al.,(2011).(
(
Human( intestinal( SGLT1( gene,( named( (SLC5A1),( has( been( cloned( and(
sequenced(and(the(chromosomal(localization(studies(mapped(the(gene(to(reside(on(
the( distal( arm( of( chromosome( 22q13.1( (Turk( et$ al.,( 1993,( Hediger( et$ al.,( 1989a,(







As( demonstrated( in( Figure( 6,( the( secondary( structure( model( of( SGLT1(
protein(comprises(14E15(exons;(it(shows(12E14(transmembrane(αEhelices(spans(with(
hydrophilic( amino( terminus( and( hydrophobic( carboxyl( terminus,( both( facing( the(
extracellular(side(of(the(plasma(membrane.(SGLT1(carrier(has(the(glycosylation(site(
(SGLT1(motifs)(and(the(putative(glucoseEbinding(sites( in( the(CEterminal(half(of( the(













SGLT1( is( a( sodiumEcoupled( glucose( symporter( that( actively( transports(







It( has( previously( been( reported( that( along( the( vertical( cryptEvillus( axis,(
SGLT1(mRNA(and(protein(are(detected(only(in(the(villus,(highest(levels(in(the(villusE
tip,( but( not( in( the( crypts.( Conversely,( along( the(horizontal( axis( of( small( intestinal(
length,( SGLT1( protein( is( more( abundant( in( the( proximal( regions( and( declined(
gradually(with(distal(progression((Hwang(et$al.,(1991,(Freeman(et$al.,(1993).(During(
development,( studies( on( neonatal( pigs( revealed( that( SGLT1( activity( and( protein(
expression( is( high( along( the( entire( cryptEvillus( axis( at( birth( and( during( suckling(
period((Yang(et$al.,(2011).((
(
SGLT1( is( also( highly( expressed( on( the( apical( membrane( (BBM)( of( the(
proximal( tubular( cells( of( S3( segment( in( the( kidney(where( it(mediates( 10%(of( the(
reabsorption(of(filtered(glucose,(while(the(majority(is(reabsorbed(by(SGLT2((Mather(
and( Pollock,( 2011;( Pajor( et$ al.,( 1992).( Unexpectedly,( it( was( observed( that( SGLT1(
expression( in(human(heart(was(about(10Efold(higher(than(that(observed( in(kidney(
tissue( (Zhou(et$ al.,( 2003).( It( is( also( found( to( increase( glucose( permeability( in( the(




et$al.,( 1995,(Wright(et$al.,( 2007)( and( its( expression( is( affected(by( lactation( in( the(
mammary(glands((Zhao(and(Keating,(2007a).(Interestingly,(SGLT1(is(multifunctional;(
it( can( also( act( as( a( water( pump( (Loo( et$ al.,( 2002),( a( sodium( unipolar( or( a( urea(
transporter.((
Alignment( of( the( SGLT1( amino( acid( sequence( showed( that( rabbit( SGLT1(
shares( a( high(degree(of( homology(with( other( species.( The(polyclonal( antibody( to(
SGLT1(used(in(this(study(was(raised(to(a(synthetic(peptide(corresponding(to(amino(









Alignment$ of$ amino$ acid$ sequences$ (from$ 402F420$ residues)$ of$ rabbit$ SGLT1$with$
the$same$region$of$sequence$of$several$other$species.$Very$high$homology$is$seen$in$




SGLT1( binds( to( a( couple( of( Na+( ions( at( the( extracellular( surface,( which(
promote( a( conformational( adaptation( allowing( one( glucose( molecules( to( occupy(
glucoseEbinding(site(at(the(receptor’s(external(surface.(The(coEtransporter(switches(
its( conformational( state( facing( both( substrates( bound( near( the( intracellular(
compartment( to( release( Na+( and( glucose( into( the( cytoplasm.( Subsequently,(





secondary( active( transport( because( the( driving( force( of( the( Na+( gradient( is(
maintained( by( the( primary( active( Na+/K+Epump( or( Na+/K+EATPase,( located( on( the(
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BLM.( The( rate( of( glucose( transport( by( SGLT1( is( organized( by( the( direction( and(
magnitude(of( the(Na+Egradients(across( the(plasma(membrane,(which( is( set(by( the(
Na+/K+/ATPase( (Zhao( and( Keating,( 2007b).( Na+( is( the( physiological( cation( driving(
sugar(transport(by(SGLT1;(otherwise,(it(can(be(driven(to(a(lesser(extent(by(H+(and(Li+(
ions((Wright(et$al.,(2003,(Hirayama(et$al.,(1994).(The(apparent(affinity(of(SGLT1(for(
sugar( is( 25( times( higher( for( Na+Esugar( cotransport( than( that( for( H+( Esugar(
cotransport.( However,( H+/glucose( cotransport( is( potentially( relevant( in( the(
duodenum,(where( the( luminal( content( has( a( high( glucose( concentration( in( acidic(








pathway,( known( as( transporterEmediated( absorption.( The( glucose( transport(
mechanism(across(the(intestinal(wall(occurs(via(the(enterocytes(that(is(mediated(by(
integrated(carriers(in(the(cell(membrane(known(as(‘’glucose(transporters’’((Takata,(




small( intestine( is( shown( in( Figure( 8.( The( transport( of( dietary( glucose/galactose(
across( the( brushEborder(membrane( (BBM)( from( the( lumen( into( the( enterocyte( is(
mediated(by(SGLT1,(while(fructose(is(passively(diffused(via(GLUT5.(On(the(basal(side(
of(the(cell,(accumulated(glucose,(galactose(and(fructose(within(the(cell(diffuse(out(
into( bloodstream( across( the( basolateral( membrane( (BLM)( through( GLUT2(
(Drozdowski(and(Thomson,(2006,(Wood(and(Trayhurn,(2003,(Burant(et$al.,( 1992).(
Intracellular( Na+( ions( are( transported( out( across( the( BLM( by( the( Na+/K+EATPase,(





However,( others( showed( that( paracellular( shunts( have( a( minor( transport(
role( not( exceeding( 2E7%( of( total( intestinal( absorption,( even( in( high( luminal(
concentrations(of(nutrients((Lane(et$al.,(1999).(It(is(suggested(that(some(glucose(is(







The$diagram$shows!mature$enterocyte$with$ the$ sugar$ transporters.$On$ the$brushF
border$ membrane$ (BBM):$ SGLT1$ transports$ glucose$ and$ galactose,$ and$ GLUT5$
enters$ fructose$ from$ the$ gut$ lumen$ into$ the$ cell.$ On$ the$ basolateral$ membrane$
(BLM):$ GLUT2$ diffuses$ glucose,$ galactose$ and$ fructose$ out$ the$ cell$ to$ the$ blood.$







dietary( sugar( transport( from( the( intestinal( lumen( into( the( blood( stream( and(
subsequently(to(be(taken(up(by(the(utilizing(tissues.(Blood(glucose(is(also(controlled(
by(insulin(and(glucagon,(which(is(a(complementary(role(of(the(endocrine(pancreas.(






different( nutrients,( including:( the(modification( of( the( intestinal( structure( such( as(
expanding( its( absorptive( surface( area( resulting( in( alteration( of( the( cell( number(
(hyperplasia)( or( size( (hypertrophy)( or( the( length( of( the(microvilli( and( thus(more(
enterocytes(per(villus((Smith(et$al.,(1991).(Another(significant(nonEspecific(factor(is(
the( maturity( of( enterocytes.( Mature( enterocytes,( which( migrate( up( to( villus( tip,(




exhibit( improved( transport( function( as( the( BBM( alters( its( fluidity( and( lipid(
composition,( being( more( rigid( and( capable( for( accelerating( sugar( transport( rate(
(Meddings( et$ al.,( 1990,( Brasitus( and( Dudeja,( 1985,( Vazquez( et$ al.,( 1997).(
Furthermore,( the( mucosal( clearance( and( the( blood( flow( rate( plus( the( gastric(
emptying( and( the( gut(motility( have( great( impact( on( nutrient( absorption.( Shifting(
the(ratio(of(transporting(to(nonEtransporting(cells(also(affects(absorption,(plus(the(
changes( in( intestinal( mass( that( occurs( during( development( and( aging( or( in(





Other( suggested( but( not( proven( indirect( mechanisms( affecting( the( Na+( E




differences( in( the(affinity(of( transporters(on(both(sides(of( the(BBM((Kimmich(and(
CarterESu,(1978,(Kimmich(et$al.,(1977).(((
(
The( specific( mechanisms( regulating( the( absorption( of( sugar( but( not(
necessarily( changing( the( absorption( of( another( nutrient,( include:( changing( the(
turnover(state(of(the(small( intestinal(cells(and(the(number(of(existing(transporters(
in(the(membrane,(by(switching(their(status(from(‘inactive’(to(‘active’(forms((Wright(
et$ al.,( 1997),( or( changing( the( rate( of( synthesis( or( rate( of( degradation( or( the( site(
density( of( glucose( transporter.( Modulating( the( substrateEbinding( affinity( of( the(
sugar( transporters,( affinity( constant,( which( is( increased( by( ATP,( but( reduced( by(
adenosine((Lachaal(et$al.,(2001,(Ferraris(and(Diamond,(1997).((
(
Importantly,( specific( apical( glucose( transport( is( primarily( regulated( by( the(
intrinsic( activity( of( SGLT1( transporter( and( its( actual( amount( of( protein( in( the(
membrane( (Dyer( et$ al.,( 2009)( (The( regulation( of( SGLT1,( is( discussed( separately).(
Moreover,( the( consumed( dietary( levels( of( carbohydrates,( fibres,( fats( and(
electrolytes(have(a(potential(regulatory(effect(on(intestinal(sugar(transport((Dyer(et$
al.,( 1997b,( Ferraris,( 2001).( The( ratio(of( unsaturated( to( saturated( fats( in(diets( can(







(Korn(et$al.,( 2001,(Vayro(et$al.,( 2001)(mRNA(accumulation( (which( is(most( likely( a(
result( of( activation( of( SGLT1( gene( transcription)( and( mRNA( stability( (Loflin( and(
Lever,( 2001),( posttranslational( intracellular( trafficking( (Delezay( et$ al.,( 1995),(
membrane(expression(and(activity.(SGLT1(is(initially(synthesized(in(the(lower(villus,(




Several( studies( revealed( no( correlation( between( the( expression( profile( of(
SGLT1( mRNA( and( SGLT1( protein( or( its( function.( The( transport( rate( and( protein(
expression(are(increased(when(the(amounts(of(SGLT1(mRNA(are(reduced,(in(25E50(h(
old( enterocytes.( It( appears( that( this( change( in( mRNA( translational( efficiency(
depends( on( the( age( of( the( enterocytes( but( not( on( their( villus( position,( and(
enterocytes(are(around(that(age(when(they(leave(the(crypts((Dong(et$al.,(1997).((
Further( work( on( mice( demonstrated( that( irreversibly( programmed( SGLT1(
expression(is(related(to(the(maturity(status(of(enterocytes.(Cells(migrate(along(the(
vertical( crypt/villus( axis,( then( they( shed( from( the( villus( tip,( this( takes( about( two(
days(in(rat(intestine((Junqueira(and(Carneiro,(1971)(and(4E6(days(in(human(intestine(
(Thomson( et$ al.,( 1994).( Owing( to( that,( the( intestinal( glucose( transport( activity(
increased(within(1E3(days(after(switching(from(low(to(highECHO(diet,(this(time(lag(is(
sufficient(to(increase(the(site(density(of(glucose(transporters.(This(also(corresponds(
to( the( time( taken( by( the( crypt( enterocytes( to(migrate( to( villi,( and( the( functional(
SGLT1(is(observed(in(the(newly(formed(mature(enterocytes((Ferraris(and(Diamond,(
1992,( Ferraris( et$ al.,( 1992,( Ferraris( and( Diamond,( 1993).( Hence,(
immunohistochemical(expression(of(SGLT1(protein( is(detected(on( the(BBM(of( the(
entire( villus( but( not( the( crypt( cells( in( the( studied( species:( rabbits,( rats,( piglets,(
horses,(dogs(and( cats( (Batchelor(et$al.,( 2011,(Dyer(et$al.,( 2009,(Dyer(et$al.,( 2007,(





Intestinal( glucose( uptake( follows( a( circadian( rhythm( related( to( periodic(
insulin(secretion,(which(is(interrupted(by(prolonged(fasting(or(continuous(intestinal(
glucose( infusion( in( animals( (Van(Cauter(et$ al.,( 1997).( There( is( a(maintained(basal(
level(of(intestinal(SGLT1(expression(and(activity(in(order(to(sustain(a(regular(blood(




physiological( factors( (lactation,( pregnancy( and( starvation)( and( pathological(
conditions( (diabetic( and( obesity)( (Moran( et$ al.,( 2010b,( Ferraris,( 2001).( Different(
species(demonstrate(dietary(and(developmental(regulation(of(the(intestinal(glucose(
absorption.(The( intestine(of(ruminant(animals( is(a(model(that( is(naturally(exposed(
to( significant( changes( in( luminal( carbohydrates(during(developmental(progression(
from( preEruminant( to( ruminant( stages.( It( has( been( shown( that( intestinal( SGLT1(




modified( by( fluctuating( dietary( carbohydrate( (Dyer( et$ al.,( 1997a,( Moran( et$ al.,(
2010b).( Similar( findings( were( observed( in( rat( intestine( and( revealed( that( the(
enhanced( carbohydrate( dietEregulated( SGLT1( expression( occurs( at( transcriptional(
level,( leading(to(more(glucose(transport.( In(pigs,(SGLT1(mRNA,(protein(abundance(
and(glucose(uptake(activity(remained(constant(when(the(weaned(piglets(were(fed(
low( carbohydrateEcontaining( diets,( while( increasing( the( dietary( carbohydrate(
content( above( 50%( rapidly( enhanced( intestinal( SGLT1( expression.( Interestingly,(
when( the( low( carbohydrate( Econtaining( diets( were( supplemented( with( artificial(
sweeteners,(the(intestinal(expression(of(SGLT1(was(increased(to(the(levels(of(highE(







al.,( 1997b,(Miyamoto( et$ al.,( 1993,(Moran( et$ al.,( 2010b),( and( glucose( absorption(
tends( to( be( higher( in( herbivores( than( in( carnivores( (Buddington( et$ al.,( 1987).(
Considering(the(substrateEdependent(regulation(of(SGLT1,(a(low(saltEdiet(decreases(




Glucose,( amino( acids( and( ions( trigger( water( transport( via( cotransporters.(
SGLT1(acts(as(water(pump(accounting(for(about(50(%(of(the(total(water(transport(







osmotic( gradient/luminal( content( tonicity( (or( experimental(medium).(Also( altered(
by( temperature,( external( Na+( and( sugar( levels( and( any( alteration( in( membrane(
potential((Meinild(et$al.,(1998).(
Subsequently,( across( the( basolateral( membrane,( intracellular( Na+( is(
exported(out( towards( the(blood(by(Na+/K+EATPAse,( and(glucose(passively(diffuses(
out(by(the(facilitated(transporter,(GLUT2.(It(is(commonly(thought(that(Na+(transport(
increases( the( local( osmotic( pressure( in( the( lateral( intercellular( spaces,( and( that(
creates(osmotic(water(flow(across(the(epithelial(BLM((Wright(and(Loo,(2000).(
Sodium( is( coEtransported( with( glucose( and( amino( acids.( Other( ions( and(
electrolytes( are( either( transported( via( specific( carriers( (uniEporter)( or( coE
transported( with( other( nutrients( (coEtransporter).( For( example:( the( apical( anion(





as(well( as( to( resist( infection( and( inflammation.( The(mucosal( chemosensation( can(
detect( harmful( components( in( the( gut( lumen( and( evoke( protective( reactions( like(




After( dietary( ingestion,( the( digestion( and( absorption( of( nutrients( are(
accompanied(by(stimulated(secretion(of(multiple(gut(hormones,(which(are(peptides(




many( endocrine( glands,( but(most( pronounced,( by( hormones( secreted(within( the(
GIT( itself.( The( digestive( system( is( the( largest( endocrine( organ( in( the( body,(
constituting(the(endocrine(cells((EEC)(within(the(gut,(which(collectively(referred(to(
as(the(enteric(endocrine(system.(Various(endocrine(cell(types(may(express(different(
hormonally( active( fragments( of( the( same( prohormone( according( to( cellEspecific(
posttranslational(processing.((
The( GI( produces( more( than( 20( hormones( that( act( either( locally( as( a(
paracrine(factors(interacting(with(neighbouring(cells(and(nerve(endings(or(distally(as(






The( most( studied( gut( hormones( include( GIP,( GLPE1,( GLPE2,( gastrin,(
somatostatin,(CCK(and(serotonin;( their(actions(are( listed( in( table(1.2( (Breer(et$al.,(
2012,(Bryant(and(Bloom,(1979,(Sjolund(et$al.,(1983,(Dockray,(2012,(Batterham(and(
Bloom,(2003,(Phillips(and(Prins,(2011,(Jang(et$al.,(2007).(These(gut(hormones(affect(
glucose(metabolism( in( different( complementary(ways:( by( regulating( appetite( and(
food( intake,( affecting( gastric( emptying( and( gut( motility,( and( modulating( mealE
related( fluctuations( in( plasma( glucose( levels( by( released( incretins( that( enhance(
pancreatic( insulin( release( and( affecting( tissue( specific( insulin( sensitivity( (Ashley(


























KDcell! Proximal(intestine( GIP( E(Promotes(insulin(secretion(
IDcell! Proximal(intestine( CCK( E(Stimulates(secretion(of(pancreatic(
((enzyme(and(gallbladder(contraction(
E(Inhibits(food(intake(




















of( peptides( depending( on( a( tissueEspecific( postEtranslational( processing.( ( The(




Both(GLPE1(and(GIP(are( incretins,(while(GLPE2( is(an( intestinotrophic( factor.(
The( two( incretins( GLPE1( and( GIP( influence( insulin( release( in( different(ways:( they(
promote( insulin( biosynthesis( and( stimulate( glucoseEdependent( insulin( secretion;(
plus,(they(increase(the(proliferation((neogenesis)(and(survival(of(the(pancreatic(islet(
βEcell((Abraham(et$al.,(2002).(Incretins(also(facilitate(glucose(uptake(by(muscles(and(
adipose( tissues( (Drucker,( 2003,( Drucker,( 2006,( Fehmann( et$ al.,( 1995).( Most(
hormones( in(the(glucagon(superfamily,( including(GLPE1,(GLPE2(and(GIP(are(rapidly(
inactivated( by( the( enzyme( dipeptidyl( peptidaseE4( (DPPE4),( and( cleared( by( the(
kidney((Kieffer(et$al.,(1995,(Tavares(et$al.,(2000,(Deacon,(2004).(
Additionally,( GLPE1( exerts( extra( roles( in( glucose( homeostasis( including(
suppression(of(glucagon(release(from(αEcells(of(the(Islets(of(Langerhans,(resulting(in(
reduced( endogenous( production( of( glucose( by( the( liver.( It( also( slows( gastric(
emptying( and( reduces( the( rate( of( nutrient( absorption.( GLPE1( can( affect( the(
hypothalamus( to( induce( satiety( and( reduce( food( intake,( thus( controlling( body(
weight((Drucker,(2007,(Yabe(and(Seino,(2011).(
GIP(is(derived(from(a(153E(residue(precursor,(preproGIP,(and(circulates(as(a(




GlucagonElike( peptide( 2( (GLPE2)( is( a( 33Eamino( acid( peptide( hormone(
produced( by( the( EEC( in( response( to( dietary( intake( especially( carbohydrates( and(
lipids( (Xiao( et$ al.,( 1999,( Drucker,( 2001a).( GLPE2( has( both( intestinotrophic( effects(
and( physiological( actions( on( the( GIT.( It( enhances( intestinal( mucosal( growth( by(
stimulating(crypt(cell(proliferation(and(suppressing(villus(cell(apoptosis((Drucker(et$
al.,( 1996,( Thulesen,( 2004).( This( adapts( the( gut( epithelium( to( luminal( nutrients(
(Burrin(et$al.,(2003,(Drucker,(1999,(Shin(et$al.,(2005)(or(repairs(intestinal(hypoplasia,(
mucosal(injury(and(atrophy(associated(with(conditions(like(total(parenteral(nutrition(
or( intestinal( resection( (Ljungmann( et$ al.,( 2001,( Munroe( et$ al.,( 1999).( Moreover,(
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GLPE2( promotes( nutrient( absorption( by( inhibiting( gastric(motility( and( gastric( acid(
secretion( and( stimulating( intestinal( basolateral( membrane( glucose( transport(
(Cheeseman( and( Tsang,( 1996).( In( addition,( it( modulates( intestinal( blood( flow,(
increases(the(barrier( function(of(the(gut(epithelium,(reduces(gut(permeability(and(
bacterial( translocation( in( cases( of( intestinal( inflammation;( and( stimulates( the(
expression(of(digestive(enzymes((Burrin(et$al.,(2003,(Drucker,(1999,(Drucker,(2001b,(






nervous( system( to(modulate( intercellular( communication( between( neurons.( They(
convey(neuronal(signals(to(target(cells(that(express(the(binding(receptors(of(these(
peptides;( hence,( they( are( known( as( neurotransmitters( or( neuromodulators.(
Neuropeptides(are(stored(in(large(granular(vesicles((LGV)(in(the(nerve(cells(and(are(
released( in( a( regulated( secretory( pathway( (Merighi( et$ al.,( 2011).( In( the( gut,( the(
most( released( neuropeptides( by( the( enteric( nervous( system( are( acetylcholine,((
vasoactive( intestinal( peptide( (VIP),( pituitary( adenylate( cyclaseEactivating(
polypeptide((PACAP)(and(substance(P((SP).((
(
( C% VIP:(VIP( is(a(neuropeptide(produced( in( the(central(and(peripheral(nervous(
systems,( including( the( neuronal( networks( of( the(GI( tract( (Gozes( and(Brenneman,(
1989).( In( the(CNS,(VIPEcontaining(nerve( fibres(are(concentrated(particularly( in( the(
cerebral( cortex,( and( specific( areas( of( hippocampus,( amygdala( and( hypothalamus(
(Loren(et$al.,(1979).(In(the(GI(tract,(VIP(is(primarily(localized(to(tiny(nerve(fibres(and(
nerve( terminals( of( the( muscle( layer,( found( throughout( the( gut( ranging( from(
esophagus(to(rectum(including(the(pancreas((Bryant(et$al.,(1976).(A(study(reported(
that(VIP(expression(is(also(found(in(all(the(layers(of(the(colon((muscle(plus(mucosa),(
but( with( highest( concentrations( in( the( submucosal( and(myenteric( plexus( (Bryant(
and(Bloom,(1979).(However,(it(has(been(documented(in(man(that(VIP(is(also(present(
in(secretory(cells(of(the(mucosal(layer,(as(well(as(the(immune(cells((de(Jonge,(2013).((
VIP(was( originally( identified( in( the( porcine( duodenum( as( a( 28( amino( acid(
residue(peptide,(and(named(for(its(potent(vasodilator(actions((Mutt(and(Said,(1974,(
Schaaper( and( Beyerman,( 1984).( It( has( pleiotropic( effects( on( gut( functions:( 1)( it(
greatly( stimulates( the( mucosal( secretion( of( water( and( electrolyte( (Barbezat( and(
Grossman,(1971,(Schwartz(et$al.,(1974);(2)(it(regulates(gut(motility(by(inhibiting(the(
peristaltic( reflex( (mediates( inhibitory( motor( neurons( in( the( gut)( and( stimulating(
contractions(of(the(circular(smooth(muscle(layer((Grider(and(Makhlouf,(1990,(Grider(
and( Makhlouf,( 1988);( 3)( dilates( peripheral( blood( vessels( and( controls( intestinal(
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blood( flow( (Theodorsson( et$ al.,( 1991);( 4)( promotes( secretion( of( pancreatic(
bicarbonateErich( fluids(and(glucagon,(while( inhibits(gastric(acid( secretion( (Holst(et$




or( local( hormone( varies( greatly( depending( on( its( tissue( location.( As( VIP( is(widely(
distributed(in(the(respiratory(and(urogenital(tracts,(exocrine(glands,(the(thyroid(and(
adrenal( glands,( it( is( involved( in( the( enhanced( mucosal( secretions,( relaxation( of(
smooth( muscle( activity,( hyperventilation,( enhanced( myocardial( contractility( and(
cardiac(output,(as(well(as(its(vasodilatation(role(to(regulate(the(blood(flow(in(those(
organs((Fahrenkrug(and(Emson,(1982).(In(addition,(VIP(has(antiEinflammatory(action(
and(modulates( the(cellular( functions( in( the( immune(system(of( the(body( (Delgado(
and(Ganea,(2013,(Delgado(et$al.,(2004a).(VIP(exerts(its(actions(by(binding(to(two(GE
proteinEcoupled(receptors,(VPAC1(and(VPAC2,(which(also(recognize,(with(a(similar(
high( affinity,( another( neuropeptide( named( pituitary( adenylate( cyclaseEactivating(
polypeptide((PACAP)((Laburthe(et$al.,(2007).(
(
C% PACAP:( PACAP,( like( VIP,( is( multifunctional( neuropeptide( acting( as( a(
prominent( neurotransmitter/( neuromodulator( in( the( central( and( peripheral(
nervous( systems,( as( well( as( the( pituitary( gland.( It( is( also( a( potent( hormone(
regulating( the( paracrine( and( autocrine( secretions( of( various( peripheral( tissues(





In( the( CNS,( it( is(most( abundant( in( the( hypothalamus,(with( lower( levels( in(
other( brain( regions( (Ghatei( et$ al.,( 1993).( In( pancreatic( islets,( PACAP( acts( as( an(
insulinotropic( factor,( at( minute( concentrations,( stimulating( insulin( secretion( in( a(
glucoseEdependent( manner( (Yada( et$ al.,( 1994),( beside( its( parasympathetic( and(
sensory( neurotransmitter( effects.( Additionally,( it( is( considered( as( an(
immunomodulatory( and( antiEinflammatory( agents( acting( through( diverse(
mechanisms( in( the( immune( system( (Delgado( et$ al.,( 2004b,( Ganea( and( Delgado,(
2002,(Leceta(et$al.,(2000).((
(
C% Substance% P:( Substance( P( (SP):( is( a( short( 11( amino( acid( neuropeptide(
known( as( a( brain/gut( peptide,( which( is( found( predominantly( in( the( dorsal( root(
ganglia(and(sensory(neurons,(as(well(as(in(the(gut(and(other(tissues.(SP(has(variable(
roles,(mainly,( it( is( an( important( element( in(pain(perception( and(as( a( regulator(of(
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neuroimmune( interactions( (Harrison( and( Geppetti,( 2001),( it( also( promotes(
epithelial( cell( growth( (Reid( et$ al.,( 1993),( and( has( proinflammatory( properties(
involved( in( inflammatory( diseases( (O'Connor( et$ al.,( 2004).( Moreover,( it( has( a(
significant( role( in( glucose( homeostasis( as( it( affects( insulin( secretion( and( its(
resistance( (Brown( and( Vale,( 1976).( SP( mediates( its( effects( through( 3( neurokinin(
(NK)( receptors,( belonging( to( the( GEprotein( coupledEreceptor( family.( The( highE
affinity(receptor(for(SP(is(NKE1,(while(NKE2(and(NKE3(bind(with(much(lower(affinity(
to(this(neuropeptide((Bellucci(et$al.,(2002).(
In( the( gut,( SP( is( released( by( neurons( of( the( myenteric( and( submucosal(
plexus( and( other( cells( like( enteroendocrine( cells,( eosinophils( and( macrophages.(
Activation(of(both(NKE2(and(NKE3(receptors(affects(GI(motility,(whereas(activation(
of(NKE1R(stimulates(chloride(secretion,(reduces(smooth(muscle(function,(modulates(




the( tachykinin( hormone( family:( substance( P,( neurokinin( A,( neuropeptide( K( and(
neuropeptide( gamma,( depending( on( differential( precursor( RNA( splicing( and(






The( superfamily( of( GPCR( are( also( known( as( 7( transmembrane( domain(
receptors(because(they(pass(through(the(cell(membrane(seven(times.(GPCRs(involve(
the( mentioned( receptors( such( as:( VPAC1,( VPAC2,( PAC1( and( GLPE2R.( Molecules(
outside( the( cell( bind( to( these( receptors( as( ligands( and( activate( them( to( induce(
tissueEspecific( responses( by( acting( through( two( principal( signal( transduction(
pathways:( the( cAMP( signaling( pathway( and( the( phosphatidylinositol( signaling(
pathway((Gilman,(1987).(These(ligands(include(nutrients,(lightEsensitive(compounds,(
odours,(hormones(and(neurotransmitters;(the(latter(are(peptides(or(large(proteins.((
GPCRs( are( engaged( in( a( wide( variety( of( physiological( processes,( they(
mediate(our(sense(of(vision,(smell,(taste,(and(pain((Vaidehi(et$al.,(2002),(as(well(as(
many( automatic( functions( of( the( body( such( as( blood( pressure,( heart( rate( and(
digestive( processes( (Harris( et$ al.,( 2008).( In( addition,( they( regulate( activity( of( the(
immune( system(and( inflammation( (Lombardi(et$ al.,( 2002).(However,( over( 90%(of(
nonsensory(GPCRs(are(expressed( in( the(brain,(where( they(are( involved( in( various(







(T2Rs)( that( belong( to( the( G( protein–coupled( receptors( (GPCRs)( superfamily(
(Bachmanov( and( Beauchamp,( 2007).( The( T1R( family( involves( three( characterized(
members:(T1R1,(T1R2(and(T1R3,(whereas(the(T2R(family(includes(many(members(of(
the( 43( human$ TAS2R( genes,( five( of( which( are( pseudogenes( (Rozengurt,( 2006,(
AndresEBarquin( and( Conte,( 2004,( Bachmanov( and( Beauchamp,( 2007).( The(
T1R2/T1R3( combination( was( identified( as( a( broadEspecificity( sweet( sensor,( while(
the(T1R1/T1R3(combination(acts(as(a(broadEspectrum(LEamino(acid(sensor((Li(et$al.,(
2002,(Nelson(et$al.,(2001).((
These( taste( receptors(are(highly(expressed(on( the(epithelium(covering( the(
tongue(located(on(the(apical(surface(of(taste(cells(in(the(taste(buds.(However,(their(
expression,(for(the(first(time(was(detected(in(enteroendocrine(cells(of(the(intestine(
(Dyer( et$ al.,( 2005).( They( are( also( found( in( other( tissues,( including( pancreas(
(Nakagawa(et$al.,(2009),(brain((Ren(et$al.,(2011,(Singh(et$al.,(2011)(and(several(cell(
types(of(the(airway(epithelium((Folwaczny(et$al.,(1999a,(Pilch,(2008,(Tizzano(et$al.,(
2010).( Generally,( these( receptors( detect( similar( stimuli( using( similar( signaling(
effectors,(but(prompt(different(responses(in(different(tissues.(
(
In( the( taste( cell,( nutrient( tastant( molecules( bind( to( taste( receptors( to(
activate( serial( intracellular( transducers( involving( the( GEprotein( αEgustducin,(
phospholipase(Cβ2((PLCβ2)(and(the(second(messengers(IP3(and(its(receptor(IP3R3,(
which(mediates(the(release(of(Ca2+(from(intracellular(stores.(Subsequently,(the(Ca2+E(
dependent( activation( of(TRPM5( channels,( on( the( cell( membrane,( leads( to( cell(



















salty.( All( other( tastes( come( from( a( combination( of( these( basic( tastes.( They( are(
explained(as(following:((
(







glutamic( acids( like( monosodium( glutamate,( LEamino( acids( and( peptides( like( 5`E
ribonucleotides((Kinnamon(and(Vandenbeuch,(2009,(Li(et$al.,(2002).(
C% Salt% taste:% Salty( flavour( is( sensed(by( salt( receptors( that( are( ion( channels(
admitting( Na+( ions( into( the( cells( resulting( in( cell( depolarization( and( Ca2+(entry.((
Hence,( it( regulates( the( intake( of( Na+( and( other( salts( important( for( fluid( and(
electrolyte(balance((DeSimone(and(Lyall,(2006).((
C%Sour%taste:%Sourness(is(the(taste(that(detects(the(acidity(of(food(and(drinks.(
It( helps( to( avoid( the( ingestion( of( spoiled( food( and( maintaining( the( acid–base(
balance( of( the( body.( The( candidate( sour( receptors,( PKD2L1,( govern( H+( ions(
entering(the(cell,(playing(a(role(as(pH(detectors((Ishii(et$al.,(2009,(Kataoka(et$al.,(
2008,(DeSimone(and(Lyall,(2006). %
C% Bitter% taste:%This( is( the(unpleasant,( sharp,(or(disagreeable( taste(of(bitter(
characteristic(of(many(toxic(compounds.(Bitter(taste(receptors(are(the(T2R(family(








al.,( 2003).( Various( taste( modalities( are( mediated( via( different( mechanisms(
according( to( the(primary( taste( receptor(and( transduction(pathway(expressed( in(a(
given(taste(cell.(As(seen(in(Figure(9,(it(is(believed(recently(that(all(tongue(areas(are(
responsiveness( to( the( five( basic( modalities( in( varying( degree( of( intensity,( as(
modalityEspecific( receptors( (response( to( one( taste( over( the( others)( are( widely(
expressed( in( discrete( subpopulations( of( taste( cells.( The( 'gustotopic'( map( of( the(
tongue( can( be( seen( in( other( tissues( of( the( gut( (e.g.( stomach,( gallbladder,( small(
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intestine,( colon,(etc),(with( taste( receptors(at(different( locations.(Also( true( for( the(
nasoEtracheal(epithelium.(The(brain(also(maps(in(its(response(to(taste((Chen(et$al.,(
2011,(Huang(et$al.,(2006).(










the( small( intestine( has( the( ability( to( sense( luminal( nutrients( via( tasteEreceptors(
(nutrient( sensors)( located( on( the( EECs,( which( are( in( direct( contact( with( the( gut(
contents.( Upon( activation( of( these( receptors,( they( trigger( intrinsic( and( extrinsic(
signalling( pathways,( communicating( with( the( intestinal( sensory,( endocrine( and(
absorptive( cells,( and(evoking(neuronal( circuits( through( the(enteric(nerve(endings,(
which(do(not(penetrate(the(mucosal(epithelium(to(reach(the(gut(lumen((Breer(et$al.,(
2012,( ShiraziEBeechey( et$ al.,( 2011a,( Powley( et$ al.,( 2011). The( chemoEsensation(
promotes( the( secretory( granules( near( the( BLM( of( the( EEC( to( release( peptides(
(stimulating( local( nerves( and( neighbouring( cells)( or( classical( circulating( hormones(
(affecting( distal( tissues)( (Janssen( and( Depoortere,( 2013,( Tolhurst( et$ al.,( 2012).(
These( secretions( are( involved( in( glucose( hemostasis( (Drucker,( 2007)( and( gene(
expression( (Moran( et$ al.,( 2010a),( plus( other( roles( as( discussed( previously( (gut(
hormones(and(neuropeptides).((
Importantly,( intestinal( sensing( enables( the( gut( to( regulate( nutrient(
transporters,(providing(an(adaptive(absorptive( function( to(match( luminal(nutrient(
concentrations.(This(chemoEsensing(concept(of(the(GI(system(became(first(evident(





Expression( of( SGLT1( has( been( shown( to( be( upregulated( in( response( to(
increased(luminal(monosaccharides,(although,(the(metabolism(of(monosaccharides(
is(not(required( for( this( response( (ShiraziEBeechey(et$al.,(1991,(Dyer(et$al.,(1997b).(
Moreover,( the( introduction( of( a( membrane( impermeable( glucoseEanalogue( also(
stimulated( SGLT1( upEregulation,( indicating( that( monosaccharideEinduced( SGLT1(
expression( is( mediated( by( luminal( sensing,( and( is( independent( of( glucose(
metabolism(or(absorption( (ShiraziEBeechey(et$al.,(2011b,(Dyer(et$al.,(2003).(These(
data( suggest( that( there( is( a( glucose( sensor,( distinct( from( SGLT1,( which( detects(
luminal(glucose(and(initiates(a(signaling(pathway(resulting(in(enhancement(of(SGLT1(








expression( and( function( on( either( lowE( or( highEcarbohydrate( diet( (1.9%( and( 70%(




was( identical( to( that( in( wild( type( animals( on( the( lowEcarbohydrate( diet.( This(
suggests(that(the(intestinal(capacity(to(absorb(glucose(is(maintained(via(basal(levels(
of(SGLT1(expression,(independent(of(luminal(sugar(sensing(by(T1R3(and(gustducin,(
although,( this( capacity( becomes( limiting( when( luminal( carbohydrate( exceeds( a(
threshold( level( that( activates( an( inducible( signaling(pathway,( dependent( on( T1R3(
and( gustducin( to( upEregulate( SGLT1( expression( in( response( to( luminal( sugars(
(Margolskee(et$al.,(2007).(
(





Dietary( monosaccharides( as( well( as( artificial( sweeteners( activate( glucose(
sensors((T1R2/T1R3),(on(luminal(surface(of(the(enteroendocrine(cells((Moran(et$al.,(
2010a,(ShiraziEBeechey(et$al.,(2011b).(Activated(receptors(engage(αEgustducin(and(
provoke( intracellular( signaling( pathways,( involving( elevated( calcium( levels,(
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membrane( depolarization( and( second( messenger( cascades,( to( promote( the(
secretion( of( gut( hormones:( GLPE1,( GLPE2( and( GIP( (Rasoamanana( et$ al.,( 2012).( In(
response(to(luminal(carbohydrates,(EECs(secrete(GLPE2(hormone,(which(is(involved(
in( the( upEregulation( of( SGLT1( expression( (Drucker,( 2001a,( Moran( et$ al.,( 2010a).(
GLPE2(interacts(with(its(receptors((GLPE2R),(residing(on(afferent(enteric(neurons,(to(
elicit( neuronal( signals( transmitted( through( the( submucosal(myenteric( plexus( and(
promotes( the( release( of( neuropeptides( at( the( nerve( ending( (Stoner,( 2005).(
Consequently,( neuropeptides( PACAP( and( VIP( bind( to( their( VPAC1( receptors,(
stimulatory(GEprotein(receptors,(on(the(BLM(of(the(absorptive(enterocytes.((
(
This( results( in( elevated( levels( of( intracellular( mediator( cAMP( and( hence,(
increases(the(postEtranscriptional(cAMPEdependent(stability(of(SGLT1(mRNA((Sharp(
and(Debnam,( 1994,( Sternini(et$ al.,( 2008).( Eventually,( enhances( the( expression( of(









It( has( been( demonstrated( that( GIP( also( participate( in( intestinal( glucose(










mutations( in( SGLT1( gene.( However,( several( missense( mutations( have( been(
identified(in(different(sequences(of(the(gene(in(GGM,(either(in(the(transmembrane(
helix( or( in( the( extracellular( loop( (e.g.( Gly318Arg( and( Ala468Val),( (Leu147Arg( and(
Cys355Ser)( and( (Ala304Val( and(Arg499His)( (Wright(et$ al.,( 2002,( Turk(et$ al.,( 1991,(
Martin(et$al.,(1996).(SGLT1(mutations(do(not(affect(protein(synthesis,(insertion(into(
the( endoplasmic( reticulum( or( glycosylation,( but( they( severely( impair( protein(











al.,( 1966).( The( diarrhoea( is( caused( by( the( intestinal( accumulation( of(
glucose/galactose,(which(attracts(water(by(their(osmotic(effect.(Moreover,(the(loss(
of(the(SGLT1(function(as(a(water(pump,(due(to(impaired(glucoseEstimulated(water(
absorption,( leads( to( more( accumulation( of( luminal( water( and( overEloading( the(
intestine( with( fluids( promoting( peristalsis.( This( diarrhoea( ceases( once( intake( of(
lactose,(sucrose,(glucose(and(galactose(are(withdrawn(from(the(diet,(but(promptly(
resumes( if( they( are( reEintroduced.(However,( children(with(GGM(are( treated(with(





( CLD( is( a( common( enzyme( deficiency( disorder( that( is( inherited( as( an(
autosomal( recessive.( It( is( due( to( mutation( in( the( lactase( enzyme( coding( gene,(
affecting( the( protein( structure( and( trafficking( pathway( (Uchida( et$ al.,( 2012).(
Therefore,( lactase( enzyme( activity( is( severely( diminished( to( 5E10%( in( the( small(
intestinal( epithelium( resulting( in( impaired( lactose( digestion( and( it( will( not( be(
absorbed,( and(hence( its( accumulation( creates( a( luminal(osmotic( effect( leading( to(








Diabetes( mellitus( (DM)( is( a( common( metabolic( disorder( characterized( by(
disturbance( in( the( metabolism( of( carbohydrates,( fat( and( proteins,( resulting( in(
uncontrolled( hyperglycaemia.( DM( is( classified( by( the( World( Health( Organization(






diabetes( mellitus( (NIDDM),( which( is( the( most( common( form( of( DM( and( mostly(
affects(adults(over(40(years(of(age((discussed(later).(Type(3(is(known(as(gestational(
diabetes( that( affects( pregnant( mothers( and( can( be( resolved( after( delivery.( Both(




It( is( a( common( heterogenic( disease( in( the( developing( countries( with(
increased(incidence(and(threatening(complications.(It(is(strongly(affected(by(genetic(
predisposition(plus( causative( environmental( factors( that( impair( the( tissue( insulinE
sensitivity,( like( consuming( high( carbohydrate( diets( and( central( obesity( (Otieno(et$
al.,(2008,(Alberti(and(Zimmet,(1998).(Patients(with(NIDDM(present(with(the(classic(
symptoms(of( diabetes( (ie,( polyuria,( polydipsia,( polyphagia,( fatigability( and(weight(
loss).( Upper( gastrointestinal( dysfunctions( are( common( among( diabetic( patients,(
such( as( abdominal( pain,( vomiting,( constipation,( diarrhea,( which( could( indicate(
diabetic(autonomic(neuropathy(involving(the(GIT((Alwakeel(et$al.,(2009,(Schlienger,(







1E Fasting( blood( glucose( level( of( ≥( 126( mg/dL( (7( mmol/L)( on( two( separate(
tests.(
2E Random(blood(glucose(level(of(≥(200(mg/dL((11.1(mmol/L).((
3E Oral( glucose( tolerance( test( (OGTT)( is( the( measuring( of( plasma( glucose(
concentration( before( the( test( (fasting)( and( after( drinking( 75g( glucose( syrup.(
The(record(of(≥(7(mmol/l(in(fasting,(or(≥(11.1(mmol/l(two(hours(after(the(OGTT(
indicates(diabetes.((








Complications( of( diabetes( mellitus( vary( between( progressive( chronic( to(
dangerous( acute( situations( due( to( uncontrolled,( i.e.( extremely( high( or( very( low,(
blood( glucose( levels.( Acute( complications( include:( diabetic( ketoacidosis,(
hyperglycemia( hyperosmolar( state,( hypoglycemia,( which( are( considered( as( a(
medical( emergency( leading( to( diabetic( coma( or( death( if( there( is( inadequate( or(




loss)( and(neuropathy( (presented( as( diabetic( foot( and( skin,( nail( and(hair( changes)(
(Alwakeel(et$al.,(2009,(Schlienger,(2013,(Sima,(2006).(Macrovascular(damage(leads(
to( brain( stroke,( cardiovascular( disease( (heart( attack)( and( diabetic( myonecrosis(
(muscle( wasting).( Additionally,( impaired( immune( response( in( diabetic( individuals(




Diabetes(mellitus( is(effectively(managed(by(multimodal( intensive( therapies(
to(maintain(glucose(homeostasis(and(to(minimize(the(risk(of(complications.(In(type(
1((IDDM),(insulin(injections(are(the(chief(line(of(treatment,(or(pancreatic(transplants(
in( severe( uncontrolled( diabetic( cases( (Folwaczny( et$ al.,( 1999b).( However,( in(
patients( with( type( 2( (NIDDM),( treatment( starts( with( controlling( blood( pressure,(
consuming( a( carbohydrateErestricted( diet,( encouraging( physical( exercise( and(
reducing(body(weight.( Insulin( injections(and(oral(hypoglycaemic(drugs((OHD)(have(
been( also( used( as( standard( medical( approaches,( prescribed( either( alone( or( in(
combination.( OHD( mainly( act( by( enhancing( endogenous( insulin( release( (insulin(
sensitizers:( metformin( and( the( thiazolidinediones),( or( increasing( its( action(
(sulfonylureas( and( meglitinides),( minimizing( insulin( resistance,( reducing( hepatic(
gluoconeogenesis( (biguanides),( limiting( glucose( absorption( through( inhibiting(
sugars( hydrolysis( by( the( intestinal( BBM( disaccharidases( (alphaEglucosidase(
inhibitors),(or(lipolysis(inhibitors((Bell,(2004,(Wagman(and(Nuss,(2001).((
However,(due(to(the(limited(efficacy(and(side(effects(of(insulin(and(OHD,(the(
development( of( new( therapeutic( alternatives( has( become( mandatory.( Recently,(
researchers(shifted(their(attention(to(manipulate(the(intestinal(capacity(for(dietary(
sugar( absorption( by( investigating( glucose( transporter( expression,( their( regulation(
and(inhibition.(This(work(gave(rise(to(a(newly(innovative(drug(Thioglycosides,(which(
control(hyperglycaemia(by(inhibiting(hSGLT1((Castaneda(et$al.,(2007).(Although,(it(is(





( Previous( studies( on( human( patients( with( nonEinsulin( dependent( diabetes(
mellitus( (NIDDM)( showed( that( the( enhanced( expression( of( intestinal(
monosaccharide( transporters( SGLT1( leads( to( the( increased( capacity( of( intestinal(
glucose(absorption((Dyer(et$al.,(2002b).(These(results(were(also(observed(in(diabetic(
rats((LorenzEMeyer(et$al.,(1977).(It(was(also(found(that(SGLT1(transporter(activity(is(







Hence,( new( strategies( can( be( designed( to( manage( postprandial(
hyperglycemia(by(reducing(the(absorption(of(dietary(sugars(from(the(gut,(resulting(
in(lower(blood(glucose(levels.(Researchers(can(contribute(by(identifying(the(factors(
and(pathways( involved( in(the(regulation(of( intestinal(glucose(transport.( Interest( is(




Some( innovative( drugs( are( under( clinical( trail,( for( treatment( of( type( II(
diabetes(with(minimal(risk(of(hypoglycemia,(such(as(inhibitors(of(SGLT1(and(SGLT2(
to( reduce( renal( glucose( reabsorption( as( well( as( to( promote( urinary( glucose(
excretion( (Kinne( and( Castaneda,( 2011,( Washburn,( 2012,( Tahrani( et$ al.,( 2013).(
LX4211,( is( a( dual( inhibitor( of( SGLT1( and( SGLT2( that( is( also(modulating( intestinal(
glucose(absorption((Lapuerta(et$al.,(2013,(Zambrowicz(et$al.,(2012).((
(
Additionally,( the( use( of( glucose( analogues( Thioglycosides( has( shown(
promising(therapeutic(potential( to(control(hyperglycemia((Castaneda(et$al.,(2007).(
The(first(drug(developed(was(the(phlorizin(analogue(TE1095,(which(blocks(SGLT2(to(
reduce( glucose( reabsorption( in( the( proximal( convoluted( tubules( in( the( kidney(
(Arakawa( et$ al.,( 2001,( Oku( et$ al.,( 2000).( TE1095( significantly( improved(
hyperglycemia( and( prevented( diabetic( neuropathy( (Ueta( et$ al.,( 2005).( Other(
examples( of( specific( SGLT2( inhibitors( include( Dapagliflozin( (BMSE512148),( which(
reduces( blood( glucose( by( 55%( after( 5( hours( of( a( single( dose( and( is( extremely(
selective( for( SGLT2( than( SGLT1( (Han( et$ al.,( 2008,(Meng( et$ al.,( 2008),( Sergliflozin(






Insulin( is( the( most( potent( hormone( regulating( the( metabolism( of( lipids,(
proteins( and( carbohydrates,( by( promoting( their( synthesis( and( storage( while(
inhibiting(their(breakdown(and(release( into(the(blood((Khan(and(Pessin,(2002).( Its(
main( anabolic( action( is( stimulating( the( uptake( of( glucose,( amino( acids( and( fatty(




Insulin( is( synthesized( by( the( islets( of( β( cells( of( the( pancreas( and( secreted(









The( main( insulinEregulated( glucose( transporter( is( the( facilitative( glucose(
transporter(GLUT4(that( is(expressed(abundantly( in(adipocytes(and(skeletal(muscle(
cells( (James( et$ al.,( 1988).( Insulin( increases( glucose( uptake( in( these( cells( by(
stimulating(the(translocation(of(GLUT4(from(intracellular(compartments,(where(it(is(
sequestered( in(GLUT4(storage(vesicles( (GSV)( in( low( insulin(state,( to(the(functional(
site( on( the( surface( of( the( cytoplasmic( membrane( (Pilch,( 2008).( This( GLUT4(
translocation(is(a(complex(process(initiated(by(the(binding(of(insulin(to(its(receptor(
(IR),(which(has( two(extracellular(αEsubunits( (hormoneEbinding(domain)( that( autoE
phosphorylates( the( transmembrane( βEsubunits( and( activates( the( tyrosine( kinase(
domain( (Gammeltoft(and(Van(Obberghen,(1986,(Kido(et$al.,(2001).( In( response(to(
insulin–receptor( binding,( intracellular( proteins( known( as( insulin( responsive(
substrates( (IRS)( are( phosphorylated,( which( in( turn,( interacts( with( other( insulin(
signaling( molecules( to( promote( further( cascades.( Eventually,( this( leads( to( the(
trafficking( of( GLUT4( vesicles( by( mediating( the( tethering,( docking( and( fusion( of(
GLUT4(protein(to(the(cell(membrane((Govers(et$al.,(2004,(Karylowski(et$al.,(2004).(
Finally,( after( achieving( the( effect( of( insulinEregulated( glucose( transport,( GLUT4( is(
removed( from( the( cell( surface( by( endocytosis( of( the( insulinEreceptor( complex(
(Chang( et$ al.,( 2004,( Larance( et$ al.,( 2008,( Rowland( et$ al.,( 2011),( and( insulin( is(




In(NIDDM,( insulin(has(normal( levels(but( the(peripheral( target( tissues(have(
reduced(sensitivity(to(insulin((partial(or(complete(insulin(resistance).(This(resistance(
is(either(due( to(defects( in(some(of( the( IRS(members( (Sesti(et$al.,(2001)(or(due( to(
misEtrafficking( of( the( insulinEstimulated( GLUT4( translocation( affecting( GLUT4(
expression(on(the(cell(surface(of(the(adipocytes(and(myocytes((Miura(et$al.,(2001).(








a( genotoxic( chemical( that( particularly( targeting( the( pancreatic( insulinEproducing(
beta( cells.( Therefore,( it( was( used( as( chemotherapy( for( treating( certain( cases( of(








(STZ( is( a( glucosamineEnitrosourea(molecule( that( has( a( similar( structure( to(
glucose,(enough(to(compete(with(glucose,(to(be(taken(up(by(the(glucose(transporter(
GLUT2( into( the( pancreatic( β( cell.( STZ( is( not( recognized( by( other( glucose(




alkylating( and( directly( methylating( the( DNA.( The( damaged( DNA( (singleEstrand(
breaks)( induce( the( crucial( step( for( the( diabetogenic( effect( of( STZ,( activating( poly(
ADPEribosylation( resulting( in( the( reduction( of( NAD+( and( ATP.( The( enhanced(
phosphorylation( of( ATP( provides( a( substrate( for( xanthine( oxidase( to( form(
superoxide( radicals,( subsequently,( generating( hydrogen( peroxidase( and( hydroxyl(
radicals.(As(a(result(after(STZ(treatment,(insulinEproducing(beta(cells(are(destroyed(
by(necrosis.(Superimposed(on(these(effects(is(the(immune(reaction(evoked(against(









hyperphagia,( altered( intestinal( functions,( and( arrested( body( weight( gain,( but(











To( investigate( potential( changes( in( morphology( and( carbohydrate(
digestive( and( absorptive( functions( of( the( small( intestine( of( control( and(
diabetic(subjects.(StreptozotocinEinduced(diabetic(rats(were(used(as(a(model(








2. The( activity( of( disaccharidases( and( SGLT1( expression( in( duodenal( biopsies(
obtained(from(diabetic(subjects(compared(with(those(obtained(from(healthy(
controls.(

























peptide( corresponding( to( amino( acids( 402E420( (STLFTMDIYTKIRKKASEK),( a(
conserved(intracellular(loop(of(SGLT1((Dyer(et$al.,(2009).(
E GLUT2(polyclonal(antibody:(two(antibodies(were(used:((
1E A(commercial(antibody( raised( in( rabbit(against(a(peptide( sequence(of( rat(
GLUT2((residues(40E55),((clone(07E1402,(Millipore(Ltd,(Watford,(UK),((
2E Antibody( raised( in( rabbits( (custom( synthesis)( to( a( synthetic( peptide(
corresponding( to( amino( acids( 523–536( (AAVEMEFLGATETA)( of( equine(
GLUT2(CEterminus(region((Stearns(et$al.,(2010).(
E T1R2( and( T1R3( polyclonal( antibodies:( T1R2( (HE90):scE50305( and( T1R3( (HE
145):scE50353,( commercial( antibodies( raised( in( rabbit( and(were( purchased(
from(Santa(Cruz(Biotechnology,(INC.,(CA,(USA.(
E Mouse( monoclonal( antibody( against( βEActin( (clone( ACE15)( was( purchased(
from(SigmaEAldrich(Ltd,(Poole,(Dorset,(UK.((
E VIP( polyclonal( antibody:( raised( in( rabbit( (AB982,( Merck( Millipore,(
Deutschland,(Germany).((




E FITC( (Fluorescein( isothiocyanate)( secondary( antibodies:( FITCEconjugated(
donkey( antiErabbit( and( antiEmouse( IgG( were( used( as( appropriate( in(
immunohistochemistry,( they( were( purchased( from( Jackson(
ImmunoResearch(Laboratories,(West(Grove,(USA.(
E (Affinity( purified( peroxidaseElinked( swine( antiErabbit( and( rabbit( antiEmouse(





the( recombinant( plasmid( pGEMETeasy( Vector( System( were( purchased( from(
Promega(Ltd.,(Southampton,(UK.((












the( Enhanced( ChemiLuminescence( kit( (ECL)( purchased( from( AmershamE
Biosciences( Ltd.,( Buckinghamshire,( UK,( and( the( spray( (WESTEone( Western(
Blot( Detection( System,( iNtRON)( was( obtained( from( Biotechnology,( UK.(
Western( blot( membranes( were( exposed( to( Kodak( Biomax( Light( film(
purchased(from(SigmaEAldrich.(




ladder( and( the( Orange( Loading( Dye( solutions( were( purchased( from( MBI(
Fermentas,(Hanover,(MD,(USA,(as(was(the(100(mM(nucleotide(NTP(set.(((
E pGEMETeasy( Vector( System( for( PCR( products( cloning( was( purchased( from(
Promega( Ltd.,( Sunderland,( Tyne( and( Wear,( UK,( as( was( the( AMV( Reverse(
transcriptase.((((
E The( radioisotopes( DE[U( 14C]Eglucose( used( for( the( transport( studies( were(













All( animal( procedures(were( carried(out(under( the( regulations(of( approved(
UK(Home(Office(project(licence.(All(Home(Office(permissions(were(in(place(and(work(
was( in( accordance( to( the( Animals( (Scientific( Procedures)( Act( 1986.( The(
Establishment( license(number((Home(Office(permission(for(Liverpool(University)( is(
40/2408.( The( use( of( intestinal( tissues( from( diabetic( and( control( rats( were( under(
project( license( number( 40/3144,( PPL( holder( Dr( Laiche( Djouhri.( Rodents( were(
provided( by( the( University( of( Liverpool( Biomedical( Sciences( Unit,( and( they( were(
sacrificed(by(schedule(1(of(the(UK(Home(Office(Regulation.((Pigs(were(provided(by(
the( University( of( Liverpool( Farm( Animal( Division,( they( were( maintained( on(







40( %( carbohydrate( diet( for( 5( to( 8( days( (diets( were( obtained( from( Purina( Mills,(
Richmond,(IN,(USA).(They(were(housed(in(a(room(kept(at(21±2°C(and(was(on(a(12E
hour(light/dark(schedule.(They(were(sacrificed(by(cervical(dislocation(and(the(entire(
small( intestine( was( removed( immediately.( It( was( cut( into( 3( equal( sections(
corresponding(to(proximal,(mid(and(distal(parts.(The(intestinal(loops(were(cut(open(
and(rinsed(clean(with(cold(saline((0.9(%(NaCl,(pH(7.4).(Then,(tissues(for(brushEborder(
membrane( vesicle( preparation( were( wrapped( in( aluminium( foil( and( frozen(
immediately( in( liquid(nitrogen(and(stored(at( E80( °C(until(use.(Pieces(of( tissue,(2E3(
cm,(were(placed( into(PBS( containing(4%(paraformaldehyde( for(4(hours(at(4°C( for(
subsequent( fixing( as( described( below( for( histological( assessments( and(
immunohistochemical(studies.(
(
( Pigs:(Male(and( female(pigs(were(used( in( this( study( (Landrace(X(Large(White).(
Weaned(pigs(were(43(days(old,(whilst(suckling(pigs(aged(28(days.(They(were(housed(
in(a(room(kept(at(21±2°C(and(was(on(a(12Ehour(reverse( light(schedule.(They(were(
sacrificed( with( an( intravenous( injection( of( 20( ml( Penobarbitone( (200( mg/ml,(
Pentoject,(Animal( care( Ltd,( York,(UK)( into( the( cranial( vena( cava( in( the( chest.( The(
small( intestine(was(removed(from(animals(and(divided( into(sections(of(duodenum(
(distal( to( the( pylorus),( jejunum( (half( way( along( the( small( intestine)( and( ileum(
(proximal(to(the(ileocaecal(junction).(The(tissue(sections(were(everted(and(cleaned(






and( diabetics.( They( were( housed( in( standard( environmental( conditions( with(
temperature(of( (21( ±( 2( °C),( humidity( (55( ±( 10(%),( and( a( 12(hour( lightEdark( cycle,(
with( available( access( to( water( and( food.( After( killing( by( cervical( dislocation,( the(
small( intestinal( tissues( were( removed( and( divided( into( proximal,( mid( and( distal(
parts.(They(were(collected(and(treated(similar(to(mouse(intestinal(tissues(described(
above(for(immunohistochemical(studies,(while(the(BBMVs(were(prepared(freshly(on(






ethics( committee( (MREC( 02/11/228/A( 2K/128)( and( King( Abdulaziz( university(
hospital( ethics( approval( (KAU( 358/2766EGE).( Written( consents( from( the( patients(
were(secured(before(tissue(biopsy(removal.(Tissue(biopsies(were(transferred(from(
KSA(to(UK(in(dry(ice(package(using(FedEx(by(express(post.((((%




>( 5.5( mmol/L,( or( random( blood( glucose( level( of( >( 10.5( mmol/L.( Three( diabetic(




frozen( immediately( in( liquid( nitrogen( then( stored( at( E80( °C( for( BBMV,( PNMF(
preparations( and( RNA( isolation( or( fixed( in( Paraformaldehyde( for(
immunohistochemical(studies.(Some(samples(were(collected(at(the(Royal(Liverpool(
University( Hospital( (Liverpool,( UK)( by( Dr( Anthony( Ellis,( consultant(
gastroenterologist.( While( some( other( samples( were( collected( at( King( Abdulaziz(




Diabetes( mellitus( in( rats( was( induced( experimentally( by( Streptozotocin(
injection((STZ,(Sigma(Aldrich(S0130).(Rats(were(kept(fasting(for(18E24(hours(before(
the( intraEperitoneal( injection( of( a( single( dose( (60( mg/kg( body( weight).( STZ( was(




After( 3( to( 7( days( of( STZ( administration,( a( random( blood( glucose(











Mannitol((Sigma)(( ( ( ( 100(mM(
HEPES/Tris,(pH(7.1((Fisher(Scientific)(( 2(mM(
C%Buffer%2%
(Mannitol(( ( ( ( ( 100(mM(
(HEPES/Tris,(pH(7.4( ( ( ( 2(mM(
(MgSO4(( ( ( ( ( 0.1(mM(
C%Buffer%3%
(((((Mannitol(( ( ( ( ( 300(mM(
(((((HEPES/Tris,(pH(7.4( ( ( ( 20(mM(
(((((MgSO4(( ( ( ( ( 0.1(mM(
(((((NaN3((Sigma)( ( ( ( (((((((((0.02%((w/v)(
(
The( method( of( isolating( brushEborder( membrane( vesicles( is( based( on( the(
differential( centrifugation( and( cation( precipitation( techniques( as( described( by(
Kessler(et$al.1978(and(Biber(et$al.1981.((
All(steps(of(the(procedure(were(carried(out(at(4(°C(and(following(the(method(
of( ShiraziEBeechey( et$ al.,( 1990.( Protease( inhibitors( were( added( to( the( hypotonic(
buffer(1,(either(Protease(Inhibitor(Cocktail((one(tablet(of(PIC(((Roche)(per(50(ml(of(
buffer( 1)( for( proximal( small( intestinal( samples,( or( mixture( of( several( protease(
inhibitors:( 0.5( mM( benzamidine( (Sigma),( 0.5( mM( 1,4Edithiothreitol( ‘DTT’( (Sigma)(
and( 0.2( mM( phenylmethylsulfonyl( fluoride( ‘PMSF’( (Fluka)( for( the( mid( and( distal(
tissue(samples.((
Intestinal( tissues( 5E10( g(were( thawed,( or( used( freshly,( in( 30(ml( of( iceEcold(
buffer( 1,( and(were( cut( into( small( pieces( by( sharp( scissors.( In( a( thickEwalled( glass(
tube,(mucosal(enterocytes(were(removed(from(the(tissue(using(a(VIBROEmixer(EI™(
with(a(23(mm(diameter(head((Chemap(AG,(CHE8604(Volketswil,(Switzerland)(on(the(
highest( sitting( for( 1(minute(or( until(muscle( pieces( appeared( smooth.(Vibromixing(
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( To( remove( soluble( membranes( and( organelles( from( the( cell( suspension,(
MgCl2( was( added( to( a( final( concentration( of( 10( mM( and( stirred( on( ice( for( 20(
minutes.( For( the( sedimentation( of( the( large( cell( organelles( and( nuclei,( the( cell(
suspension(was( centrifuged(at( 3000( x( g( for( 10(minutes( at( 4( °C( (SSE34( fixed( angle(
rotor,( Sorvall( RCE5C( centrifuge,( Kendro( Laboratory( Product,( USA).( The( pellet,(
containing( the( precipitated( nuclei,( was( discarded,( while( the( supernatant( was(
collected(and(centrifuged(at(30,000(x(g(for(30(minutes(at(4(°C.((
The(supernatant(was(discarded(and(the(pellet(was(reEsuspended(in(Buffer(2(




of( 20E30( mg/ml.( The( sample( was( homogenized( by( passing( through( a( 27Egauge(
needle(or(Hamilton(syringe(several(times.(Aliquots(of(the(brushEborder(membrane(
vesicles( were( divided( and( some( were( stored( in( liquid( nitrogen( for( uptake( tests,(
while(other(aliquots(were(stored(at(E20(°C(for(Western(blotting(and(enzyme(assays.((
For(the(diabetic(and(control(rats,(the(BBMVs(were(prepared(using(the(freshly(
removed( small( intestinal( tissue( as( soon( as( possible( after( animals( were( killed.( DE
glucose(uptake(assays(were(carried(out(on(the(same(day(as(the(use(of(fresh(tissue(
showed( better( results.( Aliquots( were( mixed( with( sample( buffer( for( SDSEPAGE(
electrophoresis( before( freezing( to( avoid( freezing/thaw,( which( leads( to( protein(
degradation.%
%
2.3.2. Preparation! of! brushDborder! membrane! vesicles! (BBMV)! from!
human!duodenal!biopsies!!
BrushEborder(membrane( vesicles( (BBMV)(were( isolated( from( frozen(human(




10/25( RotorEStator( device( for( 30( seconds.( The( Polytron( was( rinsed( with( 1( ml( of(
buffer(1(to(collect(all(cell(suspension.(50E100(µl(of(homogenate(was(preserved(for(
later(use.(MgCl2(was(added(to(the(cell(suspension(to(a(final(concentration(of(10(mM(
and(mixed( for( 20(minutes( in( a( rotary(mixer( in( a( cold( room.(After(mixing,( the( cell(









2.3.3. Preparation! of! postDnuclear! membrane! fractions! (PNMF)! from!
human!biopsies:!!
Using(the(method(described(by(Lambert(et$al.,((2002)(and(Klett(et$al.,((2004).(




120(µl(of(hypotonic(Buffer(1(containing(protease( inhibitor(cocktail( (1( tablet(of(PIC(





sample( was( mixed( and( any( visible( connective( tissue( was( removed( with( a( sterile(
pipette(tip.(50(µl(of(homogenate(was(reserved(and(stored(at(E20(°C(to(be(used(as(a(
control(for(later(studies.(The(suspension(was(centrifuged(at(500(x(g(for(10(minutes(
at(4( °C( (rotor(SSE34,(Sorvall(RCE5C(centrifuge,(Kendro(Laboratory(Product,(USA)( to(
sediment( the( nuclei.( The( nuclei( pellet( was( discarded( and( the( supernatant( was(
centrifuged( at( 30,000( x( g( for( 30(minutes( at( 4( °C.( The( final( pellet,( containing( the(
purified(postEnuclear(membrane(fractions,(was(resuspended(in(20E50(µl(of(isotonic(
























filtered( through(Whatman( filter(paper.(Then,(5(ml(were(added( to( the( tubes(of(all(
samples(and(standards(of(the(calibration(curve,(mixed(and(incubated(for(10(minutes(
at(room(temperature.((
For( both( micro( and( macro( assays,( the( absorbance( of( all( reactions( was(
measured(against(a(noEprotein(blank(at(595(nm(using(a(spectrophotometer((Hitachi(






The( transport( rate( of( DEglucose( into( the( intestinal( BBMVs( was( estimated( by(
using(the(rapid(filtration(technique(as(described(by(Shirazi(et$al.,((1981a)(DEglucose(























pore( size,( cellulose( acetate/nitrate( filters,(Millipore,( GSTF02500(Millipore,( Herts.,(















containing( Phlorizin,( to( the( tube( and(mixed( by( vortexing.( 900( μl( of( the( reaction(
mixture(was( removed( and( filtered( immediately( through( the( preEwetted(Millipore(
filters(under(suction(with(vacuum.(The(filter(was(washed(five(times(with(1(ml(of(iceE
cold( stop( solution( to( remove( excess( radioElabelled( DEglucose.( The( washed( filters(
were( then(placed( into( scintillation( vials( and(dissolved( in( 4(ml( of( scintillation( fluid(
(OptiPhase( ‘hiSafe’( 2( Liquid( Scintillation( Cocktail,( PerkinElmer,( Leics,( UK),( and(
counted( for( radioactivity( in( a( scintillation( counter( (LS( 6500( MultiEpurpose(
Scintillation(Counter,(Beckman(Coulter,(USA).((
(
Internal( standards( were( also( performed( using( the( unfiltered( incubation(
medium( (containing( either(NaSCN(or( KSCN)( that(was( selected( randomly( from( the(
samples.(50(μl(of(the(unfiltered( incubation(medium(was(mixed(with(4(ml(of( liquid(
scintillation(cocktail.(To(account(for(the(nonEspecific(binding(of(the(radioElabelled(DE





In(order( to( calculate( the(Na+( Edependent(DEglucose( transport( rate( into( the(
BBM( vesicles,( Na+( and( K+( Ebased( uptake( buffers( were( used.( Results( obtained( in(
presence( of( K+( were( subtracted( from( those( measured( in( the( presence( of( Na+( E








Sucrose((Sigma)( ( ( ( ( 56(mM((
C%Maltase%assay%buffer%
Na+(Maleate,(pH(6(( ( ( ( 100(mM(
Maltose((Sigma)( ( ( ( ( 56(mM((
C%Lactase%assay%buffer%%
Na+(Maleate,(pH(6(( ( ( ( 100(mM(







and(markers( for( the( brushEborder(membrane.(Disaccharidase( assays(were( carried(
out(based(on( the(method(of(Dahlqvist( (1964).(The(specific(enzyme(activities(were(
measured,( at( the( physiological( temperature( of( 37( °C,( in( the( brushEborder(
membrane( vesicles( (BBMV)( and( their( corresponding(homogenate( to( calculate( the(
enrichment(and(recovery(of(the(samples.(










manufacturer( using( the( supplied( solution( 1( and( suspension( 2.( To( each( sample(
reaction(tube,(1.9(ml(of(ddH2O(and(1(ml(of(Solution(1((mixture(of(powder(consisting(
of( NADP,( ATP,( MgSO4( and( Triethanolamine( buffer,( pH( 7.6,( diluted( in( 45( ml( of(
ddH2O)(was(added.((The(reaction(was(started(by(the(addition(of(20(µl(of(Suspension(
2( (contains:(Hexoquinase,( glucoseE6Ephosphate(dehydrogenase).( They(were(mixed(
and( incubated( at( room( temperature( for( 15(minutes.( Finally,( the( absorbance(was(






E Activity((µmol/ml/min)(=(!"#$%!!"#$%&! !" ×! "#$%"&'!!"#$%&!×! "#$%"&'()!!"!!"#!(!")!ℇ!×!!"#$%&!!"#$%&! !" ×!!"#$!(!"#.) ((
(
















However,( the( activity( of( maltase( was( divided( by( two,( because( a( single(
reaction(of(maltose(hydrolysis(gives(two(DEglucose(molecules.(
The( released( DEglucose( in( the( reaction( was( determined( using( the( commercial( DE

























pENitrophenylphosphate( (pNPP)( was( used( as( a( chromogenic( substrate( for(
alkaline(phosphatase(in(the(enzyme(assay,(according(to(the(method(of(Shirazi$et$al.,$
(1981b).( A( reaction( buffer( was( made( containing:( 10( mM( disodium( carbonate(




The( samples( were( diluted( appropriately( with( buffer( 3,( 50( µl( aliquot( were(
placed( in( plastic( tubes( and( incubated( at( 37( °C( for( 2(minutes( along(with( a( buffer(
blank.(The(reaction(was(started(by(the(addition(of(1(ml(enzyme(assay(mix(and(was(













E(Activity((µmol/ml/min)(=(!"#$%!!"#$%&! !" !×! "#$%"&'!!"#$%&!×! "#$%"&'()!!"!!""!(!")ℇ!×!!!"#$%!!"#$%&! !" !×!!"#$!(!"#.) (
(





The( BioERad(MiniEPROTEIN( II( dual( slab( cell( apparatus( (BioERad,( Herts.,( UK)(
was( used( for( gel( casting.( The( glass( front( plate( and( 1(mmEthick( glass( spacer( plate(
were(ethanolEcleaned(and(assembled(alongside(each(other( in(a(holding(device.(All(
reagents( for( polyacrylamide( gels(were(warmed( to( room( temperature( before( use.(
Ammonium(persulphate((APS)(solution(was(prepared(immediately(before(use.(((
























Running/separating(gel(mixture(was(poured(by(pipette(between( the( two( layers(of(
glass(plates,(avoiding(bubbles,(up(to(2(cm(below(the(top(edge.(5E7(drops(of(waterE
saturated(butanol(were(added(on(top(forming(a(thin(layer,(and(the(gel(was(allowed(
to( polymerise( for( 30E40(minutes.( Then,( the( layer( of(waterEsaturated( butanol(was(
removed(with(absorbent(filter(paper(just(before(pouring(the(stacking(gel(by(pipette(
over( the(polymerised( running(gel.(A(plastic( comb(was( inserted(between( the(glass(

























Constant( amounts( in( µg( of( protein( samples(were( diluted( at( least( 1:3( ratio(
(v/v)(with(denaturing(2X(sample(buffer.(For(the(immunoblotting(of(samples(from(pig(
intestine,( 20( µg( of( protein( was( used.( While,( for( the( immunoblotting( of( samples(



















After( gel( electrophoresis,( the( gel( was( removed( from( the( electrical( rig,( the(
glass( plates( were( separated( gently( and( the( stacking( gel( was( discarded.( In( a( tray(
containing(transfer(buffer,( the(gel(was(carefully(removed(from(the(glass(plate(and(
laid(facing(upward(onto(a(3(mm(Whatman(filter(paper.(Prior(to(using(the(Polyvinyl(
difluoride( (PVDF)(membrane( (ImmunoEBlot(PVDF,(BioRad,(UK),( it(was(activated(by(
















Trichloroacetic( acid)( was( done( to( evaluate( the( success( of( the( electrotransfer( of(
proteins( from( the( gel( to( the( membrane.( The( gel( was( discarded( and( the( PVDF(
membrane( was( removed( from( the( transfer( apparatus( and( rinsed( in( ddH2O( to(
eliminate(all(traces(of(methanol.(The(membrane(was(stained(with(Ponceau(Red(for(
30E60( seconds,( then( washed( gently( with( a( little( amount( of( ddH2O( removing(
background( staining( to( inspect( protein( bands( for( evidence( of( degradation.( The(
membrane( was( deEstained( by( rinsing( repeatedly( in( ddH2O.( It( was( air( dried(















The( PVDF( membrane( was( incubated( in( 20( ml( of( blocking( solution,( as(
appropriate( in( table(2.1,(at( room(temperature( for(1(hour(with(constant(agitation.(
Skimmed(dried(milk(was(used(as(a(blocking(agent(to(avoid(the(nonEspecific(binding(
of(the(primary(antibody(to(proteins(on(the(PVDF(membrane.(The(blocking(solution(


































The(membrane( was( then( washed( three( times( for( 10(minutes( in( 10(ml( of(








NonEspecific( protein( binding( was( blocked( by( incubating( the( PVDF(
membrane(in(20(ml(of(blocking(solution((5(%((w/v)(skimmed(milk(powder,(0.1(mM(
EDTA( and( 0.1(%( (v/v)( Triton( XE100( in( PBS)( at( room( temperature( for( 1( hour( on( a(
rocking( platform.( The( blocking( solution( was( removed( and( the( membrane( was(
incubated(with(the(primary(rabbit(polyclonal(antiEGLUT2(antibody(diluted(1:500( in(
dilution( solution( (1(%( (w/v)( skimmed(milk(powder,( 0.1(mM(EDTA(and(0.1(%( (v/v)(
Triton(XE100(in(PBS)(for(1(hour(on(a(rocking(platform.(








PVDF(membrane(was( incubated( in( 20(ml( of( blocking( solution( (5%( (w/v)( skimmed(
milk( powder,( 0.5( %( (v/v)( Triton( XE100( and( 0.1( mM( EDTA( in( PBS)( at( room(
temperature(for(1(hour(with(constant(agitation(on(a(rocking(platform.((The(blocking(
solution(was( removed(and(the(membrane(was( incubated(with( the(primary(mouse(
monoclonal( antiEβEActin( antibody( (clone(ACE15( (A5441),( Sigma)( (diluted( 1:20,000)(
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0.5(µl( in(10(ml(of(dilution( solution( (0.5(%( (v/v)(Triton(XE100(and(0.1(mM(EDTA( in(
PBS)(for(1(hour(at(room(temperature(on(a(rocking(platform.((
The( membrane( was( then( washed( three( times( for( 10( minutes( in( 10( ml( of(
washing(solution(with(constant(agitation.(Then,(the(membrane(was(incubated(with(
the( secondary( antibodyE( affinity( purified( rabbit( antiEmouse( IgG( conjugated( to(
horseradish(HRP((Dako,(UK),((diluted(1:2000)(5µl(in(10ml(of(dilution(solution,(for(1(
hour(on(a( rocking(platform.(The(membrane(was(washed(again( three( times( for(10(











Saran( wrap( and(marked( with( Tracker( Tape( (Amersham( Ltd.,( UK).( SaranEwrapped(
membrane(was(exposed(to(Kodak(BioMaxElight(film((SigmaEAldrich,(UK)(and(placed(
into( an( XEray( cassette( (Sigma,( UK).( The( required( exposure( time( was( variable(
between(5(seconds(for$βEactin(band(detection,(few(minutes(for(GLUT2,(while(up(to(
30(minutes(for(SGLT1(band(detection.((
The( film( was( developed( in( a( darkroom( using( GBX( developer/replenisher(
solution( (Kodak,( SigmaEAldrich,( UK)( then( stopped( in( stop( solution( (2.5( %( Glacial(
acetic( acid( with( acridine( orange( as( indicator).( The( film( was( fixed( in( GBX(
fixer/replenisher( solution( (Kodak,( SigmaEAldrich,( UK),( then( rinsed( with( tap( water(
and(allowed(to(dry.((





the( removal( of( the( previous( primary( and( secondary( antibodies.( Stripping( of( the(
membranes(was( carried( out( by(washing( the(membrane(with( cold( acidic( stripping(
buffer( (137( mM( NaCl,( 20( mM( Glycine,( pH( 2.5)( three( times( for( 10( minutes( on( a(
rocking(platform.( (After(stripping,(membranes(were(equilibrated(for(15(minutes( in(








to( prepare( 1X( PBS,( which( was( used( for( the( fixation( and( immunohistochemical(
process.((
10X(PBS(solution:(( NaCl( ( 1.37(M((
( ( ( ( KCl( ( 27((((mM((
( ( ( ( Na2HPO4( 81((((mM((


















0.05(%((w/v).(The(gelatine/sucrose(solution(was(then(allowed(to(cool(to(38(°C in an 




cut(and(were(fixed(in(4(%((w/v)(PFA/PBS(solution(for(4(hours(at(4(°C. The samples 










hours.( In( the( last( 10(minutes( of( the( 3( hours,( some( gelatine/sucrose( solution(was(
poured( in( the( bottom( of( plastic( weighing( boats( and( allowed( to( semiEdry.( Tissue(
samples(were(placed(on(the(dried(gelatine(in(the(boats(and(covered(with(additional(




On( the( following( day,( the( dried( gelatine( containing( the( embedded( tissue(
samples(was(cut( into(cubes.(Each(cube(was(stuck(to(a( labelled(cork(disc(with(OCT(
embedding(matrix((Raymond(A(Lomb(Ltd,(Eastbourne,(East(Sussex,(UK).(The(cubes(
were( snap( frozen( in( 2Emethylbutane( (SigmaEAldrich( Company( Ltd,( Gillingham,(





A( cryostat( device( (Leica,( CM( 1900UVE1E1,( Milton( Keynes,( Buckinghamshire,(
UK)(was(used(for(cryostat(tissue(sectioning.(Frozen(gelatine(embedded(blocks(were(
sectioned(at(thickness(of(10(μm(and(thawEmounted(onto(polyELElysine(coated(slides(

















and( tissues(were(mounted(with(D.P.X.,( neutral(mounting(medium( (SigmaEAldrich,(
UK)( and( left( to( dry( for( 20( minutes( at( 60( °C.( Tissue( sections( were( viewed( and(








E400( microscope( and( DXM( 1200( digital( camera( (Nikon,( Japan),( images( were(
captured( with( a( 4X( objective( using( ACTE1( Products( Laboratory( Software( (Version(
2.20,(Nikon)(and(stored(as(16Ebit(tiff(files.((
Using( ImageJ( software( (Wayne( Rasband,( National( institutes( of( health,(
Bethesda,(USA),(a(100(μm(gradient(slide(was(calibrated.(Villus(height(was(measured(
as(the(average(distance(from(cryptEvillus(junction(to(villus(tip(from(an(average(of(at(





( After(Haematoxylin(and(Eosin(staining,( intact( tissue(samples(were(used( for(
immunohistochemical(studies.(The(vertical( incubation(of(the(slides(during(washing(
was( carried( out( in( glass( staining( jars( filled( with( solution( to( cover( the( slides.( The(




for( 5E10( minutes.( Tissue( sections( were( circled( with( ImmEdge( Hydrophobic( Pen(
(Vector(Laboratories, Burlingame,(USA)(and(left(to(dry(for(10(minutes.(Slides(were(
washed( in( PBS( five( times( for( 5( minutes.( To( reduce( background,( nonEspecific(
antibody(binding(sites(on(the(tissues(were(preEblocked(with(10%(of(donkey(serum(in(
PBS( (or( in( blocking( solution( according( to( optimized( conditions,( as( shown( in( table(
2.2)( for(1(hour( in(a(humid(chamber.(Blocking(solution(was(tipped(off(and(sections(














T1R2!!!!!(Rabbit)! 5%( (w/v)( sucrose,( 3%( (w/v)(
BSA,( 0.1%( (w/v)( NaN3( and(











( After( overnight( incubation,( primary( antibody( solution( was( removed( and(
slides( were( washed( in( PBS( five( times( for( 5( minutes.( The( tissue( sections( were(
incubated( with( the( secondary( antibody( diluted( in( dilution( solution( (2.5( %( (v/v)(
Donkey(serum,(0.2(%((v/v)(Triton(XE100(and(0.02(%((w/v)(NaN3( in(PBS)( in(a(humid(
chamber(for(1(hour(at(room(temperature.(The(secondary(antibody(was(FITC(donkey(
antiErabbit( (Fluorescein( isothiocyanate–conjugated( affinity( purified,( Jackson(
ImmunoResearch( laboratories,( Suffolk,( UK)( diluted( 1:500( in( dilution( solution(
(except(for(VIP(and(SP:(it(was(1:100).(Finally,(unbounded(antibodies(were(removed(
by(washing(the(slides(in(PBS(five(times(for(5(minutes(before(slides(were(mounted(in(
mounting(medium(with( 4',6EdiamidinoE2Ephenylindole( (DAPI)( (Vectashield,( Vector(
Laboratories,(Peterborough,(UK).((
(
Slides(were(allowed( to(dry( in( the(dark( for(at( least(4(hours(before(viewing.(
Immunostaining(was(visualised(using(an(epifluorescence(Nikon(microscope((Nikon,(
model:(Eclipse(E400,(Kingston(upon(Thames,(Surrey,(UK)(and(images(were(captured(
with( Hamamatsu( digital( camera( (C4742E96E12G04,( Hamamatsu( Photonics( K.K,(










used( to( isolate( total(RNA( from(tissue(samples(as(described(by( the(manufacturer’s(
protocol.(RNA(was(isolated(from(intestinal(tissues(of(rats(or(from(duodenal(biopsies(
of( human( subjects.( The( frozen( tissues( at( E80( °C( were( weighted( 30E40( mg( and(
thawed(in(600(µl(of(RLT(Lysis(Buffer(with(6(µl((0.01(volume)(of(βEMercaptoethanol.((
$
F$ Note:( For( q( lab( RNA( kit,( tissues( were( thawed( in( 600( µl( of( RLT( Lysis( Buffer(
without(βEMercaptoethanol;(otherwise,(all(steps(were(the(same(for(both(kits.((
(
Tissue( samples( were( homogenized( using( a( polytron( microprobe( (Ystral,(
Goettingen,(Germany)(at(speed(5(for(1(minute.(The(lysate(was(centrifuged(at(10,000(
x( g( (14,000( rpm)( for( 3( minutes( to( sediment( any( nonEhomogenized( tissues.( The(
supernatant( of( lysate(was( collected( and( added( to( 600( µl( (equal( volume)( of( 70(%(
(v/v)(molecular(biology(grade(Ethanol(and(mixed(10(times(by(pipetting.(The(solution(
was(loaded(onto(an(RNeasy(spin(column(and(centrifuged(at(8,000(x(g((10,000(rpm)(
for(30( seconds.( The( flowEthrough(was(discarded(and( the( column(silica(membrane(










onto( the( membrane( of( PerfectBind( RNA( column( and( incubated( at( room(
temperature( for( 15( minutes.( The( membrane( was( washed( again( with( 400( µl( of(
Washing( Buffer( RW1( and( centrifuged( at( 10,000( rpm( for( 30( seconds.( The( flowE











optical( density( of( the( nucleic( acid( using( a( doubleEbeam( ultraviolet(













TAPS(( (((((Sigma)( ( 30((mM(
EDTA(( (((((Sigma)( ( 0.1(mM(
(
To(avoid(the(degradation(of(RNA(and(to(inhibit(the(RNase(activity,(all(solutions(
were( prepared( using( RNaseEfree( ddH2O,( all( plastic( materials,( glassware( and(




2( %( (w/v)( Agarose( gel( was( prepared( by( adding( 0.8( g( of( agarose( powder(
(molecular( grade,( BIOLINE( chemicals,( London,( UK)( to( 40( ml( of( TTE( buffer.( The(
powder(was(dissolved(and(melted(by(heating(until(boiling(in(a(microwave(oven.(The(
solution( was( allowed( to( cool( to( 50( °C( before( the( addition( of( Ethidium( Bromide(

























( The( isolated( total( RNA( from( rat( intestinal( tissues( and( human( duodenal(
biopsies(were(used(in(FirstEStrand(cDNA(synthesis.((
In(a(nucleaseEfree(microcentrifuge(thinEwalled(PCR(tube,(the(following(were(added:(
Total(RNA(sample(( ( ( ( ( ( 3((((((µg((
Random(Hexamer(Primers((100(ng/µl)((Invitrogen)( ( 2.5(((µl((
ddH2O(was(added(to(a(final(volume(of(( ( ( 11.4(µl.((
(






DTT(0.1(mM((Invitrogen)( ( (( ( ( 2((((µl((
dNTP(Mix((10(mM)(( ( ( ( ( 1((((µl(
RNaseOUT(™((40(Units/µl)((Invitrogen)(( ( ( 0.6(µl((
SuperScript(III™(RT((200(Units/µl)((Invitrogen)( ( 0.5(µl((
(
The( process( was( resumed( to( be( incubated( at( 50( °C( for( 60( minutes( for(
reverse( transcription.( Then,( incubated( at( 70( °C( for( 10( minutes( to( denature( the(
reverse( transcriptase.( Once( the( reaction( was( cooled( to( 37( °C,( 0.5( µl( (2( Units)( of(
RNase(H((4(Units/µl,(USB(Europe(GmBH,(Staufen,(Germany)(was(added(to(the(tube(
and(incubated(at(37(°C(for(30(minutes(to(digest(all(RNA.(Finally,(the(reaction(tubes(







( FirstEstrand( cDNA( samples( were( purified( using( QIAquick( PCR( purification( Kit(










8.5)( to( the(centre(of( the(membrane( in(QIAquick(column.(The(column(was(allowed( to(
stand(for(1(minute(then(centrifuged(at(18,000(x(g(for(1(minute.(
( (
After( purification( of( cDNA( samples,( they( were( quantified( using( a( UV(











( At( 260( nm,( one( optical( density( unit( equates( to( 33( µg/ml( of( singleEstrand(
DNA( (cDNA).( The( concentration( of( DNA( in( the( samples( was( calculated( using( the(
following(equations:(( (







After( choosing( the( sequence( of( PCR( template( (mRNA( nucleotide( sequence( from(
NCBI(website),(the(primer(sets(were(designed(using(primerEBLAST(tool(for(finding(a(
specific( sense( (forward)( and( antisense( (reverse)( primers( at( PubMed( website(
(http://www.ncbi.nlm.nih.gov/tools/primerEblast/).( The( designed( primers( were(
saved( and( checked( for( their( thermodynamic( properties( to( reduce( primer( dimer(
formation( using( the( Vector( NTI( computer( software.( The( selected( primers( were(
ordered(and(manufactured(by(Eurogentec((Berlin,(Germany).(All(primers(used(for(q(
RealETime(PCR(were(designed(to(be(between(18(and(30(bp( long,(their(GC(%(to(be(




and( they( were( used( for( rats( as( they( were( working( well( in( the( qRTEPCR.( Mouse(
primers(for(GCG(amplification(were(used(with(cDNA(from(rats.(After(cloning(of(the(
PCR( amplicon( obtained( using( these( primers,( the( sequenced( PCR( products( were(




















































































































control(mispriming(events.(This(high( temperature( incubation(step( is(also(essential(
for( the( activation( of( the$ Taq( Polymerase( enzyme( (DNA( polymerase( originally(





Reaction(Buffer(TaqEMan( ( ( 12.5(µl(
Specific(primers(20x(assay(mix( ( 1.25(µl(












PCR( tubes( were( then( placed( onto( the( RotorEGene( 3000( (Corbett( Research,(
Mortlake,(NSW,(Australia)(and(set(up(to(run(the(PCR.(Polymerase(chain(reaction(was(
initiated(by(HotEStart(incubation(step(for(2(minutes(at(95°C(to(activate(the(Taq(DNA(

















1( %( (w/v)( Agarose( gel( was( prepared( by( adding( 0.4( g( of( agarose( powder(
(molecular( grad,( BIOLINE( chemicals)( to( 40(ml( of( TTE(buffer( (30(mM(Tris( Base,( 30(
mM(TAPS,(0.1(mM(EDTA).(The(gel(was(performed(as(described(before(in(Agarose(gel(
electrophoresis( for( RNA( samples.( The( gel( was( allowed( to( dry( then( placed( in( the(
electrophoresis(rig(and(TTE(buffer(was(poured(in(to(cover(the(gel.(
( (
The( resulting( qRTEPCR( products,( cDNA( amplicons,( were( separated( by(
electrophoresis( on( the( Agarose( gel.( The( PCR( products( were( mixed( 1:5( with(
Blue/Orange(5X(Loading(Dye( (Fermentas)(before( loading(onto( the(wells(of( the(gel(
along(with( 5( µl( of( a(DNA( Ladder( (GeneRuler™( 100( bp( Plus,( 0.1(mg(DNA/ml,(MBI(
Fermentas).( Electrophoresis( was( run( in( 1X( TTE( buffer( at( constant( 100( V( for(
approximately( 40( minutes.( The( DNA( bands( in( the( gel( were( visualized( and(











( ( ( ( ( ( ( For(100(ml(
( ( NaCl( 1%( ( ( ( 1((((g(
( ( Tryptone((Difco,(London,UK)( 1%((( 1((((g(








( ( LB( medium( was( prepared( as( above( in( a( flask,( 1.5( %( BactoEagar( (Becton(







mg/ml( ampicillin( was( added( and( mixed.( Then,( the( flask( mouth( was( sterilized( by(
flame( and( LB( agar(was( poured( into( 10( cm(plates,( approximately( 30(ml( per( plate,(





( ( ( ( ( For(250(ml((
( ( NaCl(0.04(%(( ( (0.1(g(
( ( Tryptone(2%((( (( 5(g(
( ( Yeast(extracts(0.5%( (1.25(g(







SOC( medium( was( prepared( immediately( before( use.( To( prepare( 1( ml( of( SOC(
medium,(the(following(were(mixed(under(sterilized(conditions:(
((( 2(M(Mg2+(((1(M(MgCl2,(1(M(MgSO4)( 10(((µl((
( ( 2(M(DEglucose,(filtered(sterilized( 10(((µl((
( ( SOB(medium(( ( ( ( 980(µl((
(
2.15.2. !!Extraction! and! purification! of! DNA! from! agarose! gel! (band!
preparation):!





The(qRTEPCR(product(was( loaded(with( loading(dye(onto(1(%( (w/v)(agarose(
gel(electrophoresis(and(run(alongside(5(µl(of(a(DNA(Ladder;(the(DNA(was(visualized(
with(a(UV( transilluminator( (BioRad(Gel(DOC(1000)( to(ensure( the( correct( size(of( a(
single( band.( The( band( of( interest( was( dissected( of( the( gel( with( a( sterile( scalpel(
under( low( UV( illumination( and( placed( into( a( sterile( Eppendorf( tube( (UV( light(
exposure(was(minimized(to(reduce(the(formation(of(pyrimidine(dimers).(The(weight(




























This$ ‘aFtailing’!process( is(optional(but(gives(better( results(with(cloning(because( it(
facilitates( the( ligation( and( the( insertion( of( the( DNA( fragment( into( the( plasmid.( In( a(
sterile( microtube,( the( following( components( were( mixed( and( incubated( for( 30E60(
minutes(at(70(°C(in(a(standard(PCR(machine:(
Purified(PCR(product((dsDNA)( ( ( 6(µl(
Taq(polymerase(reaction(buffer(IV(10X((( 1(µl(
Taq$DNA(polymerase((5(U/(µl)( ( ( 1(µl(
MgCl2((25(mM)((Invitrogen)( ( ( 1(µl(












To( ensure( that( the( concentration( of( the( purified,( gel( extracted,( DNA( is(
enough( for( the( ligation( process,( a( single( product( should( be( detected( by( gel(
electrophoresis.( 1(%( (w/v)( agarose( gel( electrophoresis(was( run(using(1(µl( of(DNA(
product(with(loading(dye(alongside(5(µl(of(a(DNA(Ladder((GeneRuler™(100(bp(Plus,(
MBI(Fermentas)(and(visualized(in(a(UV(transilluminator.((
To( calculate( the( amount( of( PCR( product( (DNA)( needed( for( ligation,( the( following(
equation(was(used:(
Amount$needed$=$!"!!"!!"#$%&! !!"#!!"#$!!"!!"#$%&! !!!"#!!"#$!!"!!"#$%& $
(
(The( optimal( ratio( of( insert( to( vector( is( 3:1,( vector( (plasmid)( concentration( is( 50(
ng/µl(and(vector(size(is(3(kbp).(
To( set( up( the( ligation( reaction,( the( following( components( (all( supplied( by( Rapid(
Ligation(Vector(II,(Promega)(were(added(and(mixed(in(a(sterile(tube:(
( 2X(Rapid(Ligation(Buffer( ( 5(µl(
pGEMET(Easy™(Vector((50(ng/µl( 1(µl(
( T4(DNA(ligase™(3U/µl( ( ( 1(µl(
( PCR(product((purified(DNA)( ( as(calculated(
ddH2O((( ( ( ( up(to(10(µl(total(volume(
(








the(plasmid(with( the(bacterial( cell(wall.( Then,( the(bacteria(was( subjected( to(heat(
shock(in(a(water(bath(for(45(seconds(at(42(°C(before(incubation(on(ice(for(further(5(
minutes( to( allow( recovery( time( from( the( heat( shock.( 450( µl( of( nutrientErich( SOC(





In( the(meanwhile,( the( LBEampicillin( agar( plates(were( equilibrated( at( room(









absorbance( of( the( added(materials.( Then,( 50E( 150( µl( of( the( bacterial( suspension(
(transformed(cells(in(SOC(medium)(were(spread(on(the(indicator(plates((plates(with(
IPTG/xEGal)(to(grow(and(incubated(upEsideEdown(at(37°C(overnight.( (Next(day,(the(














a( sterile(pipette( tip,( a( single(white( colony( from( the(plate(was( inoculated( into( the(
tube.(To(allow( the(growth(of(bacterial( colonies,( the(universal( tube(was( incubated(
with(orbital(shacking(at(200(rpm/minute(at(37°C(for(16(hours.((After(that,(the(tubes(










10x(ThermoEStart(PCR(Reaction(Buffer(( ( ( 5(µl(
8(mM((total)(dNTP(mix( ( ( ( ( 5(µl(
10(mM(Sense(primer( ( ( ( ( 1(µl(
10(mM(AntiESense(primer(( ( ( ( 1(µl(
Thermoprime(Plus(Polymerase((Taq,(1(U/(µl)(( ( 0.5(µl(
25(mM(MgCl2(( ( ( ( ( ( 3(µl(
Bacterial(cell(suspension( ( ( ( ( 1(µl((






( ( ( ( at(55(°C(for(20(seconds(((




Following( standard( PCR,( the( PCR( products( were( loaded( onto( 1( %( (w/v)(
agarose( gel( and( electrophoresis( was( run,( as( described( previously,( alongside( the(
positive(control.(
If(the(gel(showed(that(the(PCR(products(had(a(single(band(of(the(correct(size,(







bacterial( suspension(of( successful( transformation(were( centrifuged( in(a( swingEout(




The( cells(were( lysed( in( 250(µl( of( lysis( buffer( P2( (containing(NaOH/SDS)( and(
mixed( gently( by( inverting( the( tube( until( lysis( was( completed.( The( lysate( was(
neutralized(in(350(µl(of(neutralization(buffer(N3((containing(high(salt)(leading(to(the(
precipitation( of( genomic(DNA,( denatured( proteins( and( cellular( debris.( To( remove(
Chapter(2( Materials(and(Methods(
( 90(
precipitates,( the( tube(was( centrifuged( at( 10,000( x( g( for( 10(minutes.( Leaving( the(
pellet( containing( protein,( cell( debris( and( chromosomal( DNA),( the( supernatant(




discarding( the( flowEthrough.( ( Followed( by( another( wash( with( 750( µl( of( ethanolE
containing(Buffer(PE(by(centrifuging(for(1(minute(and(discarding(the(flowEthrough.(
Further(centrifugation(for(1(minute(was(performed(to(dry(the(column(and(remove(






( Concentration(of(plasmid(ds(DNA((µg/µl)(=!!!"! !!"#!!"!!"#! !!"#$%"&'!""" (
( $$$$$$
2.15.10. !Sequencing!of!the!plasmid!DNA:!
Plasmid( DNA( (2( µg)( was( placed( in( an( eppendorf( tube( and( dried( by(
centrifugation( in( a( vacuum( with( heat.( Dried( DNA( samples( were( submitted( to( a(









Diabetes( mellitus( was( experimentally( induced( in( adult( male( rats( (SpragueE














ml( of( DMEM( was( mixed( with( 50( ml( of( FBS( (foetal( bovine( serum).( Five( ml( of(
Pencillin/Streptomycin(and(5(ml(of(glutamate(were(added(to(the(medium.(On(the(same(




(From( control( and( diabetic( rats,( the( small( intestine(was( removed( and( divided(
into( proximal,( mid( and( distal( parts.( The( intestine( was( cutEopen( and( rinsed( in( cold(
normal(saline.(The(intestinal(tissue(was(placed(on(glass(plate(and(the(serosa(was(gently(
removed( by( scalpel( under(microscopy.( Tissue( pieces(were( cut( into( 2( cm( length( and(
placed(in(microcentrifuge(tubes(to(be(incubated(with(500(µl(of( incubation(solution(at(
37( °C( for( one( hour.( After( incubation,( the( tubes( were( centrifuged( for( 10( seconds( to(
collect(the(tissue(at(the(bottom(of(the(tubes(without(damaging(the(tissue.(Aliquots(of(









All( components( of( the( kit( and( the( plate( were( allowed( to( warm( to( room(
temperature(before(use((30E45(minutes).(The(50(ml(of(20x(assay(buffer(concentrate(
was( diluted(with( 950(ml( of( distilled(water( to(make( 1x( assay( buffer( solution.( This(
assay(buffer(was(used(to(dilute(and(reconstitute(all(other(reagents(provided(in(the(
kit,( and( used( in( the( washes( of( the( plate.( The( 1x( assay( buffer( and( all( prepared(
solutions(were( allowed( to(warm( to( room( temperature( and(mixed( thoroughly( just(
before(use.(
(
The( standard( peptide( was( centrifuged(and( diluted( with( 1( ml( of( 1x( assay(
buffer( and(vortex( to(make(a( stock( solution( (concentration(of( stock:( 1,000(ng/ml).(







































The(APS(was( removed( from(the( immunoplate(and( the(contents(of( the(wells(were(







The( streptavidineEHRP( conjugate( (SAEHRP)( vial( provided( in( the( kit( was(
centrifuged(at(5,000(rpm(for(5(seconds,(and(12(μl(was(added(to(12(ml(of(1x(assay(
buffer( to(make(SAEHRP( solution.(100(μl(of( SAEHRP( solution(were(added( into(each(
well.( The( immunoplate(was( resealed(with(APS( and( incubated( for( 1( hour( at( room(
temperature((20E23(°C)(with(orbital(shaking(at(300E400(rpm.(The(APS(was(removed(




protect( from( light.( The( immunoplate(was( resealed(with( APS( and( incubated( for( 1(
hour(at(room(temperature((20E23(°C)(with(orbital(shaking(at(300E400(rpm.(The(APS(
was(removed(from(the(immunoplate(and(the(reaction(was(stopped(by(adding(100(μl(
of(2N(HCl( into(each(well,( for(a(positive(result,( the(colour( in( the(well(was(changed(





The( data( in( this( study( were( analysed( statistically( using( Prism( 5( software(
version( 5( with( unpaired( ‘student’( tEtest.( The( results( were( considered( to( be( not(
significant( if( the( pEvalue( was( >( 0.05,( significant( if( the( pEvalue( was( ≤( 0.05,( very(















Acquiring relevant techniques 













to( shed( into( the( lumen( for( continuous( renewal( (for( further( information,( see(
introduction(section(1.3.1).(((
(
The( enterocytes( have( two( membrane( domains:( the( apical( side( facing( the(
intestinal( lumen( and( known( as( the( brushEborder( membrane( (BBM)( due( to( its(
characteristic(microvilli,(and(the(basal(and(lateral(sides(are(known(as(the(basolateral(
membrane((BLM)(facing(the(circulation(and(adjacent(cells.(Each(membrane(has( its(
characteristic( surface( charges,( membrane( structure( and( lipid( composition.( These(
specific(properties(facilitated(the(selective(isolation(of(BBM(and(BLM(vesicles(using(
Mg+(precipitation(and(differential(centrifugation(techniques((ShiraziEBeechey(et$al.,(




The( pure( population( of( BBM( vesicles( (BBMV)( has( aided( transport( studies(
across( the( brushEborder( membrane( via( specific( transporters( like( the( intestinal(
Na+/glucose(cotransporter(1,(SGLT1,(eliminating(the(effect(of(the(paracellular(shunt(
and( sugar(metabolism( (Kessler( et$ al.,( 1978).( In( addition,( the( vesicles( retain( their(
functional( polarity( after( isolation,( which(makes( it( possible( to( address( the( role( of(
different(cell(membranes(under(various(conditions((Murer(and(Kinne,(1980).((
(
The( BBM( has( characteristic( transmembrane( protein( carriers( such( as( SGLT1(
and(GLUT5(sugar(transporters,(as(well(as(digestive(enzymes(such(as(disaccharidases(
and( alkaline( phosphatase( (Keelan( et$ al.,( 1985,( Prabhu( et$ al.,( 2003).( These(




these( markers( can( be( assessed( in( the( vesicles( and( homogenates( to( identify( the(
membrane(origin(of(the(vesicles.(((
(
On( the( luminal( domain( of( the( intestine,( the( BBM( digestive( disaccharidases(





sucrose( into( glucose( and( fructose( and( lactase( splits( lactose( into( glucose( and(
galactose( (Mantei( et$ al.,( 1988,( Nichols( et$ al.,( 2003,( Nichols( et$ al.,( 1998).( Those(
simple(sugars(are(then(absorbed(through(the(intestinal(absorptive(cells(from(the(gut(
lumen(to(the(systemic(circulation.(On(the(BBM(of(the(enterocyte,(monosaccharide(
carriers( SGLT1( and( GLUT5( transport( glucose/galactose( and( fructose,( respectively,(
into(the(enterocytes.((((
(
In( this( study,( to( avoid( wastage( of( human( tissues,( I( acquired( the( relevant(
techniques( such( as( BBMV( isolation,( disaccharidase( assays,( glucose( uptake( test,(




applied( to( isolate( BBMV( from( i)( intestine( of( rats,( healthy( and(with( stretozotocinE
induced(diabetes( (See( chapter(4)( and( ii)( human( intestinal( biopsies(of(healthy(and(




















Small( intestinal( tissues(were(used( from(mouse(and(pig( for( the( isolation(of(
BBMV.(To(assess(the(membrane(origin(of(these(vesicles,(the(specific(activities(of(the(
BBM(markers( sucrase,( lactase( and(maltase(were( determined( in( the( BBMV( and( in(
their( corresponding( cellular( homogenates.( The( enrichment( and( percentage(
recovery(values(of(these(enzymes(were(calculated(as(follows:(
( Enrichment! = !"#$%&%$!!"#$%!!!"#$%$#&!!"!!!"#!"#$%&%$!!"#$%!!!"#$%$#&!!"!ℎ!"!#$%&'$(
(










The( activity( of(maltase( and( sucrase(was( determined( in( BBMV( isolated( from(
the(intestinal(tissues(of(adult(mice,(maintained(on(40%(carbohydrate(diet.(Specific(












































































































































Figure' 3.1.' Specific' activity' of' maltase' and' sucrase' in' BBMV' isolated' from'
proximal'intestine'of'mice'and'their'original'homogenates''
'







































































the(BBMV( isolated( from( three( small( intestinal( regions.( For( the( assessment(of( the(
membrane( origin( of( these( vesicles,( the( specific( activities,( enrichments( and(
recoveries(were(determined(and(reported(in(table(3.2.(Enrichments(of(BBM(markers(
are( represented( as( histograms( in( figure( 3.2( showing( the( specific( activity( of(
disaccharidases(in(the(BBMVs(and(their(corresponding(homogenates.(((
(
( Generally,( the( BBM(markers(were( significantly( enriched( in( the( BBMV(over(
their(cellular(homogenates((table(3.2).(Maltase(and(lactase(were(similarly(enriched(






( The(percent( recoveries(of(maltase,( sucrase(and( lactase(were(12.8(±(2.7(%,(
4.2(±(2.4(%(and(11.3(±(3.4(%(,(respectively,(in(the(duodenum.(They(were(7.3(±(2.7(%,(
4.9(±(1.4(%(and(6.3(±(2.3(%(,( respectively,( in(the( jejunum.(While( in(the( ileum,(the(
recoveries(were(15.46(±(2.7(%,(7.9(±(2.2(%(and(4.2(±(2(%(,(respectively.((
(






























































































































































































































Lactase( activity( was( assayed( in( the( proximal( and( distal( small( intestinal(
regions( of( the( mouse.( ( As( shown( in( figure( 3.6,( the( activity( of( lactase( is( barely(












































































































( ( (((( (
The!histogram!shows!the!specific!activity!of!maltase!and!lactase!in!the!proximal!and!
the!distal!intestinal!regions!of!mouse.!This!experiment!was!carried!out!using!BBMV!








assayed( in( the( BBMVs( isolated( from( duodenum,( jejunum( and( ileum.( Results( are(
shown( in( figure(3.7,(and(the(activity(of(each(enzyme(along(the( intestinal( length( is(
shown(in(figure(3.8.(
(
As( seen( in( figure( 3.7,( maltase( has( the( highest( activity( level( among(





The( histograms( in( figure( 3.8( demonstrate( that( the( activity( of(maltase( and(
sucrase(does(not(show(great(changes( throughout( the( intestine(of(suckling(pigs.( In(












































































1.2. Development! and! optimization! of! immunohistochemical! technique! using!
small!intestinal!tissue!of!mouse:!
(
Prior( to( immunohistochemistry,(histological(analysis(of( the( intestinal( tissue(
sections( by( haematoxylin( and( eosin( (H(&( E)( staining(was( routinely( carried( out( to(






Immunostaining(was( carried( out( using( a( custom(made( antibody( to( SGLT1,(
which( has( been( used( in( our( laboratory( for( the( past( 16( years.( ( The( antipeptide(
antibody(was(raised(in(rabbit(and(made(against(a(synthetic(peptide(corresponding(
to(amino(acids(402F420(of(SGLT1(sequence((Wood(et!al.,(2000,(Dyer(et!al.,(1997a).(
This( region( is( a( conserved( intracellular( loop( of( SGLT1( and( has( a( significant( high(
degree(of( homology( in( the( amino( acid( sequencing( among( various( species;( having(
100(%,(94.7(%(and(84.2(%( identity(with(mouse,( rat( and(human,( respectively,( and(





For( morphological( analysis,( representative( images( in( figure( 3.9( shows(
different(sections(from(the(mid( intestine(of(mouse(stained(with(haematoxylin(and(





























( Skills( in( immunohistochemistry(were( developed( using(mid( intestinal( tissue(
from(mouse.( An( antiFpeptide( primary( antibody( against( SGLT1(was( used(with( the(
optimized( conditions( as( described( in( the( Methods.( The( immunohistochemical(
images( in( figure( 3.10( show( promising( results( of( specific( labelling( without(
background( staining.( To(ensure( specific( antibodyFantigen(binding,(omission(of( the(
primary( antibody(was( routinely( performed( as( a( control.( Results( show( that( SGLT1(
protein( expression( is( strongly( detected( in( the( BBM( of( the( enterocytes( along( the(
entire(length(of(the(villi,(while(no(staining(was(detected(in(the(crypts.((
(
Figure' 3.10.' Developing' the' immunohistochemical' technique' to' detect' SGLT1'
protein'using'intestinal'tissues'of'mice.'!
!!!!!!!a)! ! ! ! ! ! c)!
! !! !
!!!!!!!b)!! ! ! ! ! ! d)!!
! !! !
!























Western( blotting( technique( was( carried( out( to( investigate( SGLT1( protein(
abundance( in( brushFborder( membrane( vesicles( (BBMV)( isolated( from( small(
intestinal( tissues.( For( immunoblotting,( the( membrane( was( probed( using( a(
polyclonal( antiFSGLT1(primary( antibody,( raised( in( rabbit,( and( then( the(membrane(
was(reFprobed(using(a(monoclonal(antiF(βFactin(primary(antibody.((
( (
For( initial( practicing( of( Western( blotting( technique,( samples( of( BBMV(























of( 28( dayFold( suckling( pigs( for( the( immunodetection( of( SGLT1( protein.( In( figure(
3.12,( a( typical( picture( is( shown( of( detected( 73( kDa( immunoreactive( bands,(
corresponding( to( SGLT1( protein,( along( the( intestinal( length.( It( appears( that( the(












( ( !!!!( !!!!Lanes&:&&&&&&&&&&&&D&&&&&&J!!!!!!!!I""!!!(
!!!!!!!!! ! !!!!!!!!!!!! ! !!!! !
!
A! typical! image! of! immunoblotting! shows! the! detection! and! characterization! of!





In(an(attempt( to(use( frozen(rat( intestinal( tissue,(BBMV(were( isolated( from(
intestinal( tissue(of(adult( rats( for( the( immunodetection(of(SGLT1(protein.( In( figure(
3.13,(picture(a)(shows(protein(degradation(in(all(the(samples.(However,(as(shown(in(
picture( b),( using( fresh( rat( intestinal( tissue( to( prepare( BBMV( showed( specific(




Figure' 3.13.' Immunodetection' and' characterization' of' SGLT1' protein' using'
intestinal'tissue'from'rats.''




a)! BBMV! isolated! from! frozen! intestinal! tissue! of! rats,! showing! protein!
degradation!in!all!samples,!












( Monosaccharides,( especially( glucose,( are( essential( nutrients( for( all( the(
physiological( functions( in( the( living( organisms.( Digestion( of( carbohydrates( is(
accomplished( by( salivary( and( pancreatic( amylase.( The( resultant( disaccharides(
sucrose,( lactose( and(maltose( are( subsequently( hydrolysed(by( the( intestinal( brush(
border(membrane,(sucrase,(lactase(and(maltase,(respectively,(to(monosaccharides:(
DFglucose,(DFgalactose(and(DFfructose( (Dyer(et!al.,( 2005).( These(monosaccharides(
are( absorbed( from( the( intestinal( lumen( to( the( circulation( across( the( luminal( and(








The( apical( brushFborder(membrane( (BBM)( and( the( basolateral(membrane(
(BLM)(of( the(enterocyte(differ( in( their( structure,( composition(and( surface( charge.(
This( permits( the( selective( isolation( of( BBM( and( BLM( vesicles( depending( on(Mg+(
precipitation( and( differential( centrifugation( (ShiraziFBeechey( et! al.,( 1990).( It( has(
been( demonstrated( previously( that( this( procedure( yields( intact( and( sealed( BBM(
vesicles,( which( aided( transport( studies( as( they( are( predominantly( oriented( rightF
sideFout( facing( the(BBM(to( the(outer( (extraFvesicular)( compartment( (Hearn(et!al.,(
1981).( Thus,( providing( an( excellent( inJvitro! model( to( study( intestinal( nutrient(
transport(across(the(two(membrane(domains(as(it(functions(inJvivo.((
((
( The( aim(of( this( part( of( the( project(was( to( learn( and( develop( the( relevant(
techniques( using( available( intestinal( tissues( from(pig( and(mouse,( before( applying(
these( technologies( to( intestinal( tissues( obtained( from( rats( and( humans.( After(
isolating(BBMV,(it(was(important(to(confirm(the(membrane(origin(of(the(vesicles.(To(
this(end,(the(activity(of(BBM(marker(enzymes(was(determined(using(enzyme(assays,(





small( intestine.( Tissues( from( those( animals( also( showed( promising( results( in(
Western( blotting( and( immunohistochemical( techniques.( However,( protein(







( The( work( in( this( chapter( showed( that( the( isolated( vesicles,( using( the(
described(technique(by(Dyer(et!al.,(2002((see(Methods),(originated(from(the(brushF
border( membrane( of( the( enterocytes.( ( This( was( confirmed( by( measuring( the(
enrichment( and( recovery( of( the( BBM( markers,( maltase,( lactase( and( sucrase,(
whenever( possible,( in( the( vesicles( and( comparing( to( that( in( the( original( cellular(
homogenates.( Results( here( also( demonstrated( that( digestive( enzymes( are( not(
equally( expressed( throughout( the( small( intestine,( and( they( are( variable( between(




intestine( of( mice( and( suckling( pigs,( respectively.( Maltase( showed( significantly(
higher( activity( levels( than( sucrase( in( all( the( intestinal( regions( of( both( species.(
Generally,( the( digestive( enzymes( showed( higher( levels( of( activity( in( the( proximal(
intestine(that(decline(dramatically(with(distal(progression(throughout(the(intestine.(
This(can(be(predicted(by(the(reduction(of(the(luminal(substrate(through(the(length(
of( the( small( intestine(because(disaccharides(are(mainly(hydrolysed(by(enzymes( in(




( Lactase( was( highly( enriched( in( BBMVs( isolated( from( pig( intestine( as( they(
were( suckling( and( expected( to( have( high( lactase( activity( levels.( Although,( the(
enrichment(of(lactase(is(very(low(in(some(membrane(vesicle(samples,(this(does(not(
reflect( a( low( purity( of( the( BBMVs,( but( is( due( to( low( enzyme( expression( in( some(
intestinal( regions( in( various( animals( and( different( developmental( stages.( Lactase(
was(assayed(in(the(intestine(of(different(species,(but(its(activity(levels(were(hardly(
detected( in( adult( animals.( This( was( not( surprising( as( the( consumption( of(milk( is(
markedly( reduced( in( adults,( and( the( intestine( is( adapting( to( digest( alternative(
sources(of(carbohydrate( in( food.(As(these(pigs(are(28(days(old,(which(are(the( last(











in( our( laboratory( and( been( shown( to( yield( pure( isolated( membrane( vesicles(








BBMV( and( are( devoid( of( any( contamination( with( other( membranes( (ShiraziF
Beechey(et! al.,( 1990,(Dyer(et! al.,( 1997b).( In( our( laboratory,(western(blot( analysis(
was(also(used(to(determine(the(protein(abundance(of(BBM(and(BLM(marker:(SGLT1(
and( GLUT2( proteins,( respectively,( further( supporting( the( purity( and( membrane(
origin(of(vesicles(using(the(present(procedure((Batchelor(et!al.,(2011).(Other(studies(
also(confirmed(the(purification,(orientation(and(integrity(of(the(prepared(vesicles(by(





after( the( histological( assessment( of( the( mouse( intestinal( tissue( sections( from(
mouse.( The( morphological( analysis( by( haematoxylin( and( eosin( staining( showed(
good(architecture(of(attached(villus(enterocytes(with(intact(BBM(in(mice(intestine.(
By( immunohistochemical( technique,( the( antiFSGLT1( antibody( used( successfully(
labeled(protein(on(the(BBM(with(no(background(or(nonFspecific(staining.(Along(the(
crypt/villus( axis,( SGLT1( protein( is( expressed( along( the( BBM( of( the( entire( villus(
length( but( not( in( the( crypts( in(mouse(mid( intestine.( ( That(was( confirmed( by( the(
absence(of(this(expression(when(the(primary(antibody(was(omitted(in(control(slides.((
These( findings( were( also( shown( in( different( species( including( cats( and( dogs(
(Batchelor(et!al.,( 2011),(horses( (Dyer(et!al.,( 2009)(and(pigs( (Moran(et!al.,( 2010b).(




isolated( from( pig( intestinal( tissues.( SGLT1( protein,( between( 73F75( kDa,( was(






The( antiFSGLT1( antibody( has( been( used( successfully( in( our( laboratory( in( pig(
tissue((Moran(et!al.,(2010a).(The(antibody(was(raised(in(rabbits((custom(synthesis)(
to( a( synthetic( peptide( corresponding( to( amino( acids( 402–420( of( SGLT1.( This(





However,( glucose( transport( studies( (rapid( filtration( technique)( and( the(













SGLT1 expression in the  









and( pancreatic( amylases,( respectively,( which( break( down( starch( and(
polysaccharides( into(disaccharides.( In(the(small( intestine,(brush@border(membrane(
(BBM)( disaccharidases:( maltase,( sucrase( and( lactase( further( hydrolyze(
disaccharides:(maltose,(sucrose(and(lactose,(respectively,(into(monosaccharides((D@




Following(digestion,( luminal( glucose( (and(galactose)( is( actively( transported(
across( the( BBM( into( the( enterocyte( by( the( sodium/glucose( co@transporter( 1(
(SGLT1).(Subsequently,(it(passively(exits(from(the(cell(to(the(systemic(circulation(via(
GLUT2,(across(the(basolateral(membrane((Shirazi@Beechey,(1995).(Intestinal(glucose(




emerged( enterocytes( in( the( intestinal( crypt.( Then,( cells( migrate( along( the(
crypt/villus( axis,( during( their( lifespan,( before( they( are( shed( from( the( villus( tip.(
Subsequently,( SGLT1( protein( is( incorporated( into( the( BBM( resulting( in( the(
expression( of( functional( SGLT1( protein( (Smith,( 1985).( Upon( cell( maturation,( the(
enterocytes( are( able( to( maintain( an( electrochemical( gradient( and( develop( their(
digestive(enzymes(and(absorptive(functions.(
(
The( profile( of( SGLT1( expression( differs( along( the( small( intestinal( length(
according(to(the(site(of(absorption,(and(varies(between(species(depending(on(their(
dietary(habit.(Normally,(glucose(absorption( is(maintained(by(basal( levels(of(SGLT1(
expression,( which( is( subjected( to( circadian( rhythm( and( modulated( during(
development( and( other( physiological( and( pathological( situations( (Ferraris,( 2001,(
Stearns(et#al.,(2009).(This(basal(SGLT1(expression( is( independent(of( luminal( sugar(
concentration.( However,( when( dietary( carbohydrates( exceed( 50%,( SGLT1(
expression(is(up@regulated(to(meet(demand((Margolskee(et#al.,(2007,(Moran(et#al.,(
2010b).(In(pathological(conditions(like(diabetes(and(obesity,(abnormal(expression(of(
intestinal( SGLT1(has(been(observed( in( various( species,( including(humans( (Dyer(et#
al.,( 1997a,( Ferraris,( 2001,( Batchelor( et# al.,( 2013),( which( appears( to( be( due( to(







In( diabetes( mellitus,( studies( have( shown( enhanced( intestinal( capacity( to(
absorb(D@glucose,(which(is(not(responsive(to(luminal(carbohydrate(concentrations,(
blood(glucose(or(insulin(levels((Sharp(et#al.,(1997,(Olsen(and(Rosenberg,(1970).(This(




Diabetic@associated( mucosal( hyperplasia( expands( the( intestinal( absorptive(
surface( area( for( all( nutrients( in( general,( providing( longer( villi( supporting( greater(
number(of(absorptive(enterocytes(with(prolonged( lifespan( (Debnam(and(Ebrahim,(
1990).(In(addition,(diabetes(appears(to(induce(earlier(maturation(of(enterocytes(and(
changes( in( their( BBM( properties,( thus,( enhancing( their( digestive( and( transport(
functions( (Fedorak( et# al.,( 1991,( Debnam( and( Ebrahim,( 1989).( The( activity( and(
expression(and(activity(of(BBM(disaccharidases(are( increased( in(diabetic( intestine,(
providing( more( available( luminal( sugars( to( be( absorbed( than( normal,( which(
exacerbate( the( situation( (Liu( et# al.,( 2011).( Increased( expression( and( activity( of(
SGLT1( in( enterocyte( has( been( reported( (Dyer( et# al.,( 1997a),( in( addition( to( the(
recruitment( of( additional( SGLT1( onto( the( BBM( of(more( lower( villus( enterocytes,(





when( the( lumen( was( perfused( with( high( concentrations( of( glucose( or( fructose(
(Kellett(and(Helliwell,(2000),(and(in(adaptation(to(the(BBM(transport(of(fructose(in(
diabetes( (Corpe( et# al.,( 1996),( proposing( that( GLUT2,( in( addition( to( SGLT1( and(
GLUT5,( is( involved( in( the( apical( transport( of( luminal(monosaccharides.( However,(
this( is( controversial,( because( mutation( in( human( SGLT1( gene( results( in( glucose@
galactose( malabsorption,( which( is( characterized( by( life@threatening( osmotic(
diarrhea( and( dehydration,( indicating( that( SGLT1( is( the( major( glucose( (and(
galactose)( transporter(on(the(BBM(of(enterocytes(and( is(not(compensated(by(any(










The( main( objective( was( to( induce( experimental( diabetes( in( rats( using(
streptozotocin( (STZ)( injection,(a(potent(diabetogenic(agent,(and( to(determine(any(





2. To( assess( the( effect( of( streptozotocin@induced( diabetes( on(whole( body(
parameters.((
3. To( analyse( the( morphometric( changes( in( the( control( and( diabetic(
intestine.(
4. To( estimate( the( activity( levels( of( BBM( enzymes:( maltase,( sucrase( and(
intestinal( alkaline( phosphatase( in( the( small( intestine( of( control( and(
diabetic(rats.((
5. To(investigate(the(expression(pattern(of(SGLT1(at(the(mRNA,(protein(and(






• Determination( of( Na+/D@glucose( transport( rates( using( rapid( uptake(
filtration(technique(
6. To( determine( whether( GLUT2( protein( is( translocated( into( BBM( of(










4.1.1. Enrichment* and* percentage* recovery* of* BBM* markers* in* vesicle*
preparations*
Maltase,(sucrase(and(lactase(are(classical(markers(of(the(BBM.(The(activity(of(
sucrase( and( maltase( were( measured( in( membrane( vesicles( isolated( from( the(
intestinal(tissue(of(adult(rats.(Lactase(level(is(known(to(be(negligible(in(the(intestine(
of( adult( animals,( so( it( was( not(measured.( To( assess( the(membrane( origin( of( the(
membrane(vesicles,(the(specific(activity,(enrichment(and(recovery(were(determined(





0.5(and(7.5(±(1( fold,( respectively,(with( recoveries(of(34(±(11.6(%(and(18.6(±(8(%,(




As( seen( in( figure( 4.1,( western( blot( analysis( showed( that( SGLT1( protein,( a(
BBM(protein,(is(enriched(in(the(purified(membrane(vesicles(with(negligible(levels(in(
the( respective(homogenates.(However,( there(was(no(detectable(GLUT2(protein,(a(
classical( BLM( marker,( when( the( same( membrane( vesicles( were( immunoblotted(
using( an( antibody( to( GLUT2( (data( not( shown).( These( data( indicate( that( the(
membrane(vesicles(originate( from(the(BBM(domain(with(negligible(contamination(
by(the(BLM.((((

























































































To( confirm( the( induction( of( diabetes,( blood( glucose( concentration( was(
measured( in( the( morning( from( the( tail( blood( of( rats.( This( was( recorded( 1=day(
before( and( 3=days( after( STZ( treatment,( for( control( and( diabetic( rats,( and( then( 5(
weeks(post(STZ(injection(for(diabetic(rats(only.((Some(of(the(rats(were(not(diabetic(
after(the(first(injection(of(STZ,(therefore,(those(rats(were(re=injected(with(a(second(
dose.( Blood( glucose( concentrations( in( control( rats( were( between( 6.9( and( 8.9(




For( both( control( and( STZ=induced( diabetic( rats,( body( weight( and( small(
intestinal(weight(and(length(were(measured(and(recorded(in(table(4.2.((
It( was( observed( that( streptozotocin=diabetic( rats( had( a( statistically(
significant( body( weight( loss( by( 1.3=fold( when( compared( with( control( rats( of( the(
same( age( (369.3( ±( 10.8( g( vs( 500( ±( 6.8( g,(p<0.0001).( However,( the(weight( of( the(



























4.2.3. Histological* and* morphometric* analysis* of* the* small* intestine* in*
control*and*STZ@induced*diabetic*rats.**
Haematoxylin(and(eosin((H&E)(staining(of(rat(intestinal(tissue(sections(were(
carried( out( for:( 1)( histological( analysis( prior( to( immunohistochemistry( to( assess(






Rat( intestinal( tissue( sections( were( stained( with( H( &( E( and( representative(
images(are(shown(in(figure(4.2.(Images(a)(and(b)(show(that(the(structure(of(the(rat(
intestine( had( a( disrupted(mucosa,(with( some(enterocytes( on( the( villi( being( shed,(
and(the(BBM(being(not(completely( intact.(Those(rats(were(killed(by(phenobarbital(
injection(and(tissue(were(removed(in(more(that(20(minutes(later.(Therefore,(other(
rats(were( killed( by( cervical( dislocation( and( tissues(were( collected( in( less( than( 10(
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diabetic( rats( were( stained( with( haematoxylin( and( eosin( to( assess( any( potential(
intestinal(morphometric(changes(brought(about(by(diabetes.(As(seen(in(figure(4.3,(it(
appears( that( the( villi( are( longer( in( the( intestine( of( diabetic( rats( than( that( in( the(
controls.((
(
Using( Image( J( computer( software,( villus( height( was( determined( by(
measuring(the(distance(from(villus(tip(to(crypt(villus(junction,(and(crypt(depth(was(
determined( by( measuring( the( distance( from( crypt( base( to( crypt( villus( junction.(
Results(are(depicted(in(table(4.3(and(demonstrated(as(histograms(in(figure(4.4.((
(
Generally,( the( length(of( the( intestinal(villi(was( longest( in( the(proximal(part(
and( decreased( with( distal( progression( throughout( the( intestine.( Morphometric(
measurements,( represented( in( table( 4.3,( showed( that( the( intestinal( villi( in( the(
diabetic(rats(were((statistically(significant)(longer(than(those(of(the(controls(by(1.2(




Figure& 4.3:& & Morphometric& analysis& of& small& intestinal& sections& of& control& and&
diabetic&rats. 
    *
Representative*images*showing*haematoxylin*and*eosin*staining*of*the*distal*small*























































Figure&4.4:* *Morphometric&measurements&of& the&villus&height&and&crypt&depth& in&
the&small&intestine&of&control&and&diabetic&rats&
&











(IAP)(were( assayed( in( BBMV( isolated( from( the( three( intestinal( regions( of( control(
and(diabetic(rats.(Their(specific(activity(levels(were(determined(to(identify(if(i)(there(
were( changes( in( their( activity( in( the( diabetic( intestine( and( ii)( there( was( any(
correlation(between(the(changes( in( the(activity(of(BBM(enzymes( to( that( in(SGLT1(
expression( in( the(diabetic( condition.(However,( lactase( could(not(be( included(as( it(
has(low(expression(in(the(intestine(of(adult(animals.((
(
Table( 4.4( represents( the( specific( activity( values( of( alkaline( phosphatase,(
maltase( and( sucrase( along( the( small( intestine( of( control( and(diabetic( rats.( Figure(
4.5,( displays( graphs( comparing( the( activity( of( each( enzyme( in( the( intestine( of(
controls( and( diabetics.( Generally,( in( each( group( of( control( and( diabetic( rats,( the(
activity(levels(of(alkaline(phosphatase(and(maltase(were(much(higher(than(sucrase(
throughout( the( small( intestine.( By( comparing( the( diabetic( and( the( control( rats,(




3( and( 3.3( fold( in( the( mid( and( distal( intestine,( respectively,( in( the( diabetic( rats(
compared( to( that( in( the( controls.( Figure( 4.5( b)( shows( that( maltase( levels( were(
increased( by( 1.1,( 1.6( and( 2.5( fold( in( the( proximal,( mid( and( distal( intestine,(
respectively,(in(the(diabetic(rats(compared(to(that(in(the(controls.(While,(as(seen(in(
figure(4.5( c),( sucrase( levels(were( significantly( higher(by(1.1,( 2( and(3.3( fold( in( the(
proximal,(mid(and(distal(intestine,(respectively,(in(the(diabetic(than(the(control(rats.((
(

















































































Graphical*presentation* showing* the* specific*activity*of*a)*Alkaline*phosphatase,*b)*
Maltase*and* c)* Sucrase* in*BBMV* isolated* from*all* three* small* intestinal* tissues*of*







4.4. Expression* of* SGLT1* in* the* small* intestine* of* control* and* STZ@induced*
diabetic*rats.**





Dyer(et* al.,( 1997a).( The( antibody(was( raised( in( rabbit( against( a( synthetic( peptide(
corresponding( to(amino(acids(402=420(of( rabbit( SGLT1,(which(has(94.7(%( identity(
and(94.7(%(similarity(with(rat(SGLT1.(
(
SGLT1( protein( expression( was( investigated( along( the( crypt/villus( length(
(horizontal( axis)( as(well( as( among( the( proximal,(mid( and( distal( intestinal( regions(
(longitudinal(axis)( in(diabetic(rats(after(1(week(and(5(weeks( induction(of(diabetes.(
Representative( images( for( SGLT1( immunostaining(are(displayed( in( figures(4.6,( 4.7(
and(4.8(for(the(proximal,(mid(and(distal(intestine,(respectively.(((
(
In(general,( the(results(revealed(that( in(the(small( intestine(of(both(control(
and(diabetic(rats,(SGLT1(protein(expression(was(exclusively(expressed(on(the(brush=
border( membrane( of( the( enterocytes,( whereas( no( staining( was( detected( on( the(












was( first( detected( in( the(mid( villus(with( increasing( intensity( toward( the( villus( tip,(
but(little(staining(was(observed(in(the(lower(villus(and(no(staining(in(the(crypts.(In(















Representative* immunofluorescence* images* (of* four*animals)* show* the*expression*


















Figure& 4.7:& Immunohistochemical& detection& and& localization& of& SGLT1& protein& in&
the&mid&intestine&of&control&and&diabetic&rats*
a) Control&rat&*







Representative* immunofluorescence* images* (of* four*animals)* show* the*expression*
of*SGLT1*protein*(Red*label)*in*the*mid*intestine.*SGLT1*protein*was*detected*on*the*






























Representative* immunofluorescence* images* (of* four*animals)* show* the*expression*
of*SGLT1*protein* (Red* label)* in* the*distal* intestine.*SGLT1*protein*was*detected*on*
the*BBM*of*the*upper*villus*enterocytes*and*the*villus*tip*in*the*intestine*of*control*
rats*(a).* In*contrast,* it* is*detected*along*the*BBM*of*the*entire*villus*enterocytes*in*


















4.4.2. Quantitative* RT@PCR* analysis* of* SGLT1* mRNA* levels* along* the*
length*of*the*small*intestine.*
The( quantitative( real=time( PCR( was( carried( out( to( analyse( the( intestinal(
expression(of(SGLT1(at(the(mRNA(level(in(control(and(STZ=induced(diabetic(rats(after(
one(and(five(weeks(induction(of(diabetes.(Rat(SGLT1(primer(set(was(used(with(25(ng(





demonstrated( that(SGLT1(mRNA(abundance(was( similar( throughout( the( intestinal(
length;(with(a(slight(decline(distally.( Interestingly,( in( the(diabetic( rats,( the(relative(
SGLT1(mRNA( expression(was( significantly( higher( by( 2( fold( (2.04( ±( 0.17( vs( 1.02( ±(
0.05,(P=0.002(),(2.2(fold((1.98(±(0.2(vs*0.91(±(0.1,(P=0.001)(and(2.3(fold((1.6(±(0.2(vs*
0.7( ±( 0.08,( P=0.008)( in( the( proximal,( mid( and( distal( intestine,( respectively,(
compared(to(that(in(the(control(rats.((
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analysis( of( the( relative( SGLT1( protein( abundance,( quantified( using( scanning(
densitometry((Phoretix).((
There( was( a( trend( to( higher( levels( of( SGLT1( protein( abundance( in( the(
diabetic(rats(compared(to(the(controls(by(1.5(fold((1.4(±(0.27(vs(0.9(±(0.2,(P=0.3),(1.4(
fold((1.33(±(0.2(vs(0.9(±(0.03,(P=0.2)(and(2.2(fold((1.31(±(0.2(vs(0.6(±(0.06,(P=0.06)(in(




Figure& 4.10.& Immunodetection& of& SGLT1& protein& in& BBMV& isolated& from& the&
intestinal&regions&of&control&and&STZUinduced&diabetic&rats&
&
( ( ( ( (((((Control* *******Diabetic* ** *. . !!!!!!!P!!!!!M!!!!!!D!!!!!!!!!P!!!!!M!!!!!!D!























To( analyse( the( transport( function( of( SGLT1,( Na+=dependent( D=glucose(
uptake(rates(were(determined(using(the(rapid(filtration(technique,(as(described(in(
the(Methods.(For(transport(studies(in(rat(intestinal(tissue,(freshly(prepared(BBMVs(
were( used( to( avoid( protein( degradation( and( vesicular( damage( as( discussed( in(
Methods.(The(histogram( in( figure(4.11(shows( the( initial( rate( (3(second(uptake)(of(




slightly(higher( in(the(order(of(mid(>(proximal(>(distal( intestine.(This( is(adapting(to(
the( bioavailability( of( the( substrate( (glucose)( in( the( intestinal( lumen,( which( is(
digested(in(the(proximal(region(and(mostly(absorbed(in(the(mid(region,(then,(little(
sugars(reach(the(distal(small(intestine.((
However,( the( rate(of(D=glucose(uptake(was( significantly(higher( in( the( intestine(of(
diabetic( rats( compared( to( that( in( the( controls( by( 2( fold( (149( ±( 71( vs( 73.4( ±( 50(
pmol/mg( protein/sec,( P=0.4),( 3.3( fold( (274.80( ±( 23.3( vs( 88.61( ±( 34.4( pmol/mg(
protein/sec,( P=0.002),( and( 3.5( fold( (192.3( ±( 30.3( vs( 45.5( ±( 22.5( pmol/mg(







A* representative* histogram* showing* the* Na+Ldependent* DLglucose* transport* by*
SGLT1* into* BBMVs* isolated* from* proximal,* mid* and* distal* intestinal* regions* of*

















GLUT2( or( to( residues( 511=524( (the( C=( terminus( region)( of( equine( GLUT2.( As( a(
































Figure& 4.13:& Immunohistochemical& detection& and& localization& of& GLUT2& protein&
along&the&villus&in&rat&intestine&&
*
( ( ( ( (
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4.5.2. Absence* of* GLUT2* protein* detection* in* BBMV* isolated* from* the*
intestine*of*control*and*diabetic*rats.**










4.5.3. Expression* of* GLUT2* mRNA* levels* along* the* intestinal* length* of*
control*and*diabetic*rats.**
After(determining(that(GLUT2(protein(is(exclusively(expressed(on(the(BLM(of(




The( graph( shown( in( figure( 4.14( demonstrated( that( for( both( control( and(






















rats( and( subsequently( diabetes( was( confirmed( by( measuring( blood( glucose(
concentrations.( The( present( work( determined( the( intestinal( structural( changes,(
BBM( enzymatic( activity,( the( expression( and( functional( levels( of( SGLT1( along( the(
small( intestine( of( control( and( STZ=induced( diabetic( rats.( Moreover,( the( GLUT2(
expression(was(assessed.((
(
Initially( in( this(study,( intact(BBMV(could(not(be(prepared(successfully( from(
frozen(tissues(of(rats,(and(SGLT1(immunoblotting(showed(degraded(proteins(in(the(
isolated( BBMV( (see( figure( 3.13( page( 111,( frozen( vs( fresh( tissue( used( for( BBMV(
preparation).( The( reason( for( this( may( be( due( to( the( time( between( killing( the(
animals( and( removing( the( tissue,( or( isolating( BBMV( from( frozen( rat( intestinal(
tissues.(Considering(these(factors(that(may(have(affected(the(integrity(of(the(tissue(
or( the( vesicles,( tissue( collection( was( done( very( rapidly( after( killing( the( rat,( and(
BBMVs(were(isolated(from(freshly(removed(tissues.(Additionally,(protease(inhibitors(
were( included( in( buffers( employed( in( vesicle( preparation( to( prevent( protein(
degradation.(For(glucose(uptake(studies,(it(was(difficult(to(assess(glucose(transport(
function( in( frozen(BBMV( isolated( from(rat( intestine,( thus( the( transport( study(was(
carried(out(on(the(same(day(of(vesicles(preparation.(For(Western(blotting,(protein(
samples( were( mixed( with( the( sample( buffer( prior( to( freezing;( then,( protein(
separation(was(processed(on(another(day.( It(was(shown(that( the( isolated(vesicles(
originated( from( the( BBM( of( the( enterocytes( by( determining( the( enrichment( and(
percent( recovery( of( BBM( markers( (maltase( and( sucrase)( in( the( vesicles( and(





For( morphological( analysis( in( this( work,( it( was( a( challenge( to( obtain(
intestinal(tissue(from(rats(with(good(architecture.(In(initial(attempts,(it(was(noticed(
that( some(enterocytes(were( shed( from( the(villi( and( the(BBM(was(not( completely(
intact.(This(could(have(been(due(to(the(proteases(present( in( the( luminal(contents(
and( the( slow( tissue( removal.(These(were(avoided(by( removal(of( tissue(within( ten(
minutes(of(sacrifice,(and(the(use(of(protease(inhibitors(in(fixation(solutions.(Tissues(
from( the( latter( animals( showed( good( structural( integrity(with(well=attached( cells(









increase( in( intestinal(weight(and( length(by(2.7(and(1.2( fold,( respectively.(This(was(
accompanied(by(longer(villi(in(the(three(intestinal(regions(by(1.2(fold(in(the(diabetic(
rats( compared( to( that( in( controls.( Results( also( showed( that( the( activities( of(
intestinal(maltase,(sucrase(and(alkaline(phosphatase,(were(increased(in(the(diabetic(
rats(compared(to(that(in(the(controls.(In(the(proximal(intestine,(they(were(higher(by(





levels( are( higher( by( 2,( 2.2( and( 2.3( fold( in( the( proximal,(mid( and( distal( intestine,(
respectively,( of( diabetic( rats( compared( to( controls.( SGLT1( protein( was( immune=
blotted(as(a(single(band(of(75(kDa,(and(showed(increased(SGLT1(protein(abundance(
by( 1.5,( 1.4( and( 2.2( fold( in( the( proximal,(mid( and( distal( intestine,( respectively,( of(
diabetic( rats( compared( to( controls.( However,( enhancement( of( glucose( transport(
rates( (SGLT1( function)( was( higher( than( increase( in( SGLT1( mRNA( and( protein(
expression.(The(function(was(enhanced(by(2,(3.3(and(3.5(in(the(BBMV(isolated(from(
the( proximal,(mid( and( distal( intestine,( respectively,( of( diabetic( rats( compared( to(
controls.(This(disparity(between(transport(rates(and(protein(abundance(is(likely(due(
to( differences( in( the( sensitivity( of( techniques,( glucose( uptake( studies( using(
radiolabelled( glucose( appears( to( be( more( sensitive( than( Western( blotting.( The(
limitation(of(Western(blot( findings(could(be(due( to( the( freezing(and(defrosting(of(








whereas,( it( was( extended( to( the( lower( villus( in( diabetic( rats.( Negligible( SGLT1(
protein(detection(was( found( in( the(crypts(of(both(groups.(This(expression(pattern(

















The( morphometric( analysis( reported( here( are( consistent( with( previous(













STZ=diabetic( rats( compared( to( controls( (Burant( et* al.,( 1994),( and( significantly(
increased( in(chronic(diabetes( (30=( to(60=day(after(STZ( injection)( (Miyamoto(et*al.,(
1991).(Our(Western(blotting(showed(greater(changes(in(SGLT1(protein(expression(in(
the( ileum(than( in(the(duodenum(and( jejunum,(similar(to(that(observed(previously(
with( changes( in( SGLT1( expression( being( confined( to( the( ileum( and( jejunum( of(
experimentally( induced( diabetic( rats( compared( to( controls( (Burant( et* al.,( 1994,(
Fedorak(et*al.,( 1991).(At( the( cellular( level,( SGLT1(protein(was(previously( found( in(
villus( enterocytes( of( diabetic( ileum,( but( not( control( ileal( tissue( (Debnam( et* al.,(
1995). Other(work(showed(a(recruitment(of(specific(phlorizin(binding(in(the(mid(to(
lower(villus(of(chronically(diabetic(rats((Fedorak(et*al.,(1991,(Fedorak(et*al.,(1989).(
Furthermore,( similar( results(were(previously(documented(by(Debnam(et*al.,( 1995(
that( SGLT1( function( is( significantly( higher( in( the( diabetic( intestine,( and( that( this(
enhancement( is( due( to( increases( in( the( maximum( velocity( of( glucose( uptake(








intestine( of( diabetic( rats( compared( to( controls,( there( is( no( change( in( the( villus(
length(and(in(the(activity(of(the(BBM(enzymes.(However,(there(is(a(2=(fold(increase(
in(SGLT1(mRNA(expression(and(function,(indicating(that(increased(SGLT1(expression(
brought( about(by(diabetes(may(be(due( to( enhancement(of( the(number(of( SGLT1(
transporters( per( enterocytes.( ( This( pattern( of( expression( is( different( in( mid( and(
distal(regions(of(the(intestine(of(diabetic(rats.(The(lower(villus(enterocytes(of(control(
rats( do( not( express( SGLT1( protein,( whereas( in( diabetic( rats,( intestinal( SGLT1(
expression( spreads( to( lower( villus( enterocytes.( It( is( likely( that( the( 2=( and( 3=( fold(










































































The expression of SGLT1  
in the intestine of  
non-diabetic (control) humans and 







In( the( human( digestive( system,( dietary( carbohydrates( are( digested( by(
intestinal(brush=border(membrane( (BBM)(hydrolases( into(monosaccharides,(which(
are( absorbed( from( the( gut( lumen( to( the( systemic( circulation( via( transmembrane(
carriers(on(the(luminal(and(the(serosal(sides(of(the(enterocytes.((
Intestinal(SGLT1(is(an(integral(membrane(protein(localised(in(the(BBM(of(the(
intestinal(epithelium.( It( is(a(symporter( importing(glucose,(or(galactose,(coupled(to(
Na+(and( its(associated(electrochemical(gradient( from(the( intestinal( lumen( into( the(
enterocytes( across( the( BBM.( Subsequently,( all( monosaccharides( are( passively(
moved(down(their(concentration(gradient(out(of( the(cells( to(the(blood(stream(via(
GLUT2( across( the( basolateral( membrane( (Gould( and( Bell,( 1990,( Wright,( 1993,(
Shirazi=Beechey,(1995).(((((((
(
The( expression( of( intestinal( SGLT1( has( a( persistent( basal( level,( which( is(
independent( of( local( luminal( nutrients,( to(maintain( the( glucose( absorption( in( the(
gut( even( in( starvation.( However,( the( expression( is( regulated( in( response( to( the(
fluctuation( in( luminal( carbohydrate,( above( a( threshold( exceeding( 50(%(of( dietary(
contents.( It( has( also( been( reported( that( this( SGLT1( expression( is( normally(
modulated(according(to(the(developmental(stage(and(other(physiological(conditions(
like(pregnancy(and(lactation((Rhoads(et*al.,(1998,(Ferraris,(2001,(Dyer(et*al.,(1997a,(
Dyer(et*al.,( 1997b).( Interestingly,( there( are( increased( levels( of( SGLT1(protein( and(
mRNA( that( are( independent(of( luminal( sugars( and(blood( glucose(or( insulin( levels(
observed(in(diabetes(and(obesity((Burant(et*al.,(1994).(Studies(revealed(that(SGLT1(
expression( and( activity( are( enhanced( in( the( intestine( of( human( subjects( with(
NIDDM((Dyer(et*al.,(2002b).(Limited(work,(however,(has(been(carried(out(to(explain(
the(molecular( basis( of( the( enhanced( intestinal( capacity( for( glucose( absorption( in(
patients(with(diabetes(mellitus.((
( Diabetes(mellitus((DM)(is(a(chronic(metabolic(disorder(with(disturbances(in(
carbohydrate,( fat( and( protein( metabolism.( It( is( characterized( by( chronic(
hyperglycaemia(due( to(either(absolute(or( relative( insulin(deficiency,(or(peripheral(
tissue(resistance(to(insulin.(Diabetes(is(diagnosed(by(measuring(the(plasma(glucose(
levels(in(fasting(≥(7.0(mmol/L((126(mg/dL)(and(2(hours(after(75(g(glucose(drink(≥(7.8(




diabetes( mellitus( (NIDDM)( and( type( 3,( the( gestational( diabetes.( They( all( have(
multiple(etiologies(plus(the(genetic(predisposition(for(developing(the(disease.(About(




tissue( resistance( to( insulin( and( relative( insulin( deficiency.( This( is( in( contrast( to(
type(1,(which( results( from(autoimmune(destruction(of( insulin=producing( β=cells( of(
the(pancreas,(leading(to(absolute(insulin(deficiency((Knowler(et*al.,(2002).((
The( rising( prevalence( of( type( 2( diabetes( is( an( epidemic( health( problem(
especially( in( developing( countries( and( causes( a( financial( burden( to( health(
authorities.( Diabetes( can( be( a( life=threatening( disease( if( blood( glucose( is( not(
managed( properly.( It( has( serious( long=term( complications( such( as( nephropathy,(
neuropathy(and(retinopathy(due(to(high(blood(glucose,(which(can(cause(disability(
or( end=stage( organ( failure.( The( acute( complications( include( diabetic( ketoacidosis(
and( nonketotic( hyperosmolar( diabetic( coma,( which( could( lead( to( coma( or( death(
from( severe( hypo=glycaemia( (Sarwar( et* al.,( 2010,( American( Diabetes( Association,(
2011).(
Therefore,( effective( management( of( diabetes( is( vital( to( maintain( glucose(
homeostasis( and( to( minimize( the( risk( of( complications.( In( type( 1( (IDDM),( the(
definitive( treatment( is( insulin( injections,( or( pancreatic( transplants;( the( latter( is(
rarely( done( for( those( with( badly( uncontrolled( diabetes.( By( contrast,( in( type( 2(
(NIDDM),( endocrinologist( deal( with( this( disorder( in( different( ways,( such( as(
modifying( diets( and( lifestyles,( reducing( body( weight( and( promoting( exercise.( In(
addition,( oral( administrated(hypoglycemic( agents( (OHAs)( are( generally( prescribed(
to( patients(with(NIDDM,( either( alone( or( in( combination(with( insulin( injections( as(
needed(in(some(cases.(Different(classes(of(OHAs(are(available,(which(have(various(
modes( of( action:( they( stimulate( insulin( secretion( or( its( action,( reverse( insulin(
resistance,( reduce( gluconeogenesis( by( the( liver( and( inhibit( the( gut( enzymes( that(
convert(dietary(carbohydrates(into(simple(sugars(to(reduce(glucose(absorption(after(
meals.(
Research( is( now( focused( on( innovative( new( treatments( for( diabetes(
mellitus.(As(SGLT1(plays(a(major(role(in(intestinal(glucose(transport,(it(is(considered(
a( novel( target( to( control( postprandial( hyperglycemia.( However,( better(










The( aim( of( the( work( presented( in( this( chapter( was( to( investigate( the(
enhanced(SGLT1(expression(in(the(intestine(of(human(diabetics.(To(this(end,(human(
biopsies( were( collected( by( endoscopy( from( the( duodenum( of( non=diabetic(
individuals( and( patients( suffering( from( type( 2( diabetes( mellitus.( The( expression(
pattern( of( SGLT1( protein( and( SGLT1( mRNA( levels( were( assessed( in( diabetic(
intestinal(biopsies(and(compared(to(that(of(control(biopsies(from(intestine(of(non=




1. Isolation( and( characterisation( of( BBMV( isolated( from( human( duodenal(
biopsies(and(assessment(of(their(membrane(origin.(
2. Measurement( of( the( specific( activity( of( the( BBM(marker,(maltase,( in( post(
nuclear( membrane( fractions( (PNMF)( prepared( from( duodenal( biopsies( of(
control(humans(and(diabetics.(














For( the( isolation( of( BBMVs( from( intestinal( biopsies,( the( microscale(
procedure(was(used(as(described(by(Shirazi=Beechey(et*al.,((1990).(Specific(activity,(
enrichment(and(percent(recovery(of(maltase,(as(a(brush(border(membrane(marker,(






















































5.2. Specific* activity* of* a* BBM* marker,* maltase,* in* PNMFs* prepared* from*
duodenal*biopsies*of*control*humans*and*diabetics*
PNMFs( were( isolated( from( the( duodenal( biopsies( of( control( and( diabetic(
humans.(The(specific(activity(of(maltase(was(determined(to(correlate(the(enhanced(
expression(of(BBM(enzymes(to(the(expression(of(SGLT1(in(the(diabetic(condition.((












The( opportunity( was( taken( to( compare( maltase( specific( activity( in( the(
duodenum(of(human(subjects(to(that(measured(in(other(species.(As(shown(in(table(
5.1,( it(appears(that(maltase(level( in(the(proximal(intestine(of(rat( is(close(to(that(in(
mouse.( ( Similarly,( close( levels( of( maltase( activity( are( seen( in( the( duodenum( of(
humans( and( pigs.( Interestingly,(maltase( activity( in( the( intestine( of(mice( and( rats(
(small( mammals)( was( 10( times( higher( than( that( measured( in( the( intestine( of(
humans(and(pigs((large(mammals).(*
(
Table& 5.1.*Maltase& specific& activity& in& BBMVs& isolated& from& the& proximal& small&
intestine&of&different&species&&















& ( ( ( (
Results*are*expressed*as*mean*±*S.E.M.*(n=4*or*6)*or*S.D.*(n=2).** *































5.4. Morphological* assessment* of* human* duodenal* biopsies* by* haematoxylin*
and*eosin*staining.*
Human(duodenal( samples(were( sectioned(and( stained(with(haematoxylin(
and( eosin( (H( &( E)( to( assess( tissue( morphology( and( integrity( prior( to(
immunohistochemistry.(Representative(images(of(the(intestinal(tissue(sections(with(
H(&( E( staining( are( shown( in( figure( 5.3.( As( the(human( samples( used( in( this( study(
were(collected(by(endoscopy,(the(duodenal(biopsies(only(contained(tissue(from(the(
mucosal(layer.(It(appears(that(the(tissue(samples(retained(their(integrity(with(brush=
border( membrane( (BBM)( and( intact( attached( enterocytes( along( the( crypt=villus(


























Figure& 5.4.& Immunohistochemical& detection& and& localization& of& SGLT1& protein& in& the&
duodenum&of&control&and&diabetic&humans&
* * Control*human*********** *
*a)*20*X*magnified* * * *
(((((((((( (
b)*40*X*magnified*




((((((((( ( (( (
*
Representative*images*show*the*immunostaining*of*SGLT1*protein*in*the*duodenal*
biopsies* of* nonLdiabetic* humans* and* diabetic* patients.* The* expression* of* SGLT1*




















The( expression( of( SGLT1( mRNA( level( was( analysed( using( quantitative( RT=
PCR.(The(PCR(reaction(was(carried(out(with(50(ng(cDNA(generated(from(duodenal(
samples( of( healthy( controls( and( diabetic( patients.( Figure( 5.5( demonstrates( that(














relative SGLT1 mRNA abundance








































Post=nuclear( membrane( fractions( (PNMFs)( were( isolated( from( duodenal(
biopsies( of( non=diabetic( controls( and( patients( with( NIDDM( for( the( detection( of(
SGLT1(protein(by(Western(blotting.(Proteins(in(PNMFs(were(separated(by(SDS=PAGE(
gel(electrophoresis(on(acrylamide(gels.(Isolated(proteins(were(transferred(from(the(









the( samples( of( both( diabetics( and( controls.( This( indicated( that( the( protein( was(
loaded( equally( (10* μg)( in( all( the( lanes.( Concluding( that( in( some( samples( SGLT1(
protein(was( degraded.* The( shortage( of( human( biopsies( limited( the( availability( of(
more(PNMF(samples.(
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b)*βLactin*protein*band*of*42*kDa* in*PNMF* isolated* from*the*duodenal*biopsies*of*
control* individuals*and*diabetic*patients.* c)*bands*of* SGLT1*protein*were*detected*
only* in* some*PNMF* samples.*While,* bands* of* βLactin* protein*were* detected* in* all*
PNMF*samples*isolated*from*control*and*diabetic*human*intestine.**
* (
SGLT1  ~ 75 kDa 
(










Discussion* * * *
(
Diabetes(mellitus((DM)(is(a(serious(common(metabolic(disease(characterized(







Postprandial( hyperglycemia( can( also( be( managed( by( reducing( the(
absorption(of(dietary(sugars(from(the(gut.(Researchers(can(contribute(by(identifying(
the( factors( that( control( intestinal( glucose( transport.( The( main( route( for( glucose(
uptake( from( the( gut( lumen( into( enterocytes( is( the( glucose( transporter( SGLT1.(
Hence,( interest( has( recently( focused( on( the( expression( of( SGLT1( as( a( new(
therapeutic(target(for(diabetic(patients(by(modulating(intestinal(glucose(uptake.((
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from( non=diabetics,( indicating( that( the( activity( of( SGLT1( was( enhanced( in( the(
intestine(of( humans(with( type(2( diabetes(mellitus( (Dyer(et* al.,( 2002).( Similarly,( it(
was(observed(that(the(maximum(capacity(for(intestinal(sugar(transport(is(increased(
in( the( intestine(of(Alloxan=(or(streptozotocin=induced(diabetic( rats( (Fedorak(et*al.,(
1989).((
(
In( this( study,(human(duodenal(biopsies(were( removed(by(endoscopy( from(
non=diabetic( controls( and( patients(with(NIDDM.( Brush=border(membrane( vesicles(




of( maltase,( as( a( BBM( marker.( However,( as( preparation( of( PNMFs( yields( more(







of( non=diabetic( human( biopsies( showed( similar( levels( of( activity( to( those( in( the(
duodenum(of(pigs.(Similarly,(maltase(levels(in(rats(were(equivalent(to(those(in(mice(
in(the(proximal(intestinal(region.(The(latter((small(mammals)(showed(10(times(more(
maltase( activity( than( humans( and( pigs( (large( mammals);( that( could( be( modified(
depending(on(the(nature(of(food(intake.(
(
Results( in( this( chapter( demonstrate( that(maltase( activity,( a( BBM(digestive(
enzyme,( is(higher( in( the(diabetic( intestine(by(2.1( fold( than( in( the( controls.(SGLT1(
mRNA(expression(was( increased(by(2.7=fold( in( the(duodenum(of(diabetic(patients(
compared( to( that( in( control( subjects.( SGLT1( protein( expression( was(
immunodetected( on( the( BBM( of( the( enterocytes( along( the( entire( villus( length,(
having(similar(pattern(in(the(duodenum(of(both(diabetic(and(non=diabetic(humans,(
with(no(expression(detected( in( the(crypts.( This(expression(was( relatively( stronger(
on( the( BBM(of( the( enterocytes( lining( the( villi( in( the( diabetic( intestine.( However,(
there(were(difficulties(immunoblotting(SGLT1(protein(that(could(be(due(to(protein(
degradation( in( some( of( the( prepared( PNMF.( The( morphological( analysis( by(
haematoxylin(and(eosin(staining(showed(good(integrity(of(the(mucosal(layer(with(an(
intact(BBM(and(absence(of(submucosal(and(muscularis(externa((but(not(consisting(
the( deeper( layers( of( the( gut( wall.( Unfortunately,( morphometric( measurements(
could(not(be(analysed(due(to(the(shortage(of(human(duodenal(samples(and(the(few(
villi(in(the(tissue(sections.(
In( this( study,( it( was( also( aimed( to( estimate( maltase( activity( and( SGLT1(
protein(abundance( in( the(same(post=nuclear(membrane( fractions( (PNMF)( isolated(
from(duodenal(biopsies(of(non=diabetic(controls(and(patients(with(type(2(diabetes(
mellitus.( By( immunoblotting,( a( single( band( of( 75( kDa,( corresponding( to( SGLT1(
protein,( was( detected( only( in( some( PNMFs( samples.( Unfortunately,( other(
immunoblotting( experiments( failed( to( detect( any( bands( in( the( PNMF( samples.( It(
seems( that( the( SGLT1( protein( was( degraded( in( those( samples,( and( due( to( the(
shortage(of(human(samples,(this(investigation(could(not(be(repeated.((
(
However,( work( was( done( in( our( laboratory( (using( PNMF( and( BBMV)( and(
reported(that(the(abundance(of(SGLT1(protein(is(significantly(higher(by(3.3=fold(and(
4.3=fold( in( the( PNMF( and( the( BBMV,( respectively,( isolated( from( the( duodenal(
biopsies( of( diabetic( patients( compared( with( that( isolated( from( control( subjects(
(Dyer(et*al.,(2002b).(Previous(investigations(in(this(laboratory(also(revealed(that(the(
estimated(abundance(of(the(structural(proteins(villin(and(beta=actin(were(increased(
by(2=fold( in( the( intestine(of(diabetic(patients(compared( to( that(of( controls.(Other(
BBM(proteins( like(sucrase(and( lactase(were(also(enhanced(by(1.5=(to(2=fold( in(the(






(Dyer( et* al.,( 2002b).( The( qRT=PCR( findings( that( SGLT1( mRNA( expression( was(







analysis(of( [3H](phlorizin(binding,( that(diabetes( lead(to( increase( in( the(transporter(
density(by(10=fold(in(enterocytes(during(early(stages(of(their(migration((Fedorak(et*
al.,( 1991).( ( Diabetes( also( promotes( early( cellular( induction( of( the( SGLT1( gene( in(
crypt( cells( and( enhances( SGLT1( mRNA( stability( and( protein( trafficking( from( the(
Golgi( compartment( leading( to( increased( numbers( of( SGLT1( protein( in( each(
enterocytes((Burant(et*al.,(1994).(Furthermore,(the(recruitment(of(additional(sugar(
carriers( on( the( BBM( probably( in( the( midvillus=to=crypt( region,( allowing( glucose(
transport( across( the( BBM( in( enterocytes( that( do( not( normally( transport( glucose(
(Fedorak(et*al.,(1987,(Burant(et*al.,(1994,(Fedorak(et*al.,(1989).((((
(
Those( findings( support( to( data( presented( here( to( suggest( that( the(
stimulated( intestinal(capacity(to(absorb(monosaccharides( in(the(diabetic(human(is(
caused(by(a(combination(of(1)(the(diabetic=induced(tissue(hypertrophy(expands(the(
absorptive( surface( area,( this( provides( a( greater( number( of( enterocytes( along( the(
villus( supporting( SGLT1( expression,( 2)( a( specific( enhancement( in( the( activity( and(
expression( of( glucose( transporters,( SGLT1,( per( enterocyte,( 3)( diabetes( promotes(
earlier(expression(of(SGLT1(on(the(BBM(of(relatively(premature(enterocytes.(
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The molecular basis underlying 
the enhanced expression of 










the( intestinal( lumen( directly( regulate( SGLT1( expression( (Ferraris( and( Diamond,(
1993,( Shirazi=Beechey( et* al.,( 1991,( Dyer( et* al.,( 1997c),( and( that( metabolism( of(
monosaccharides( is( not( required( for( sugar=induced( SGLT1( upregulation( (Shirazi=
Beechey( et* al.,( 1991,( Solberg( and( Diamond,( 1987).( Furthermore,( introduction( of(
membrane=impermeable( glucose( analogues( to( the( lumen( of( the( intestine( also(
stimulates( SGLT1( expression( (Dyer( et* al.,( 2003a),( arguing( that( there( is( a( glucose(
sensor(on( the( gut( luminal(membrane( responsible( for( detecting( luminal( sugars,( to(
modulate(SGLT1(expression((glucose=induced(SGLT1(expression).((
(
Further(work,( using( in* vitro(models( suggested( that( sugar(mediated( up=
regulation( of( SGLT1( is( likely( to( involve( a( G=protein=coupled( second( messenger(
pathway((Dyer(et*al.,(2003a).(The(discovery(that(the(lingual(epithelium(sweet(taste(







deleted( (knockout(mice)(provided(convincing(evidence( for( the( involvement(of( the(
gut=expressed( glucose( receptor( and( gustducin( in( intestinal( sweet( transduction(
(Margolskee(et*al.,(2007,(Dyer(et*al.,(2007).(Abolishing(sweet(taste(transduction(in(
mice( by( deletion( of( either( α=gustducin( or( T1R3( prevented( the( dietary(
monosaccharide=induced( up=regulation( of( SGLT1( expression( observed( with( wild(
type( mice( (Margolskee( et* al.,( 2007).( In( wild( type( mice( maintained( on( a( high=
carbohydrate( diet( (70%( sucrose),( there( was( a( 2=fold( increase( in( SGLT1( mRNA,(
protein(abundance(and( initial( rate(of(Na+=dependent(glucose( transport,( compared(
with( mice( fed( an( isocaloric( low=carbohydrate( diet( (1.9%( sucrose).( T1R3=and(
gustducin=knockout(mice,(however,(showed(no(change(in(SGLT1(mRNA(protein(and(
function( on( either( diet( (Margolskee( et* al.,( 2007).( Thus,( knocking( out( either( α=
gustducin(or(T1R3(eliminated(the(ability(of( the(mouse( intestine(to( increase(SGLT1(
expression(in(response(to(increased(dietary(carbohydrates.((
The(expression(of( SGLT1( in(both( types(of( knockout(mice(was( identical( to(
that( in(wild( type(animals(on( the( low=carbohydrate(diet,( suggesting( that( there( is(a(










Further( experimental( data( suggested( that( T1R2=T1R3,( expressed( on( the(
luminal(membrane(of(villus(endocrine(cells,( senses( luminal(glucose(concentration.(
Luminal(glucose(above(a(threshold(level(activates(a(signaling(pathway(in(endocrine(
cells( involving(T1R2=T1R3,( gustducin(and(other( signaling(elements( resulting( in( the(
secretion( of( the( gut( hormone( glucagon( like( peptide( 2( (GLP=2)( (Margolskee(et* al.,(
2007).( GLP=2( binding( to( its( receptor( residing( on( enteric( neurons( elicits( an( action(
potential( (Bjerknes( and( Cheng,( 2001),( evoking( the( release( of( the( neuropeptides(
vasoactive( intestinal( peptide( (VIP)( or( pituitary( adenylate( cyclase=activating(
polypeptide (PACAP).(Binding(of(VIP(/PACAP(to(its(receptor(VPAC1(expressed(on(the(





and( calcitonin( gene=related(peptide( (CGRP)( had(no( effect( on( SGLT1(up=regulation(
























of( SGLT1( in( the( intestine( of( diabetic( humans( is( independent( of( changes( in(
concentrations( of( glucose( in( the( lumen(of( the( intestine.( The( expression( of( SGLT1(
remained( high( in( the( intestine( of( human( diabetics(maintained( on( either( diabetic(
(low(carbohydrate)(or(normal((high(carbohydrate)(diets.(Furthermore(hypoglycemic(
drugs,( sulfonylureas( and( biguanides( did( not( affect( the( increased( levels( of(
monosaccharide( transporters( in( the( intestine( of( diabetic( patients.( Sulfonylurea(
drugs,( gliclazide( or( glibenclamide,( act( mainly( by( augmenting( insulin( secretion.(
While,( the( biguanide( drug( metformin( exerts( its( effect( mainly( by( decreasing(
gluconeogenesis(and(by(increasing(the(peripheral(utilization(of(glucose,(according(to(
the( British( National( Formulary.( This( suggests( that( the( enhanced( expression( of(
intestinal( monosaccharide( transporters( is( independent( of( any( changes( in( blood(
glucose(or(insulin(levels.(It(was(hypothesised(that(enhanced(expression(of(SGLT1(in(





In( this( chapter,( the( main( objective( was( an( attempt( in( identifying( the(
molecular(basis(underlying(enhanced(SGLT1(expression(in(the(diabetic(intestine.(To(





















( Immunohistochemical(studies(revealed(that(T1R2(protein( is(expressed( in(the(
enteroendocrine(cells( (EEC),(which(are(few(scattered(cells(amongst(the(absorptive(
enterocytes.(Figure(6.1(shows(the(flask=shaped(EEC(stained(with(T1R2(antibodies(in(
the( duodenal( biopsies( of( non=diabetic( and( diabetic( humans.( Omission( of( the(
primary(antibody(confirmed(specific(antibody(binding.((
(
Figure& 6.1:& Immunohistochemical& detection& and& localization& of& T1R2& protein& in&
human&intestine&*
a)*20X*magnified* * * * b)*40X*magnified*
( (( (
c)*20X*magnified* * * * d)*40X*magnified****
( ((( (
(
Representative* immunostaining* images* shows* that* T1R2* protein* expression* is*











Immunohistochemistry( demonstrated( a( similar( expression( pattern( for( T1R2(
being( located( in( enteroendocrine( cells,( as( shown( in( the( human( intestine.(
Furthermore,( there(were(no( changes( in( the(number(of(endocrine( cells( expressing(
T1R2( in( diabetic( rats( compared( to( controls.( Figure( 6.2( shows( the(
immunohistochemical(detection(of(T1R2(protein(in(the(intestine(of(a(control(rat.((No(














































Proglucagon( protein( (coded( by(GCG( gene),( is( a( precursor( of( glucagon( that(
gives( rise( to(GLP=1( and(GLP=2,( gut( hormones( secreted( by( the( enteroendocrine( L=
cells((Brubaker,(1991,(Bryant(and(Bloom,(1979).(Using(qRT=PCR(reactions,(as(shown(
in(figure(6.4,(the(relative(abundance(of(GCG(mRNA,(normalized(to(the(βLactin(gene,(
was( determined.( Expression( levels( increased( with( distal( progression( through( the(
small( intestine( for( both( control( and( diabetic( rats.( There( was( no( change( in( the(

















Table( 6.1( and( figure( 6.5( demonstrate( that( in( control( rats,( exposure( of(
intestinal(tissue(to(high((10%)(glucose(concentrations(increased(GLP=2(secretion(by(
1.4( and( 1.6( fold( in( the( mid( and( distal( intestine( compared( to( low( glucose(













































Graphs* show* that* intestinal* exposure* to* low* glucose* (LG)* and* high* glucose* (HG)*
concentrations* evoke*more*GLPL2* release* in* the* intestinal* regions* of* diabetic* rats*






GLP=2( receptor( (GLP=2(R)( is( expressed(on( the( afferent( enteric( neurones( in(
the( submucosal( layer(of( the( gut.(As( a( result( of( substrate=receptor(binding,( action(
potentials( are( generated( in( the( afferent( fibres( of( the( enteric( nervous( system(
(Drucker,(2002,(Shirazi=Beechey(et*al.,(2011a).((
( Using(qRT=PCR,(figure(6.6(demonstrates(that(mRNA(expression(of(GLP=2R(in(
the( diabetic( intestine( is( significantly( lower( by( 1.5( fold( (P=0.012)( and( 1.4( fold(
(P=0.032)( in( the( proximal( and( mid( regions,( respectively,( compared( to( that( of(
controls.(However,(no(expression(changes(were(found(in(the(distal(intestine.((
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VIP( (vasoactive( intestinal( peptide)( is( one( of( the( neuropeptides( that( are(
released( from( secretory( granules( at( the( enteric( nerve( endings,( in( response( to(
neuronal( activation,( for( signal( transmission( to( enterocytes.( Subsequently,( VIP(











































Immunohistochemical( results( revealed( that( VIP( protein( expression( is(
detected( in( the( lamina( propria( of( villus( and( the( nerve( fibres( of( submucosal( and(






Figure&6.9:& Immunohistochemical&detection&and& localization&of&VIP&protein& in& rat&
intestine&&
(
Representative* immunofluorescence* images* show* VIP* expression* in* the* proximal,*
mid*and*distal* intestine*of* control* (A,*C*and*E)*and*diabetic* rats* (B,*D*and*F).*VIP*
protein*expression*is*detected*in*the*lamina*propria*of*villus**(v),*submucosal*plexus*
(sp)*and*myenteric*plexus*(mp)*and*axonal*projections*spreading*from*submucosal*




































Pituitary( adenylate( cyclase=activating( polypeptide( (PACAP)( is( another(
neurotransmitter(released(from(enteric(nerve(endings.(PACAP(as(well(as(VIP(bind(to(
the( same( receptor( VPAC1( and( VPAC2( as(well( as( to( additional( PAC1( receptors( on(
enterocytes.( PACAP( potently( stimulates( adenylate( cyclase( leading( to( ‘cAMP(
formation’( in( target( cells( beside( its( neurotransmitter( function( (Heinemann( and(
Holzer,( 1999).( qRT=PCR( analysis( showed( a( significant( increase( in( PACAP( mRNA(
expression( in( the( diabetic( intestine( compared( to( controls,( as( displayed( in( figure(
6.10.( PACAP( mRNA( expression( was( higher( by( 2.5( fold( (0.39±0.07( vs* 0.157( ±
0.052,(P*=*0.033),(2.6(fold((0.44±0.05(vs*0.17(±0.06,(P*=*0.03)(and(2.1(fold((0.26




















VIP( and(PACAP,( but( not( substance(P( (SP),( enhances( SGLT1(expression.( Therefore,(
potential(changes( in(SP(expression(in(the(diabetic( intestine(were(assessed.(SP(acts(
via(a(stimulatory(GPCR(to(increase(accumulation(of(cAMP,(because(the(promoter(of(
substance(P( receptor,(NK1R,(contains( regions( that(are(sensitive( to(cAMP(affecting(
its( intracellular( level.( However,( SP( protein( expression( in( intestinal( tissue( of( the(
diabetic(rat(was(even(lower(than(controls((Belai(et*al.,(1985).((
As( shown( in( figure( 6.11,( mRNA( expression( of( the( TAC1( gene,( encoding(
substance( P,( was( lower( in( the( intestine( of( diabetic( rats( compared( to( that( of(
controls.((
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Results(of( immunohistochemistry(are( shown( in( figure(6.12.( It( appears( that(






Figure& 6.12:& Immunohistochemical& localization& of& substance& P& protein& in& rat&
intestine&
*
Representative* images* show* the* immunostaining* of* substance* P* in* the* intestinal*
regions* of* control* (A,* C* and* E)* and* diabetic* rats* (B,* D* and* F).* The* fluorescent*







































In( intestinal( glucose( absorption,( SGLT1( is( regulated( in( response( to( dietary(
carbohydrates((Dyer(et*al.,(1997a).(This(process( is(mediated(by(sugar(activation(of(
intestinal( glucose( sensors( (T1R2=T1R3)( in( endocrine( cells,( evoking( neuroparacrine(
signaling(mechanism( enhancing( SGLT1(mRNA( stability( leading( to( up=regulation( of(
SGLT1(protein( in( neighbouring( enterocytes( (Shirazi=Beechey(et* al.,( 2011b,(Daly(et*
al.,(2012,(Dyer(et*al.,(2007,(Dyer(et*al.,(2003a,(Dyer(et*al.,(2003b).((
However,(it(has(been(documented(that(the(gut(capacity(to(absorb(glucose(is(
enhanced( in( the( intestine( of( diabetic( humans( due( to( increased( activity( and(





high( carbohydrate( diets,( oral( hypoglycemic( drugs( or( insulin( injections.( Indicating(
that( the( mechanism( controlling( SGLT1( expression( is( deregulated,( leading( to(
enhanced(glucose(absorption(in(the(diabetic(intestine.((
Work( in( this( chapter( assessed( the( expression( of( some( key( components(















































































Interestingly,( it(was(observed(that( in(the( intestine(of(diabetic(rats,(GLP=2( is(
secreted(significantly(more(than(that(in(controls(in(response(to(low(glucose((and(to(
a( lesser( extent(high( glucose)( concentrations,( indicating( that( the(diabetic( intestine(




Work( from(other( laboratories(has( shown(that( intestinal(mucosal(growth( in(
diabetic( rats( is(associated(with(elevated(GLP=2(concentrations( in(both(plasma(and(
ileal(tissue((Fischer(et*al.,(1997).(However,(the(level(of(GLP=2(secretion(by(diabetic(
humans( is( controversial.( GLP=2( hormone,( besides( its( intestinal( trophic( effect(
(Drucker(et* al.,( 1996),( is( known( to( increase( SGLT1( expression( (Ramsanahie(et* al.,(
2003,( Cheeseman,( 1997,( Sangild( et* al.,( 2006).( mRNA( levels( of( GLP=2( receptors,(
which( are( located( on( afferent( enteric( neurons( (Baldassano( et* al.,( 2009,( Bjerknes(
and(Cheng,(2001),(are(either(decreased(or(not(changed(in(the(intestine(of(diabetic(
rats(compared(to(controls.(However,(several(studies(strongly(support(the(idea(that(
the( enteric( nervous( system( is( involved( in( the( up=regulation( of( SGLT1( expression(
(Sharp(et*al.,( 1996,(Debnam,(1985).(Unpublished(work( from(our( laboratory,(using(
murine(intestine,(has(shown(that(electric(field(stimulation(of(enteric(neurons(leads(
to( enhanced( SGLT1( expression;( which( was( inhibited( by( the( neuronal( sodium=
channel(blocker(tetrodotoxin(TTX.(
(
(It( is( known( that( diabetic( neuropathy,( resulting( from( excess( blood( sugar(
levels(injuring(the(walls(of(the(capillaries(that(nourish(nerves,(affects(the(gut=brain(
axis(and(enteric(neurons(in(the(diabetic(intestine(and(hence,(nerves(do(not(conduct(
signals( normally.( As( a( result,( the( generated( action( potentials( stimulate( nerve(
endings( to( release( more( of( the( neuropeptides( VIP( and( PACAP( as( evidenced( by(
significantly(higher(mRNA(expression(in(the(intestine(of(diabetic(rats(for(VIP/PACAP(
and(humans(for(VIP.(This(was(consistent(with(higher(expression(of(VIP(protein(in(the(




in( response( to( VIP( and( PACAP( in( a( dose=dependent( manner( in( the( intestinal(
epithelial(cell( line,(Caco=2( (unpublished(data),(while(substance(P,(CGRP((Calcitonin(
gene=related( peptide)( and( CRH( (Corticotropin=releasing( hormone)( neuropeptides(
had( no( effect( on( SGLT1( expression.( Other(workers( have( shown( that( the( diabetic(





The( data( obtained( in( this( chapter( suggests( that( secretion( of( the(
neuropeptides(VIP(and(PACAP(brought(about(by(diabetic(neuropathy(and(possibly(
increased( secretion( of( GLP=2( are( involved( in( the( deregulation( of( the( pathway(










































The( technical( skills( needed( for( the( work( carried( out( in( this( thesis( were(
developed( using( available( intestinal( tissues.(Membrane( vesicles(were( successfully(
isolated( from( frozen( intestinal( tissues( of( mice( and( pigs.( The( enrichment( and(
recovery( values( indicated( that( the(membrane( vesicles( originated( from( the( brush(
border( membrane( (BBM).( In( mouse,( sucrase( and( maltase( activity( was( higher( in(
proximal(than(distal(intestine.(While(lactase,(as(expected,(showed(very(low(activity(
in(the(intestine(of(adult(mice(because(milk(consumption(is(reduced(in(adulthood.(In(
contrast,( in( suckling( pigs( lactase( activity( was( similar( to( maltase( and( more( than(
sucrase.(This(reflects(the(adaptive(response(of(the(intestinal(digestive(capacity(to(be(
prepared( for( the( transition( from(milk( feeding( to( solid( food( in( the( last(days(of( the(
suckling( period.( Generally,( in( mice( and( pigs,( maltase( showed( significantly( higher(




In( the( intestine( of( mouse,( SGLT1( protein( was( expressed( on( the( BBM( of(
enterocytes(along(the(entire(villus(length,(with(negligible(expression(in(crypts.(This(
pattern(of(expression(has(been(shown(in(the(intestine(of(other(mammalian(species.(
SGLT1( protein( was( detected( as( a( 73=75( kDa( immunoreactive( band( in( BBMVs(
isolated(from(intestinal(tissue(of(suckling(and(weaned(pigs.( In(suckling(pigs,(SGLT1(









By( assessing( whole( body( and( small( intestinal( parameters,( STZ=induced(
diabetic(rats(had(body(weight(loss(by(1.3=fold,(compared(to(control(rats.(However,(
the(small(intestine(of(diabetic(rats(was(increased(in(weigh(and(length(by(2.7(and(1.2(
fold,( respectively.( Moreover,( villi( in( the( intestine( of( diabetic( rats( were( 1.2( fold(
longer(than(those(of(controls.(
Generally,( the( activities( of( intestinal( BBM( enzymes( (maltase,( sucrase( and(
alkaline( phosphatase)(were( increased( in( diabetic( rats( compared( to( controls,(with(
more(significant(changes( in( the(mid(and(distal( intestine.( In( the(proximal,(mid(and(
distal( intestine(of(diabetic(rats,(maltase(activity( increased(by(1.1,(1.6(and(2.5(fold,(
respectively,( and( sucrose( activity( was( higher( by( 1.1,( 2( and( 3.3( fold,( respectively,(
compared( to( that( in( controls.( However,( alkaline( phosphatase( was( significantly(






SGLT1( protein( was( expressed( on( the( BBM( of( enterocytes( along( the( entire(
villus(length(in(the(proximal(intestine(of(both(control(and(diabetic(rats.(Interestingly,(
in( the(mid( and( distal( intestine,( SGLT1( expression( on( the( BBM(was( limited( to( the(
upper( villus( region( in( control( rats,( whereas,( was( extended( to( the( lower( villus( in(




SGLT1( mRNA( levels( increased( significantly( by( 2,( 2.2( and( 2.3( fold( in( the(
proximal,( mid( and( distal( intestine,( respectively,( in( diabetic( rats( compared( to(
controls.(SGLT1(protein(abundance(was(higher(by(1.5,(1.4(and(2(fold(in(the(proximal,(
mid(and(distal( intestine,(respectively,(of(diabetic(rats(compared(to(controls.(SGLT1(
function( (D=(glucose( transport( rate)(was(enhanced(by(2,(3.3(and(3.5( in( the(BBMV(























3) Recruitment(of( additional( sugar( carriers,( SGLT1,(on( the(BBM(of( relatively(
premature(enterocytes(that(do(not(normally(transport(glucose.((
(






Maltase( activity,( a( BBM( digestive( enzyme,( was( higher( in( the( duodenum( of(
diabetic( patients( by( 2.1( fold( compared( to( that( in( non=diabetic( controls.( SGLT1(
mRNA(expression(was(increased(by(2.7=fold(in(the(duodenum(of(diabetics(compared(
to( that( in(non=diabetics.(SGLT1(protein(was(expressed(on( the(BBM(of(enterocytes(
along( the( entire( villus( length( in( the( duodenum(of( both( diabetic( and( non=diabetic(
individuals,( with( relatively( stronger( staining( on( the( BBM( lining( the( villi( of( the(
diabetic(intestine.(However,(no(expression(was(detected(in(the(crypts.((
(
Unfortunately,( SGLT1( protein( abundance( in( the( duodenum(of( diabetics( and(
controls(could(not(be(estimated,(as(there(were(difficulties(in(the(immunoblotting(of(
SGLT1( protein,( which( might( be( due( to( protein( degradation( in( some( samples( of(




Previous( work( in( our( laboratory( revealed( that( the( increased( abundance( of(
glucose( transporters,( SGLT1,( is( greater( by( twofold( than( the( increase( in( the(
structural( proteins( (villin( and( β=actin)( and( BBM( disaccharidases( (sucrase( and(













Work( in( this( chapter( assessed( changes( in( the( expression( of( some( key(
components( involved( in( the( mechanism( underlying( the( regulation( of( SGLT1(
expression(in(the(intestine(of(diabetics(and(controls.((
In( humans( and( rats,( the( glucose( receptor( subunits( T1R2/T1R3( protein( was(
only( expressed( in( the( enteroendocrine( cells,( with( no( change( in( the( number( of(
expressing( cells( between( controls( and( diabetics.( No( significant( change( of( T1R3(
mRNA(in(the(intestine(of(control(and(diabetic(rats.(No(changes(seen(in(proglucagon(
gene(mRNA(expression( (encoding( for(GLP=2)(between(the( intestine(of(control(and(
diabetic(rats.(
(
In( control( rats,( exposure( of( intestinal( tissue( to( high( (10%)( glucose(
concentrations(evoked(significant(GLP=2(secretion,(which(was(higher(by(1.4(and(1.6(
fold(in(the(mid(and(distal( intestine(in(response(to(high((10%)(glucose(compared(to(
low( glucose.( In( contrast,( proximal( intestine( did( not( respond( to( glucose(
concentration.( In( diabetic( rats,( intestinal( GLP=2( secretion(was( higher( than( that( in(
controls,( which( was(more( significant( in( the(mid( and( distal( region.( However,( this(
increase( was( not( affected( greatly( by( glucose( concentration.( In( response( to( low(
glucose,(GLP=2(release(was(significantly(higher(in(the(diabetic(intestine(compared(to(
controls(by(1.2,(1.6(and(1.9(fold(in(the(proximal,(mid(and(distal(regions,(respectively.((
While,( in( response( to( high( glucose,( it( was( higher( by( 1.2,( 1.4( and( 1.4( fold( in( the(




In( humans,(VIP(mRNA( expression(was( significantly( higher( by( 2.3( fold( in( the(
duodenum( of( diabetic( patients( than( that( in( non=diabetic( individuals.( In( rats,( VIP(
mRNA(expression(was(significantly(higher(by(2.1,(2.5(and(2.3( fold( in( the(proximal,(
mid(and(distal(intestine,(respectively,(of(diabetics(compared(to(controls.(VIP(protein(
expression(was( higher,( in( the( nerve( fibres( of( submucosal( and(myenteric( plexuses(
and(the(lamina(propria(of(villi,(in(the(intestine(of(diabetic(rats(compared(to(controls.(
PACAP( mRNA( expression( was( significantly( increased( in( the( diabetic( intestine(
compared( to( controls( by( 2.5,( 2.6( and( 2.1( fold( in( the( proximal,( mid( and( distal(
intestine,(respectively.((((
(
mRNA( expression( of( TAC1( gene,( encoding( substance( P,( was( lower( in( the(
intestine( of( diabetic( rats( compared( to( that( of( controls.( These( data( confirm( that(
exposure( of( absorptive( enterocytes( to( VIP( and( PACAP,( but( not( substance( P( (SP),(
enhances( SGLT1( expression,( as( shown( in( previous( work( done( in( our( laboratory.(











on( the( BBM.( The( key(molecules( increase( the( stability( of( SGLT1(mRNA( leading( to(




of( rats( is( different( from( that( of( human( subjects,( as( demonstrated( in( the(diagram(
below;(this(could(be(due(to(different(species(or(different(type(of(diabetes.((
(
((((((((Human*duodenum** * * * Rat*mid*and*distal*intestine:*






















function( plus( the( immunohistochemical( expression( of( SGLT1( protein( along( the(
crypt=villus(axis( in(different(animals(with(type(II(diabetes(mellitus.(Furthermore,(to(
identify( the( involved( molecules( underlying( the( enhanced( expression( of( SGLT1( in(
those(diabetic(models,(as(well(as(the(morphometric(changes.((
It(would(be(worthwhile(to(use(intestinal(tissues(of(mice(with(type(II(diabetes(






Further( investigation( is( needed( to(understand( the(underlying(mechanism(of(
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